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XXXII Cycle 
This thesis is focused on the fabrication and characterization of biopolymeric microbeads and on their 
application in the field of micro-engineered soft tissues. The development of techniques to create and use 
micro-structured hydrogels (granular hydrogels) has enabled the generation of cell cultures with an in 
vivo like architecture. Specifically, the work has been focused on in vitro models of central nervous 
system (CNS). Chapter 1 describes the transition from 2D to 3D in vitro models, underlining the 
importance of 2D model as a gold standard for many patophysiological studies, and pointing out the 
advantages of a 3D model in order to better mimic the in vivo tissue.  In particular, different techniques 
to fabricate microbeads and the advantages that make them well suited for clinical application are 
reported in this chapter. A detailed description of the brain extracellular matrix, the model of the 
development of a neuronal cell in a 2D standard culture and the importance to develop a 3D neuronal 
model, are provided in Chapter 2. In Chapter 3 it has been demonstrated that Chitosan possesses 
excellent processability, film forming properties and more importantly bioactivity towards all neuronal 
populations. In Chapter 4 the fabrication of chitosan microbeads by dripping technique, and their use to 
create a soft 3D scaffold able to support the development of a neuronal network with an in vivo like 
morphological and electrophysiological activities, is described. To validate chitosan microbeads as a 
proper candidate in tissue engineering of CNS, the degradation of chitosan microbeads-based scaffold 
coupled with neuronal cells was carried out and reported in Chapter 5. An alternative microbeads 
fabrication method, based on microfluidic approach, is provided in Chapter 6; in this chapter, an 
innovative method to convert protein-based GelMA microbeads into powders is described. This approach 
allowed to preserve physical and chemical properties of macromolecules, decreasing contamination, 
facilitating the shipment and decreasing processing energy and cost. On the overall, this thesis highlights 
that biopolymeric microbeads represent a great opportunity to create 3D hydrogel-based scaffold which 
support different types of cell cultures with more biological functionality and architecture, as concluded 
in chapter 8. 
ABSTRACT 
 The increase of different types of cell cultures, which can be used for the in vitro studies of 
physiological and/or pathological processes, has introduced the need to improve culture techniques 
through the use of materials and culture media that promote growth, recreating a cellular micro-
environment that can be asserted in in vivo condition. Therefore, it is important to design and develop 
new biologically sustainable methods, such as to contribute to the “closer-to-in vivo” condition. 
 In particular, the design of a 3D in vitro model of neuronal culture is an important step to better 
understand the mechanisms of cell-cell communication, synaptogenesis and neurophysiological circuits. 
In order to mimic the ECM environment, a granular, porous and soft structure is preferred in the design 
of an artificial neural network. The granular structure is preferred due to the fact that CNS tissue seems 
to be organized as a greater proportion of the microscale tissue, that can be thought of as granular. For 
this reason, the thesis is focused on the production and characterization of bipolymeric microbeads as a 
3D scaffold for soft tissue engineering. 
The biopolymer Chitosan is presented as an alternative adhesion factor and support for 2D and 
3D neuronal cell cultures. Chitosan is a copolymer of glucosamine and N-acetyl-glucosamine, obtained 
by the deacetylation of chitin; it is well known for its low-cost, biocompatibility, biodegradability, muco-
adhesiveness, antibacterial activity as well as its bioaffinity. Chitosan backbone shows positive charges 
of primary ammines that favor the electrostatic interactions with the negatively charged cell membranes 
promoting cell adhesion and growth. 
The standard studies focoused on the development of nervous system, have been performed using 
traditional monolayer culture onto supports modified by extracellular matrix components or synthetic 
biopolymers such as poly-ornithine and poly-lysine which are expressed at stages critical for neuronal 
differentiation in situ and are functional in neurite outgrowth in vitro, acting as adhesion proteins. 
Morphological and functional characterization of 2D neuronal culture grew up onto chitosan susbtrates 
are carried out and compared with the gold standard reported in literature, in order to validate the ability 
of chitosan to support neuronal adhesion, networks development and the differentiation capacity. 3D 
cultured neurons on chitosan microbeads based-scaffold, showed a structural development of a functional 
network that are more representative of the in vivo environment.  The studies reported in this thesis, 
successfully demonstrate the alternative use of the polysaccharide chitosan as adhesion factor and as a 
structural component for 2D/3D neuronal cultures. Definitely, thanks to its low cost and versatility, it 
could be easily functionalized for the fabrication of personalized of in vitro models. 
 In this thesis, a new technology to converts monodisperse microbead hydrogels to fine powders, 
is reported. Microengineered emulsion-to-powder (MEtoP) technology generates microgels with all the 
molecular, colloidal, and bulk characteristics of fresh microbeas upon resuspension in aqueous media. 
GelMA microbeads are fabricated by microfluidic technique, that is one of the most effective techniques, 
and allows precise tuning of the compositions and geometrical characteristics of microbeads.  
Gelatin-methacryloyl (GelMA) is a semi-synthetic hydrogel which consists of gelatin derivatized with 
methacrylamide and methacrylate groups. These hydrogels provide cells with an optimal biological 
environment (e.g., RGD motifs for adhesion) and can be quickly photo-crosslinked, which provide shape 
fidelity and stability at physiological temperature. 
MEtoP technology is based on protecting the dispersed phase of an emulsion to preserve its 
physical and chemical cues during harsh freezing and lyophilization procedures. This technology avoids 
the persistent problems of colloids, including difficulty in sterilization, bacterial and viral contamination, 
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Figure 1.1 (A) 2D cell culture, (B) 3D cell culture (Reprinted from Baker, B. M. & Chen, C. S [46]). 
 
Figure 1.2 Different droplet production processes by dripping, spraying and microfluidic device. Simple 
dripping, electrostatic extrusion, coaxial flow, vibrating nozzle, jet cutting and spinning disk (Reprinted 
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Figure 1.3 Schematic illustration of emulsion techniques in microfluidic devices A) single (W/O), B) 
double (W/O/W) and C) triple (W/O/W/O) emulsions. 
 
Figure 1.4 Schematic illustration of various channel geometries, A) cross-flow, B) co-flow, C) flow-
focusing, D) step-emulsification channel arranged with four parallelized drop markers. 
 
Figure 2.1 Distinct modulus of human tissues suggesting tissue-specific stiffness. Different tissues with 
their specific elastic modulus in the body are correlated with their functions (Reprinted from Cox et al., 
[100]). 
 
Figure 2.2: Extracellular matrix in brain. The extracellular matrix (ECM) in the brain is divided into 
three major components. The basement membrane (basal lamina) which lies around the cerebral 
vasculature, the perinueonal net which surround neuronal cell bodies and dendrites, and the neural 
interstitial matrix which are diffusely distributed between cells in the parenchyma. The blue, purple, and 
yellow cells depict astrocytes, microglia, and neurons, respectively (Reprinted from Kim Y. et al, [103]). 
 
Figure 2.3 Perineuronal nets (PNNs). Brain stained with microtubule-associated protein 2 (MAP2) 
(green) and Wisteria floribunda agglutinin (WFA) (red) (A). Model of PNNs (B). Hypothetical PNN 
ternary complex of tenascin, chondroitin sulfate proteoglycans (CSPGs) and hyaluronic acid (HA), 
(Reprinted from Bonneh-Barkay D et al, [101]). 
 
Figure 2.4 Major brain proteoglycans. Proteoglycans consists of a protein core decorated with 
unbranched sulfated glycosaminoglycan sugar chains. CSPG core proteins are decorated with one or 
more chondroitin sulfate sugar chains. Based on the core protein they are classified into lecticans (which 
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includes neurocan, brevican, versican, and aggrecan), phosphacan, and NG2. HSPGs are decorated 
with HS chains. Syndecans are transmembrane proteins, while glypicans are anchored to the cell 
membrane with a GPI linkage. Decorin is a secreted proteoglycan with dermatan sulfate side chains 
(Reprinted from George N et al, [104]). 
 
Figure 2.5 Chemical structures of poly-ornithine and poly-lysine. 
 
Figure 2.6 Stages of development of hippocampal neurons in culture (Reprinted from Dotti et al, [124]). 
 
Figure 2.7 Schematic depiction of the neural environment. (a) Spatial arrangement of the brain tissue 
compartments (cyan cells = neurons, purple cells = astrocytes, zoom-in subplot: ECM = a net-like cover 
attached to the surface of neural cells. (b) Enlarged view of the zoom-in subplot of the brain ECM in (a). 
The net-like cover = hyaluronic acid (HA) secreted by cells acting as a trestle for the ECM net-like 
structure. The penniform objects crossing the gaps between the HA chains = glycoproteins. Orange 
triple-circle = tenascin linking glycoproteins up. Multicoloured single circles = components of 
interstitial fluid (ISF), e.g., water molecules (H2O), extracellular vesicles (EVs), matrix metallopeptidase 
(MMP), glucose (Glu), dopamine (DA), and tissue plasminogen activators (tPAs). This figure is reused 
and reprinted from Progress in Neurobiology, Lei and co-workers. (Reprinted from Mahumane G.D. et 
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Figure 3.1 Chemical structure of chitin and chitosan. 
 
Figure 3.2 Banker’s model, neuronal stages’ development from 0 to 7 DIV (Reprinted from Dotti et al, 
[124]. 
 
Figure 3.3 Set-up airbrush. 
 





Figure 3.5 FT-IR spectra of CHITO samples neutralized in NaOH solution at different molarity, a) pure 
chitosan (blue), 2% CHITO in NaOH 0.8 M (red), 2% CHITO in NaOH 0.25 M (pink), 2% CHITO in 
NaOH 0.1 M (yellow). The spectrum of the reference KBr was subtracted from each samples. 
 
Figure 3.6 FT-IR spectra of CHITO samples cross-linked with genipin; 1 % CHITO in NaOH 0.25 M 
(blue), 1% CHITO in NaOH 0.25 M cross-linked in genipin (red). The spectrum of the reference KBr 
was subtracted from each sample. 
 
Figure 3.7 Optical images of 1% CHITO films obtained with different sprayed layers A) 1L, B) 3L, C) 
6L and D) 10L; E-F) 1% chitosan-3L onto active area of MEA. Scale bar: 50 µm. 
 
Figure 3.8 Optical contrast phase images of 2D neuronal network: (A) 2% CHITO film untreated with 
a. p. at DIV 15; (B) 2% CHITO film treated with a. p at DIV 15; (C) petri dish untreated with a. p. at 
DIV 15; (D) 2% CHITO untreated film labeled for Tubulin-bIII (green) and NeuN (red) at DIV 25; Scale 
bar: 50 µm. 
 
Figure 3.9 (A) Neurons grown for 25 DIV on CHITO film marked for the pre-synaptic antibody vs 
Synapsin (green) and NeuN (red); Scale bar: 20 µm. (B) Neurons grown for 25 DIV on CHITO film 
marked for vesicular GABA transporter, VGAT (red) and vesicular glutamate transporter, VGLUT 
(green); Scale bar: 50 µm. 
 
Figure 3.10 Optical contrast phase images of 2D films neuronal network at DIV 15, CHITO film 
untreated with adhesion proteins (a.p.), (left); CHITO-Genipin film untreated with a.p.(middle); CHITO 
membrane coated with a.p. (right); Scale bar: 50 µm. 
 
Figure 3.11 Immunostaining for GFAP and NeuN to distinguish the two different populations. (A) The 
population of neuron and glia at DIV 3, 7, 15 and 21. (B) Percentage variation of glia vs neurons at DIV 
3,7,15,21. 
 
Figure 3.12 Optical images of hippocampal neurons at 4h and 24 on CHITO at 0.01% (A-B), 0.05 % 




Figure 3.13 Plating efficiency, n° neurons adhered after 4h and 24h on different CHITO concentrations 
substrates and poly-ornithine. There is nt signgnificant statistical differences between the two substrates 
at different time points. 
 
Figure 3.14 Stages of neuronal development, A-D) Optical images of hippocampal neurons at 4, 24, 48, 
72 hours on spray coating 1% CHITO 1L and onto PORN (E-F). Scale bar: 50μm. 
 
Figure 3.15 Time dependence of the effects of substrate-bound chitosan on neurite lengths. Cells were 
maintained for 4, 24, 48, 72hr in culture, and the length of all neurites of process-bearing cells was 
measured for neurons on the control substrate (PORN) and on chitosan (CHITO). Results show the 
number of neurites per cells (A), the average lengths of all neurites (B), the average lengths of major 
neurites per cell (C), the total lengths of minor neurites (C). 
 
Figure 3.16 A-E) Hippocampal culture development on spray-coating chitosan staining for MAP-2 
(green) and TAU (red) at 4, 24,72 hours 5 and 7 days in vitro; F-L) hippocampal culture development 
on PORN staining for MAP-2. 
 
Figure 3.17 2D neuronal network on CHITO patterned film, Hippocampal culture development on 
spray-coating chitosan patterned film staining for MAP-2 (green) and GFAP (red). Scale bar:500 µm. 
 
Figure 3.18 (A) Number of active electrodes (hippocampal culture), (B) number of active electrodes 
(cortical culture), (C) Neuronal culture development on CHITO substrate on MEA staining for MAP 2 
(green) and NeuN (red) at DIV 24, scale bar: 20 µm; (D) Comparison of mean firing rate between 2D 
neuronal networks developed on CHITO and PORN substrates at DIV 22, (E) Comparison of mean 
bursting rate between 2D neuronal networks developed on CHITO and PORN substrate at DIV 22. (F) 
Neuronal culture development on CHITO substrate on HD-MEA staining for MAP-2 (green) and NeuN 
(red) at DIV 24, scale bar: 50 µm. 
 
Figure 3.19 Spontaneous activity characterization of hippocampal cultures: (A) Raster plot showing 10 




Figure 3.20 Comparison of the effects of substrates, CHITO, PORN and poly-lysine on the length of 
major neurites. 
 
Figure 3.21 Chemical structures of Chitosan, poly-ornithine and poly-lysine. 
 
Figure 4.21 Nisco Encapsulation Unit VAR J30. 
 
Figure 4.22 Covalent crosslinking of CHITO cross-linked with genipin. 
 
Figure 4.23 Set-up configuration, (A) Micro-electrode arrays (MEAs) made up of 60 planar 
microelectrodes (TiN/SiN, 30 mm electrode diameter, 200 mm spaced) arranged over an 8 X 8 square 
grid with inserted PDMS (internal diameter 5 mm) constraint on the active area; (B) 3D CHTO scaffold 
macroscale assembly onto MEA labeled for MAP-2. 
 
Figure 4.24 Characterization of CHITO microbeads, (A) Histogram of the distribution of 1% CHITO 
microbeads size; (B) Histogram of the distribution of 2% CHITO microbeads size; (C) Topography AFM 
image (second order flattened) of 15 X 15 mm2 of a single 2% CHITO microbeads in culture medium, 
the insert shows the profile of the raw data from a single line (blue line); (D) Stiffness values measured 
by AFM on 1% and 2% CHITO microbeads. 
 
Figure 4.25 Three representative AFM force-distance curves taken on 1%, 2% CHITO microbeads, and 
a reference hard surface, respectively, using a the same tipless cantilever. Both approach-loading and 
retract-unloading portions of the curves are plotted (black and red lines, respectively). A rather constant 
slope in the region after contact can be clearly observed for all curves. The lower slope when pressing 
against a CHITO microbead indicates that the bead deforms under the applied load. Such deformation 
can be calculated at any given force as indicated in the graph. 
 
Figure 4.26 FE-SEM images, (A) 1% CHITO microbead, scale bar: 20 μm; (B) 2% CHITO microbead, 
scale bar: 5 μm; (C) CHITO-genipin microbead, scale bar: 10 μm. (D) 1% CHITO microbeads, Scale 
bar: 100 μm; (E) zoom of 1% microbead surface, Scale bar: 2 μm; (F) 2% CHITO microbeads, Scale 




Figure 4.27 Low-mag TEM micrograph of a portion of chitosan scaffold with the neuronal network, (A) 
CHITO microbeads are marked with the asterisks, while cells appear darker, the dark arrow highlight a 
glial cell. (B) A neuron grown between two microbeads (1000x). The dark arrows indicate dendrites 
inside the chitosan. (C) A detail (2500x) of the interface cell-CHITO microbeads. Synapses are marked 
with the letter s. (D) High-mag (15000x) detail of dendrites taken far (15 mm) from the bead surface. 
 
Figure 4.28 Confocal microscope images of 3D neural network at DIV 25: (A) 3D neural network on 
2% CHITO microbeads (left), single 2% CHITO microbead surrounded by almost six neurons (middle) 
and a section of 3D neural network on 2% CHITO microbeads (right), MAP-2 (green) and Synapsin 
(red). (B) 3D neuronal network on glass microbeads (left), single glass microbead surrounded by five 
neurons (middle) and a section of 3D neural network on glass microbeads (right), MAP-2 (green and 
red). The blue arrows point the cell soma while the white one points neuritic fragmentation. (C) 3D 
neural network on 2% CHITO microbeads (left) labeled for MAP-2 (green), Tubulin βIII (red) and DAPI 
(blue), 3D neural network on 2% CHITO microbeads (right) labeled for Synapsin (green). 
 
Figure 4.29 Optical images of glial cells labeled for GFAP (DIV 25): (A) 2D network on CHITO film; 
(B) 3D network on 2% CHITO microbeads; (C) 2D network on petri dish. The white arrows point CHITO 
microbeads. 
 
Figure 4.30 Max intensity projection, Orthogonal View and Rendering 3D of population neurons 
network on the scaffold labeled (DIV 24) for MAP-2: Cross-sectioning along different axes XZ (A), 
XY(C), YZ (D); (B) Volumetric representation (XYZ) of neuronal networks from the same sample. 
 
Figure 4.31 Spontaneous activity characterization, A) 10 s of raw data recorded from a single 
microelectrode. Raster plot showing 300 s of spontaneous activity of 3D network on (B) CHITO 1% 
microbeads and(C) on glass bead; (D) mean firing rate, (E) percentage of random spiking activity, (F) 
mean bursting rate, (G) mean burst duration, (H) network bursting rate, network bursts duration. 
(Kruskal-Wallis, *p < 10_3). 
 
Figure 5.1 Catalytic action of the chitosanase of subclass I. 
 
Figure 5.2: Catalytic action of the chitosanase of subclass II. 
X 
 
Figura 5.3 Structure of GH46 (reprinted from Shoko Shinya et al. [215]). 
 
Figure 5.4 β-Glucosidase action mechanism. 
 
Figure 5.5 Optical images of 2% CHITO microbeads exposed to 25 µl of Chitosanase solution at (0.5 
U/ml). A) 0h, B) 6h, C) 24h, D) 48h, E) 6 days. Scale bar: 100 µm. 
 
Figure 5.6 Optical images of 2% CHITO microbeads exposed to 25 µl of Chitosanase solution at (1 
U/ml). A) 0h, B) 6h, C) 24h, D) 48h, E) 6 days. Scale bar: 100 µm. 
 
Figure 5.7 Optical images of 2% CHITO microbeads treated following the first protocol in three 
different conditions at the last step of the protocol (A) β-glucosidase (50 µl), (B) β-glucosidase (50 µl) 
+ Chitosanases (25 µl), (C) β-glucosidase (25 µl) + Chitosanases (25 µl), at different time points 1) 0h, 
2) 6h, 3) 12 h, 4)24 h and 5) 48h h. Scale bar: 100 µm. 
 
Figure 5.8 Optical images of 2% CHITO microbeads treated following the first protocol in three 
different conditions: only β-glucosidase (50 µl), (B) Chitosanases (50 µl) and then β-glucosidase (50 µl), 
(C)) β-glucosidase (25 µl) + Chitosanases (25 µl), at different time points 1) 0h, 2) 6h, 3) 12 h, 4)24 h, 
5) 48h. Scale bar: 100 µm. 
 
Figure 5.9 Optical images of 2D neuronal network. A) 2D neuronal culture not exposed to enzymicatic 
solution; B) 2D neuronal culture immediately after the exposition to the enzymicatic solution; C) 2D 
neuronal culture exposed to enzymicatic solution after 20 DIV. Scale bar: 50 µm. 
 
Figure 5.10 Optical images of 3D neuronal networks on CHITO microbeads based-scaffold exposed to 
enzymes solutions: A) not exposed to enzymicatic solution, B) 24h after the exposition to the enzymicatic 
solution, C) 48h the exposition to the enzymicatic solution and D) 72 h the exposition to the enzymicatic 
solution. Scale bar: 100 µm. 
 
Figure 5.11 Time dependence of the effects of Chitosanase and β-Glucosidase solutions on CHITO 
microbeads. Microbeads were exposed for 12, 24, 48, 72hr and the number of the microbeads not 
degraded was measured. Results show the effect of 50 µl of chitosanase solution after 24h and 50 µl of 
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β-Glucosidase solution after 48h (blue line), 25 µl of chitosanase solutions after 24h and 50 µl of β-
Glucosidase solution after 48h (red line), and chitosanase + β-Glucosidase solution after 48h (black 
line). 
 
Figure 5.12 Time dependence of the effects of Chitosanase and β-Glucosidase solutions on CHITO 
microbeads after 19 in incubator at 37°C. Microbeads were exposed for 12,24, 72hr and the number of 
the microbeads not degraded was measured. Results show the effect of the only 50 µl of β-Glucosidase 
solution (pink line), 25 µl of chitosanase + 25 µl of β-Glucosidase solutions after 24h (red line), and 50 
µl of β-Glucosidase solution after 24h (blue line). 
 
Figure 6.1 MEtoP technology to convert microfluidic-enabled hydrogel particle emulsions to powders. 
A)  parallelized step emulsification device was used for the high-throughput fabrication of GelMA 
polymer microbeads. B) Procedure to convert emulsion microbeads in powder. 
 
Figure 6.2 Comparison between the powders produced via the MEtoP technology and conventional 
freeze-drying. A) Schematic of individual beads produced via the MEtoP technology compared to those 
yielded through the conventional freeze-drying. C) The average size of GelMA aerogel beads obtained 
from the MEtoP technology showing that regardless of polymer concentration (7−20%), the bead size is 
uniform and depends only on the initial microgel size. SEM images of GelMA beads post conventional 
lyophilization (D) and MEtoP processing (E). 
 
Figure 6.3 Effect of freeze-drying on GelMA microbeads converted to powders via the MEtoP method. 
Powder GelMA obtained from microgels including (A) 7% w/v, (B) 10% w/v, and (C) 20% w/v of 
polymer. The freezing process was conducted (1) at -80 °C followed by 5 min of liquid N2-assisted 
freezing or (2) without the liquid N2 freezing step. 
 
Figure 6.4 Swelling recovery of beaded GelMA powders produced via the MEtoP technology compared 
with the conventional method. (A) The swelling time-lapse of powder particles obtained from the MEtoP 
and conventional methods. (B) The diameter of GelMA beads produced via the MEtoP method 




Figure 6.5 Effect of freeze-drying on the swelling recovery of GelMA microbeads prepared via the 
MEtoP method. Panels show the rehydration dynamics of powder GelMA obtained from microgels 
including (A) 7% w/v, (B) 10% w/v, and (C) 20% w/v of polymer. The freezing process was conducted 
with or without liquid N2-assisted post-freezing.  
 
Figure 6.6 Annealing capability of hydrogel beads (GelMA) prepared using the MEtoP technology or 
conventional lyophilization. (A and C) Optical images of hydrogel beads prepared via the conventional 
method and MEtoP technology.  (B- D) Exposure to UV light in the presence of a photoinitiator (PI). 
 
Figure 6.7 Microstructure and mechanical strength of annealed hydrogels obtained from the MEtoP 
powders. Self-standing hydrogels may readily be constructed by annealing resuspended (A) 7, (B) 10, or 
(C) 20% GelMA beads, obtained from the METoP technology. Bright-field images of hydrogels in panels 
A−C are presented in panels D−F, respectively, which show packed structures made up of spherical 
beads. Two-dimensional (2D) slices of annealed beaded hydrogels obtained from confocal fluorescence 
microscopy show that regardless of the polymer concentrations (G: 7%, H: 10%, and I: 20%), the beads 
are able to make microporous structures. Analysis of 2D slices among the annealed beads with GelMA 
concentrations (J) ∼7, (K) 10, and (L) 20%. (M) Median pore diameter of annealed beaded GelMA 
scaffolds versus pre-UV exposure incubation time. (N) Void space fraction for beaded GelMA scaffolds 
prepared using varying biopolymer concentration and precross-linking incubation time. (O) The 
compression moduli of beaded scaffolds. pValues lower than 0.05 (*p < 0.05), 0.01 (**p < 0.01), 0.001 













Table 1.1 Advantages and disadvantages of hydrogels as tissue engineering matrices, Reprinted from 
Wasupalli G.K., Verma D. Polysaccharides as biomaterials [65]. 
 
Table 2.1 Extracellular matrix (ECM) components. Abbreviations: PNN = perineuronal net; CSPG = 
chondroitin sulfate proteoglycan; Abbreviations: PNN = perineuronal net; CSPG = chondroitin sulfate 
proteoglycan; GAG = glycosaminoglycan; CNS = central nervous system; GPI = glycosyl 
phosphatidylinositol; HSPG = heparan sulfate proteoglycan; FGF = fibroblast growth factor; VEGF = 
vascular endothelial growth factor; HB-GAM = heparin-binding growth-associated molecule; bFGF = 
basic fibroblast growth factor; TGFβ = transforming growth factor β; LTP = long-term potentiation; 
MMP = matrix metalloproteinase; TIMP = tissue inhibitors of metalloproteinase; tPA = tissue 
plasminogen activator; ADAMTS = A disintegrin and metalloproteinase with thrombospondin motifs; 
PDGF = platelet-derived growth factor; (Reprinted from Bonneh-Barkay D et al, [14]). 
 
Table 3.1 Average growth rate in µm/h. 
 




















1.1 Importance of in vitro models 
Tissue engineering (TE) was defined as “an interdisciplinary field which applies the principles of 
engineering and life sciences toward the development of biological substitutes that restore, maintain, or 
improve tissue function” [1]. The aim of TE is design, develop and fabricate an in vitro models of healthy 
or pathological tissues and organs, which can be employed for drug screening and the evaluation of new 
therapies, as well as the investigation of the complex phenomena regulating disease onset and 
progression.  
The complexity of in vivo tissue organization allows cells to interact with each other and with the 
surrounding extracellular matrix (ECM). The extracellular matrix (ECM) is the non-cellular component 
of tissues and is comprised of a combination of polysaccharides, growth factors, and proteins including 
collagen, fibronectin, laminin, and elastin. The physico-chemical characteristics of the ECM play a 
fundamental role in regulating relevant physiological cellular processes and in different pathological 
situations [2, 3]. The TE idea is based on the combination of living cells with a natural, synthetic, or 
bioartificial support to develop a biological substitute or a 3D living construct that is structurally, 
mechanically, and functionally equal to a real tissue [4].  To date, most in vitro functional studies have 
been performed using oversimplified traditional monolayer cultures. However, in the last few years, a 
large number of research groups have been focusing on the setting up of cellular models which mimic 
the in vivo microenvironment [5, 6]. This approach has proven to be essential to gain information on 
pathological processes like cancer, where cell-cell and cell-microenvironment interactions play a major 
role [7]. The availability of 3D culture platforms, specifically designed to mimic different tissues towards 
the development of organ-on-a-chip [8], is expected to have a strong impact not only in the study of 
physiological and pathological processes, but also in drug screening and in toxicity assays [3, 9-13]. 




(developmental/regenerative) and bottom-up (compartmentalized) approaches.  Top-down or 
regenerative approaches involve encapsulation of cells within a substrate and allowing them to 
spontaneously form structures within the soft substrata in which the cells are able to degrade and 
reconstruct. Cells are cultured on scaffolds specifically designed to mimic the tissue to be modeled in 
terms of structure, composition, and mechanical properties. Bottom-up is the methodology that include 
firstly, the design of the scaffolding structure and then seeding it with the cells, adding biochemical 
components into the preformed structures. That is, all of the factors are assembled into specific spatial 
coordinates at specific time points. These modular scaffolds can be obtained through both 
microencapsulation and microfabrication techniques as well as employing traditional cell culture 
strategies [14]. The model should be properly designed to recapitulate the particular conditions that are 
intended to be mimicked. Mimic a tissue is extremely complex since several aspects must be taken into 
account and each single tissue has different features. In this context, the fundamental elements that should 
be considered are (I) scaffolds, (II) cell sources, and (III) chemical and physical stimuli.  
The basic requirements for designing scaffolds based on polymeric components are as follows: 
1. The surface should permit cell adhesion, promote cell growth, and allow the retention of 
differentiated cell functions 
2. The scaffolds should be biocompatible, neither the polymer nor its degradation by-products 
should provoke inflammation or toxicity in vivo 
3. High porosity with adequate surface area and pore size distribution. This porous architecture 
allows cells migration also in the inner part of the 3D construct and permits nutrient/oxygen 
diffusion and waste removal [15] 
4. Biodegradability with the rate of degradation corresponding to the rate of neotissue regeneration 





The choice of the most appropriate cell source is a challenge in the design and further 
development of a tissue-engineered model. In fact, the development of representative in vitro tissue/organ 
models depends on the availability of tissue-specific cellular phenotypes, able to recapitulate in vitro the 
characteristics of normal or pathological natural tissues. Moreover, the number of cells to be included in 
the model should be carefully considered to guarantee a physiologically relevant 3D replica of the tissue 
functional unit [16]. The in vivo environment guarantees the presence of fundamental molecular cues 
that direct cell behavior, while the vascularization provides nutrient supply and waste removal. In the 
design of a 3D model, it should be considered that cells in the middle of the construct could behave 
differently from cells growing on the surface, depending on nutrients concentration gradient. During the 
design and the development of 3D tissue model, the main problem for the diffusive transport of nutrients 
is the thickness of the 3D structure. To avoid local concentrations and overcome the diffusion limits, that 
affect cell behavior, chemical, and mechanical signals should be coupled [17]. In particular, cells respond 
to dynamic cues, such as electric fields, osmotic and hydrostatic pressure, stress, strain, fluid flow, and 
streaming potential, by modifying the surrounding ECM [18]. Mechanical stimuli are usually provided 
to tissue-engineered constructs by bioreactors specifically designed to reproduce the in vivo conditions. 
In particular, bioreactors provide mechanical or electrical stimuli and allow a fine modulation of culture 
conditions to reach tissue maturation [19,20]. The choice of the most suitable biomaterial for scaffold 
fabrication is a key element for the model design, since it strongly influences cellular functions; should 
be carefully selected depending on the modeled tissue/organ, acting as a synthetic ECM that interacts 
with cells at the molecular level, influencing cell functions and driving the complex cellular processes 
that lead to the development of a valid in vitro engineered tissue model. To replicate in vitro, the 
architecture of the native tissue, i.e., its ECM framework to let cells to adhere, spread, proliferate, 
differentiate, maturate, and produce ECM, similarly to what they do in vivo.  Natural gels are typically 




biocompatible, bioactive, biodegradable, low cytotoxic, injectable and possibly suitable for many 
biomedical applications as they promote many cellular functions. Naturally derived hydrogels can be 
classified in 3 groups: protein-based materials, polysaccharide-based materials, including collagen, silk 
fibroin, hyaluronic acid, chitosan, alginate and those derived from decellularized tissue. Three-
dimensional culture systems for in vitro development of tissue, employing a wide range of scaffold types 
including hydrogels, solid porous polymers, fibrous materials and decellularized tissues as well as 
microfluidic devices and lab-on-a-chip systems. These different types are prepared by different methods, 
which makes it more suitable for the application intended for it, including gas foaming, [21,22] fiber 
extrusion and bonding, [23] three-dimensional printing, [24] phase separation, [25,26] emulsion freeze-
drying, [27] and porogen leaching. [28,29], hydrogel microbeads [30,31]. 
The introduction of these models in the biomedical field may lead to numerous advantages, such 
as the reduction of animal use as well as the overcoming of the limits associated with traditionally 
employed models and the achievement of more reproducible data, thanks to the possibility to tightly 
control the experimental parameters, with lower cost and less time.  
 
1.2 From 2D to 3D in vitro models 
The culture of mammalian cells in vitro provides a defined platform for investigating cell and 
tissues physiology and pathophysiology. Traditionally, this has been done by culturing single cell 
populations on two dimensional (2D) substrates. Experiments whit 2D cell cultures have provided the 
base for the interpretation of complex biological phenomena, including molecular biology, stem cell 
differentiation [32], and tissue morphogenesis [33]. The majority of 2D approaches employ rigid 




do not spread in the same way as cells cultured on 2D substrates, but cells sense the stiffness of their 
environment and modify their shape, proliferation, and stiffness in response.  In vivo, the ECM guides a 
host of cell and tissue level functions including regulation of cellular architecture [34], directing tissue-
specific stem cell specification [35, 36], guiding cell migration [37], maintaining homeostasis [38], and 
influencing tissue development [39-41], including controlling branching morphogenesis [42,43]. One of 
the major function of the ECM is to regulate cell shape and its connectivity to surrounding cells which 
in turn regulates the cellular epigenetic state, gene expression, and function [39,44]. Strategies aimed at 
a closer approximation of tissue dimensionality involve pseudo-three dimensional (3D) or 2.5D 
environments, which aims to reduce the artificial polarity of 2D culture while maintaining the ease on 
the culture manipulation. An example of a pseudo-3D environment is the creation of micro-wells which 
are topographically structured surfaces that comprise a high density of micron sized cavities of a desirable 
geometry. They can be created via curing a gel solution, most commonly polydimethylsiloxane (PDMS) 
or polyethylene glycol (PEG), onto a silicon master [45].  Pseudo-3D platforms are useful for replicating 
higher order dimensionality to study the transition from 2D to 3D, where true 3D materials are difficult 
to yield coherent data on cell-cell and cell-ECM interactions. Pseudo-3D systems have proved a viable 
alternative, and show promise in mapping the differences between 2D and 3D towards translating the 
large number of 2D studies to 3D materials and in vivo systems. While 2D systems can give insight into 
many cellular functions, the addition of a third dimension enables a closer mimic to the in vivo 
environment. The ECM is a hydrophilic 3D micro-matrix whit two major solid structures: collagen fibers 
and proteoglycan filaments. The collagen fibers present as bundles and extend through the interstitium, 
providing the tensile strength and durability for the surrounding tissue. The proteoglycan filaments are 
coiled structures, made from protein and hyaluronic acid which entrapped interstitial fluid, that is a 






Figure 1.1 (A) 2D cell culture, (B) 3D cell culture (Reprinted from 46. Baker, B. M. & Chen, C. S [46]). 
 
Hydrogels scaffold have received a considerable attention due to their unique compositional and 
structural similarities to the natural ECM. From 2D plastic-ware to 3D hydrogels, model systems have 
come a long way in controlling the presentation of biochemical and biophysical cues to cells in culture 
towards elucidating the complex cellular orchestration underlying tissue morphogenesis. The design 
criteria should include both mechanical and physiochemical parameters (such as biodegradation, porosity 
and proper surface chemistry), and biological performance parameters (such as biocompatibility and cell 
adhesion), as well as demonstrating enhanced vascularization.  
Biodegradation: a basic requirement of a scaffold for tissue engineering is to maintain cellular 
proliferation and desired cellular distribution during the life of the scaffold. The rate and extent of 
biodegradation are critical design considerations for hydrogels in tissue engineering. Some tissue 
engineering applications may not require complete scaffold degradation, such as whit corneal 
replacement or articular cartilage. For these types of tissue, semi-permanent or permanent scaffolds may 
be the best choice to replace the basic function of lost or damaged tissue. In general, degradable hydrogel 
scaffolds are developed via incorporating cleavable crosslinks and/or cleavable moieties into the polymer 




digestion. Biodegradable hydrogel scaffolds can also be made by incorporating naturally biodegradable 
ECM components. 
Biocompatibility: the ability of a material to perform with an appropriate host response in a 
specific application. It means that no or very limited harmful immunological, toxic, or foreign body 
responses should take place as a results of regenerative medical intervention. 
 
1.2.1 Hydrogel scaffolds 
One of the most common forms of 3D culture is to encapsulate cells within hydrogel scaffolds 
consisting of different ECM proteins or peptides [47-51]. This technique involves the mixing of cells and 
a liquid gel and allowing the solution to set into the desired shapes. Synthetic polymers are preferred due 
to the ability to control their physical and chemical properties, but they lack the biological activity of 
natural polymers [52]. Hydrogels are used as tissue engineering scaffolds typically because their soft, 
hydrated form resembles that of naturally occurring living tissue. The mechanical properties of hydrogels 
can be tuned and the high water content and highly porous nature of hydrogels allow for facile transport 
of oxygen, nutrients and waste as well as effective transport of soluble factors [53]. An additional 
attraction of hydrogels is their ability to be administered via injection [54]. After injection, they can 
conform to the available space, allowing for uniform tissue regeneration. However, hydrogels have to be 
maintained in a hydrated state, therefore could possibly suffer from long term stability issues in vitro 
[55]. The scaffolds designed may contain pores size suited for living cells accommodation or may be 
regulated to degrade creating pores by releasing growth factors where cell penetrates and proliferates. 
Using hydrogels to mimic in vivo microenvironments has proved useful in deconstructing the 
biochemical and biophysical cues that influence cellular morphology [56-57], proliferation [57-61], 




interconnectivity and decoupling it from the matrix stiffness has tremendously limited the applicability 
of stiff hydrogels for 3D cellular engineering, e.g., in hard tissue engineering. A recent study showed a 
new concept to convert thermosensitive polymers with chemically-crosslinkable moieties into annealable 
building blocks, forming 3D microporous beaded scaffolds in a bottom-up approach and can be quickly 
photo-crosslinked, which provides shape fidelity and stability at physiological temperature [67].  
 
Table 1.1 Advantages and disadvantages of hydrogels as tissue engineering matrices, Reprinted from Wasupalli G.K., 
Verma D. Polysaccharides as biomaterials [65]. 
 
Engineered extracellular matrices have proved useful in decoupling the environmental parameters that 
guide cellular processes, the form and function of tissue. While hydrogels provide excellent scaffolds 
that mimic the natural ECM, they are limited in scale-up because of long term storage issues, stability 
and batch-to-batch variability. Highly porous solid scaffolds can be manufactured in a controlled and 
reproducible fashion, can be appropriately moulded, are inert in structure and have long term stability 







Aqueous environment can protect cells and fragile drugs 
(peptides, proteins, oligonucleotides, DNA) 
 
Can be hard to handle 
 
 
Good transport of nutrient to cells 
and products from cells 
 
Usually mechanically weak 
 
 
May be easily modified 
with cell adhesion ligands 
 
 
May be difficult to load drugs and 
cells and then cross-link 
 
Can be injected in vivo as a liquid 
that gels at body temperature 
 
 









make them ideal for highly interactive 3D cell cultures [52].  In porous scaffolds theoretically, there 
should be deeper and more uniform nutrient transport and also allows cells to freely migrate throughout 
the structure without much resistance. The pores themselves can also limit the size of colonies, which 
when too large can cause cells to become necrotic [52]. The mechanical stability of solid porous scaffolds 
makes them a more practical material for handling, which is difficult with soft hydrogels. The key 
limitations of solid scaffolds however are, firstly, they are typically opaque and have poor light 
transmission properties, making in situ imaging difficult [66]. Secondly, the Young’s modulus of many 
solid porous scaffolds is quite different to that of specific tissue as CNS tissue (0.1–16 kPa) [68] and so 
these scaffolds may not provide realistic tissue and disease models. An array of techniques has been used 
to synthesize solid porous scaffolds, including salt leaching, phase separation, freeze drying, gas 
foaming, emulsion templating and 3D printing [53]. 
Culturing cells in 3D materials more closely recapitulates the in vivo environment, when 
compared to conventional 2D systems; however, most of these materials only offer a static image of what 
is otherwise a dynamic and complex environment.  
 
1.3 Microbeads-based scaffolds 
Cells in the body exist in a 3D microenvironment comprising of proteins and polysaccharides, which is 
defined as the extracellular matrix (ECM). The properties of ECM strongly influence cellular phenotype 
and function. Biocompatible hydrogel microbeads with sizes ranging from 60 to 200 μm are promising 
platforms for in vitro cell culture, as they perform as 3D matrices that can mimic various aspects of the 
ECM [69,70]. Their properties such as stiffness and porosity can be tuned by altering the gel components. 
In addition, the intrinsic porous structure and the high surface-to-volume ratio of hydrogel microbeads 




environment and retaining cell viability. The function of a tissue is typically governed by multiple cues, 
such as intercellular signaling and cell interactions with the surrounding ECMs. Cell-laden microgel 
“modules” carrying different types of cells can be combined or reconfigured to mimic various types of 
tissues.  These applications of microbeads depend on their properties which correlate with their size, 
structure, composition and configuration. Based on the structural prerequisites, one of the main goal of 
the production of microbeads is to ensure accurate control over their macroscopic properties (e.g., 
geometry, mechanical strength, density, porosity) and microstructure (e.g., size, pore interconnection). 
Microbeads with sizes ranging from 1 µm to 1000 µm have great potential in the fields of drug delivery, 
cell biology and biosensors; the small size of the hydrogel microbeads is particularly attractive for 
injectable cell delivery systems in regenerative medicine, as it allows direct delivery of cells through 
needles to the damaged tissue area [72]. This minimizes surgical invasiveness and thus is beneficial in 
practical clinical applications such as drug delivery, tissue engineering, biosensing, and cellular life 
science. Depending on their structure, they can be classified into microcapsules and microspheres.   
Microcapsules: They consist of a central nucleus (containing the drug, in liquid or solid form) 
surrounded by a polymeric membrane (wall) of coating [73]. There are different configurations: 
 Microcapsules with core-shell structure: they are typically composed of solid, liquid surrounded 
by protective shell. 
 Janus microparticles, they have two separate compartments with distinctive physicochemical 
properties which make them appealing for drug delivery, micromotors, and self-assembly. 
 Microparticles with complex structure (multi-core, higher order: The structure of microcapsules 
can be much more diversified by incorporating an additional compartment in the emulsion 
droplet, either in the core or the shell. For example, microcapsules with multi-core components 




can be either separated by a solid shell or have a single Janus core within the shell after UV 
irradiation. 
 Porous microparticles: they can be prepared by introducing sacrificial templates into the 
precursor droplet and subsequently removing them after solidification. In addition, phase 
separation can also be employed to prepare porous microparticles 
 
 
Figure 1.2 Different types of microbeads (Reprinted from Li W et al, 2018, [72]). 
 
Microspheres: They have a monolithic structure, that is they are constituted by a polymeric matrix.  
Microbeads also have a number of specific requirements: 
• chemically inert materials 
• non-toxic 
• sterilizable or not 
• chemically and physically stable 
• good mechanical strength 





The choice of process to be applied depends on the assessment of a number of factors: 
 Nature of the material to be encapsulated, physical state (solid or liquid), 
hydrophilia/lipophilia, thermal stability or pH dependent. 
 Nature of the encapsulation medium: organic or aqueous solvents, gas. 
 Structure of the microbeads to be obtained: microspheres, mononucleus microcapsules, 
multinucleus, etc. 
 Economic: cost/benefit ratio, existence of patents, available equipment and/or technology, 
etc.  
 
In particular, encapsulation can be defined as a process that involves the complete envelopment of 
preselected core material(s) within a defined porous or impermeable membrane using various techniques. 
The techniques used vary depending on the polymer used and the appropriate application [72].  The main 
techniques used in encapsulation can be classified into three main categories such as chemical, 
physicochemical, and mechanical processes.  Chemical processes are those that involving mainly 
polymerization and polycondensation and in which the capsule shell is made by in situ formed polymers. 
The disadvantage is the tendency to form very thin polymer membranes. Physico-chemical process 
involves the formation of the capsule shell form a preformed polymer using processes such as solvent 
removal, gelatin, or coacervation. Mechanical processes produce the polymer shell around the core using 
techniques such as spray drying and spray cooling, dripping and jet break-up techniques. In particular, 






Figure 1.3 Different droplet production processes by dripping, spraying and microfluidic device. Simple dripping, 




     1.3.1 Dripping by nozzle 
The Dripping mode is most widely utilized method due to the high monodispersity of droplets generated.  
The droplets are generated from a polymer extruded through a nozzle, and mechanical means are used to 
increase the normal dripping processes at the orifice of the liquid stream break up when it passes through 




liquid and will be solidified either by a physical or chemical means.  In this mode, the size of droplets 
can be tuned by changing the nozzle size and flow rate of the fluids phases. Other factors influence the 
formation of microgels: the concentration, feeding rate, and surface tension of the polymer solution, 
solvent, temperature, and nozzle diameter [74]. The solidification of the formed microgel particles is 
performed in an additional step. For solidification of the gel, coacervation (either simple or complex) is 
an optimal choice. The formed particles are collected in a solidification liquid (ionic or polymer solution). 
The size and shape control of particles is dependent on various factors. The distance, concentration, 
surface tension of the solidification liquid, and the time of the process have a significance in the particle 
size and the physical properties of the beads (gel strength, porosity, etc.). The most important limitations 
of the extrusion are the viscosity of the polymer because of potential blockage of the nozzle; as such, the 
settings for optimal, narrow particle size distribution, and shape are required. For the scale-up of the 
process, multiple-nozzle solutions have been presented. In particular, the droplets formation is dependent 
on the velocity v of the extruded polymeric solution, surface tension, gravitation, impulse and friction 
force [72]. The extruded solution sticks to the edge of the nozzle until the surface tension is overcome 
by gravitational force that results in the release of the droplet. This mechanism is well known as 
“dripping”. The diameter of the droplet, dd formed during this mechanism can be estimated from 
Equation (1). The balance between the two main force is approximated, the gravitational force is pulling 
the drop down when the surface tension is holding into the tip at the instant of drop detachment. 
Moreover, as seen in the Equation (1), size of the droplets produced with this mechanism is dependent 










dd, = diameter of the nozzle 
σ = surface tension of the extruded liquid 
g = acceleration due to gravity 
ρ =  density of the fluid 
 
The droplet formation is dependent on the velocity v of the extruded liquid, surface tension, gravitation 
and impulse. At very low velocity, single droplets are directly formed at the orifice of the nozzle. 
Increasing the velocity will cause the formation of an uninterrupted laminar jet, which eventually breaks 
by axial symmetrical vibration and the surface tension.  The influence of the parameter can be describing 
by the dimensionless Ohnesorge (Oh) number and Reynolds number (Re): 
 
Re = vdd ρ/η  Equation 1.2 
Oh = η / (ρddσ)  Equation 1.3 
v = velocity of polymeric solution at the point of impact 
η = viscosity of the polimeric solution 
dd, = diameter of the nozzle 
σ = surface tension of the extruded liquid 
ρ = density of the fluid 
 
 
An increase of flow rate (or Re) of a solution at constant Oh will lead the droplet detachment mechanism 
to a transit form dipping to jetting. The transition between dripping and jetting is strongly dependent on 





   1.3.1.1 Electrostatic extrusion 
Electrostatic extrusion is a process that uses electrical forces to overcome the surface tension force ad 
pull the droplet of the orifice. Two main methods can be used, the dripping mode and the jetting mode. 
In the dripping mode, a low current is applied on the polymer solution flowing slowly through the nozzle. 
The electrical force then breaks-up the liquid and monodispersed microspheres between 500-1500 µm 
are obtained. Smaller beads can be produced by increasing the current and using a smaller orifice, 
however an increase in the electric current will lead to a broader size distribution of the beads due to 
splitting of the polymer solution filament into numerous side filament within the intense electric field. 
Increasing velocity, it will bead formation of a stable jet, and a higher electric current will then be 
necessary to break the jet into small droplet. This is the jetting mode, in which small monodispersed 
particles of 1-15 µm can be produced with a high productivity. 
1.3.1.2 Vibrating-jet 
The vibrating-jet techniques, also called vibrating nozzle or prilling is one of the most widely used 
techniques to produce microspheres. The technology is based on the principle that the application of a 
vibration frequency with defined amplitude to the extruded laminar jet will break it into equally sized 
droplets. The vibrational frequency and the jet velocity are the two main parameters to be determined in 
order to achieve optimal droplet formation with a given nozzle diameter. Uniform-sized droplets can be 
obtained with a range of frequencies which depend on the nozzle diameter, the rheology of the fluid and 
the surfaces tension. The vibration system is theoretically based on liquids with Newtonian fluid 
dynamics. When droplets are formed by the break-up of a jet by the vibration method, they are often 
dispersed by a system based on electrostatic repulsion force. Having the droplets flying through on 
electrostatic field after the break-up will charge them, therefore the droplets do not hit each other during 




beads. The electrode potential is in the range of 400-1500 V depending on the droplet diameter, the jet 
velocity, and the geometrical setup. 
1.3.1.3 Jet Cutter and Spinning Disk Atomization 
The principle of the jet cutter is to form a solid jet by pressing the polymer out of a nozzle and then to 
cut it into uniform segments using a cutting tool formed of several wires. The segments then form 
spherical beads due to surface tension, as they fall into the cool medium. The diameter of the resulting 
droplet is dependent on the number of cutting wires, the number of rotations of the cutting tool, the mass 
flow rate through the nozzle, and the mass flow depending both on the nozzle diameter and the velocity 
of the fluid. This method allows the production of beads with a size range of 200 µm up to several 
millimeters, even when using viscous fluids. However, the main disadvantages of this method are the 
loss of material occurring during each cut of the liquid jet, knows as the cutting loss, its inability to 
produce beads smaller than 200 microns and to produce high quantities of beads. 
The principle of spinning disk atomization is to distribute a liquid onto a rotating disk which, due to 
centrifugal forces and wetting ability, disperses into a thin film. The liquid gains in velocity, is 
transported to the disk rim and is spread into droplets, which are thrown off tangentially from the disk 
and form a spray. The size of the drops depends essentially on the rotary speed, disk geometry and liquind 
properties. Once drops are detached, interfacial forces keep the atomized liquid into a spherical shape to 
minimize the specific surface area. According to their size each drop falls at a different distance from the 
disk atomization is a technique that can produce monodispersed, homogeneous, and spherical beads, with 
a narrow size distribution, it can be used different viscosities of liquid solutions and operate under sterile 
conditions. This method has the advantage to be able to produce a large quantity of beads in a short time 
and can be scaled-up easily by increasing the flow rate, the disk size and the rotation speed of the disk. 
However, spinning disk fabrication requires a large surface or volume to collect the produced beads 




Furthermore, to produce small beads, it necessary increase speed; high speeds can cause the disk to 
vibrate and produce of satellites drops.  
 
1.3.2 Spray drying and spray congealing 
Spray drying is widely used in the industry for microencapsulation of volatiles, probiotics, and viable 
cells. Besides the obvious drawback (high loss, low yield), the numerous advantages make this 
technology very popular (uniform particle size, all steps carried out in one apparatus, use of organic 
solvents, the capability of encapsulating heat-labile materials). Depending upon the removal of the 
solvent or cooling of the solution, the two processes are named spray drying and spray congealing 
respectively. The polymer is first dissolved in a suitable volatile organic solvent such as dichloromethane, 
acetone, etc.  This dispersion is then atomized in a stream of hot air. The atomization leads to the 
formation of the small droplets or the fine mist from which the solvent evaporates instantaneously leading 
the formation of the microspheres in a size range 1-100 μm. Microparticles are separated from the hot 
air by means of the cyclone separator while the traces of solvent are removed by vacuum drying and as 
a result, regular shaped, micron-sized, uniform particles are created. The extruded wax particles can be 
solidified using congealing, which offers a solution for embedding hydrophilic component to perform 
sustained release via the slow erosion of the wall in the biological medium.  Very rapid solvent 
evaporation, however leads to the formation of porous microparticles. 
 
1.3.3 Microfluidics in Microparticle Fabrication 
Microfluidics also presents promising results regarding microparticle production [74]. A wide range of 




Droplet microfluidic provides a unique method for fabrication of monodisperse microparticles whit 
control over the size, morphology and functionality, in high throughput manner. This technique also 
allows on-chip encapsulation of various bioactives, such as drugs, cells and other bio-reagents in 
microparticles whit high efficiency, and even direct co-encapsulation of multi-components. These 
advanteges make microfluidically engineered microparticles beneficial for various biomedical 
application including development of innovative delivery vehicles and fundamental studies of cell 
biology. 
 
1.3.3.1 Droplet generation 
An emulsion is a mixture of two immiscible liquids where one liquid is dispersed in an another 
immiscible liquid. The conventional methods for generating emulsions involve droplet breakup using 
shear or impact stresses generated by agitation.  
 Single emulsion technique 
The micro particulate carriers of natural polymers i.e. those of proteins and carbohydrates are prepared 
by single emulsion technique. The natural polymers are dissolved or dispersed in aqueous medium 
followed by dispersion in non-aqueous medium like oil, figure 1.4A. In the next step, the cross linking 
of the dispersed globule is carried out. The cross linking can be achieved either by means of heat or by 
using the chemical cross linkers. The chemical cross linking agents used are glutaraldehyde, 
formaldehyde, acid chloride etc. Heat denaturation is not suitable for thermolabile substances. Chemical 
cross linking suffers the disadvantage of excessive exposure of active ingredient to chemicals if added at 
the time of preparation and then subjected to centrifugation, washing, separation. The nature of the 
surfactants used to stabilize the emulsion phases can greatly influence the size, size distribution, surface 




Double emulsion technique  
Double emulsion method of microspheres preparation involves the formation of the multiple emulsions 
or the double emulsion of type w/o/w and is best suited for water soluble drugs, peptides, proteins and 
the vaccines. This method can be used with both the natural as well as synthetic polymers. The aqueous 
solution is dispersed in a lipophilic organic continuous phase. The continuous phase is generally 
consisted of the polymer solution that eventually encapsulates of the protein contained in dispersed 
aqueous phase. This results in the formation of a double emulsion. The emulsion is then subjected to 
solvent removal either by solvent evaporation or by solvent extraction, figure 1.4B.  
 
Figure 1.4 Schematic illustration of emulsion techniques in microfluidic devices A) single (W/O), B) double (W/O/W) and 
C) triple (W/O/W/O) emulsions. 
 
 
Triple emulsion technique  
Triple emulsion method of microspheres preparation involves the formation of the multiple emulsions or 
the double emulsion of type w/o/w/o, figure 1.4C. The high droplet stability ensures accurate and 
independent control of droplet size and the number of the inner droplets in multiple emulsions. 
Furthermore, triple emulsion droplets can also be prepared by simultaneous breakup of a core-sheath 
stream in a single step without sequential emulsification. One major advantage of this approach is that it 




ultra-thin shells in double emulsion droplets. For both cases, the shell thickness can be reduced to less 
than 1 µm, which is difficult to achieve through sequential emulsification [74]. 
The droplets generation mechanism is a process well-controlled, where various forces acting on 
the fluids flow are balanced. These forces include inertial force, viscous force, interfacial tension and 
buoyancy.  In some case, also external forces are utilized such as electric, magnetic and centrifugal forces. 
The complex phenomenon of droplet breakup is determined by various dimensionless numbers, Capillar 
number (Ca) and Weber number (We), which are related to the fluid properties, channel geometries and 
flow conditions. The Ca represents the relative effect of viscous forces and surface tension, while the We 
number reflects he balance between inertial and surface tension forces.  
The droplet breakup modes ca be applied to various channel geometries including cross-flow, co-flow, 
and flow-focusing. These three device geometries rely mainly on the viscous shear force for droplet 
breakup, figure 1.5. 
 
 
Figure 1.5 Schematic illustration of various channel geometries, A) cross-flow, B) co-flow, C) flow-focusing, D) step-





In cross-flow geometry, also called T-junction, the dispersed phase is sheared in T-shaped junction which 
has an angle θ (0° < θ < 180°) between the dispersed and the continuous phase channels, figure 1.5A. 




the size of the droplets generated is generally larger than 10 µm due to the limitation of the channel 
dimension. 
In the co-flow geometry, also called coaxial junction, the dispersed phase channel is inserted into and 
aligned with the continuous phase channel, and dispersed phase and continuous phase fluids flow in 
parallel through the channels, figure 1.5B. The CV is less than 3% and the size of the droplets generated 
are larger than 10 µm. The flow-focusing mode has a channel geometry similar to the co-flow but has as 
a focus unit that shrinks the fluid passageway, figure 1.5C. There are also geometries that allow 
parallelization of multiple nozzles to obtain high throughput production droplets, figure 1.5D. 
Two dominant types of droplet microfluidic  devices used in generating various types of emulsion 
droplets: one is glass capillary microfluidics that have the advantage of high chemical resistance and 
ideal coaxial flow-focusing which enables preparation of droplets with wide range of material 
compositions and structures; the second one is soft-litographically fabricated poly(dimethilsiloxane) 
(PDMS) devices that have the advantage of preparing a large number of identical devices  with micron-
scale resolution, greater flexibility in the channel design compared to capillary devices, optical 
transparent, biologically inert, permeable to gases, and low in cost fabrication. 
Other microfluidic devices, for example, fluoropolymer-based devices are commonly used in 
systems that involve chemical reactions with long-residence-time due to excellent chemical stability and 
moderate heat resistance. Organic reaction under strongly acidic and basic conditions ca be carried out 
in perfluoropolyether (PFPE) devices even at elevated temperatures. Quantum dots can be synthesized 
using the polytetrafluoroethylene (PTFE)-based microfluidic devices. Recently, 3D printed devices are 
gaining more attention in microsystems, the advantages are to obtained 3D design channels such as 
tapered geometry in XYZ in a cost-effectiveness manner and also the automation of microfluidic kit.   
Microfluidic channels as well as pumps expert user can producer functional modules whit 3D printing 




have many remaining challenges, such as low resolution, lack of suitable materials, ad immature method 
to modify the surface wetting properties. Finally, microfluidic devices can also be prepared through hot-
embossing, which is a versatile replication method that uses high pressure and elevated temperature to 
transfer structure in the master to the polymer. Advantages of hot-embossing for microfluidic include the 
ability to achieve very clean and precise features quickly and cost-effectively with materials that 
otherwise cannot be prepared using other technologies. 
Microbeads with sizes ranging from a few microns to hundreds of microns can be generated by 
droplet microfluidics. For instance, as drug delivery vehicles [74-76] microcapsules or multi-core 
microbeads can be prepared with well-defined structures and compositions that allow for high 
encapsulation efficiency and well-controlled release of the encapsulate. As cell carriers, [69] hydrogel 
microbeads can be produced to act as extracellular matrix (ECM) to protect cells from the surrounding 
environment and maintain efficient nutrient and metabolic exchanges for long term cell culture. As a 
result, these cell-laden microbeads have direct applications in tissue engineering [77], stem cell therapy 
[78], and single cell studies [79]. In addition, liposomes or polymersomes with multicompartment 
structures can be generated by droplet microfluidics in an exquisite and facile manner, making them ideal 
candidates for artificial cells [80,81]. Therefore, it allows precise tuning of the compositions and 
geometrical characteristics of microbeads [82,83]. Exploiting these advantages, engineered microbeads 
with controlled sizes, monodispersity, diverse morphologies, and specific functions can be generated, 
and are playing an increasingly important role in biomedical fields [84,85]. Although nanoscale particles 
can be fabricated by droplet microfluidics [72], low concentration of precursor solutions are used, which 
reduces the production rate. Hydrogel microbeads produced by droplet microfluidics can serve as ideal 
ECM-like materials for 3D cell culture. There is a growing interest in the application of these cell-laden 




However, encapsulation of cells with controlled number of cells per particle is still a big challenge, 
especially for single cell study 
  
1.4 Fabrication Methods 
The produced droplets are converted into solid microparticles by chemical or physical crosslinking 
techniques. 
1.4.1 Chemical crosslinking 
 Covalent bonds are normally formed among polymer chains in chemically cross-linked hydrogels, and most 
of their linkages are strong and permanent when they are compared with those of the physically cross-linked 
hydrogels. Up to now, several crosslinking methods have been reported, and they typically involve free radical 
polymerization induced crosslink, enzymatic induced crosslink, Diels–Alder “click” reaction, Schiff base 
formation, oxime formation and Michael type-addition [68]. Compared with physically cross-linked 
hydrogels, chemically cross-linked hydrogels usually exhibit enhanced stability under physiological conditions 
and excellent mechanical properties as well as tunable degradation behavior. 
In general, there are four types of chemical crosslinking 
1. Crosslinking Molecules 
2. Polymerization 
3. Photopolymerization 
4. Enzymatic Crosslinking 
1.4.1.1 Crosslinking Molecules 
Polymer chains can be conjugated through use of crosslinking molecules or can be directly bound to each 




base, where di-aldheyde cross linkers (such as glutheraldehyde) are used for hydrogelation. Crosslinking 
molecules also present a facile method to bind biofunctional molecules into hydrogel [68] 
1.4.1.2 Polymerization techniques 
The polymerization reaction is normally initiated with radiation, ultraviolet, or chemical catalysts. A 
small amount of cross-linking agent is added in any hydrogel formulation. The choice of a suitable 
initiator depends upon the type of monomers and solvents being used. The polymerized hydrogel may 
be produced in a wide variety of forms including films and membranes, rods, particles, and emulsions. 
Polymerization is the simplest technique which involves only monomer and monomer-soluble initiators. 
High rate of polymerization and degree of polymerization occur because of the high concentration of 
monomer. However, the viscosity of reaction increases markedly with the conversion which generates 
the heat during polymerization. These problems can be avoided by controlling the reaction at low 
conversions [86]. 
 1.4.1.3 Photopolymerization  
Photopolymerization is one of the most prevalent ways to initiate polymerization due to the fast response time, 
which can induce polymerization within seconds, enabling less consideration of emulsion stability [72]. The 
advantage of this method is the rapid formation of hydrogel networks at ambient temperature under mild 
conditions, and the mechanical properties of hydrogels can be tuned by controlling the crosslinking reactions 
[87]. The cross-linked site is also ready to be accurately selected, because the photo-initiated polymerization 
takes place under light exposure and only the irradiated areas are involved in hydrogel crosslinking. Photo-
initiated polymerizations are related to the presence of unsaturated groups, in most situations, the 
(meth)acrylates. The double bonded carbons in these groups are highly reactive and promote a free radical 
chain-growth polymerization when they are exposed to photo irradiation. Conventionally, water-soluble 




(GMA) and N-(3-aminopropyl) methacrylamide to introduce vinyl groups.102 Formation of biomedical 
hydrogels usually requires the presence of cytocompatible photoinitiators, such as Irgacure 2959, Irgacure 
1173, Irgacure 819, Irgacure 651. Those photo-initiators can absorb specific light at different wavelengths, 
including UV (250 nm–370 nm), visible blue & purple (405 nm–550 nm) and red light (750 nm–810 nm) and 
either decompose (Type I) or abstract hydrogen from a donor molecule (Type II) to form radical initiating 
species.  However, there are still some concerns about DNA damage caused by UV radiation. Some studies 
claimed that UV radiation posed a potential risk of accelerating organ/tissue aging and cancer onset. Thus, 
visible light photoinitiation might be an alternative candidate. Blue light (visible) photo-initiators have been 
used, such as camphorquinone and eosin Y, lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), 
riboflavin and ruthenium. These photo-initiators were able to effectively photo encapsulate various cells with 
high viability. Besides, visible light more readily penetrates tissue, which creates a pre-polymer solution 
forming hydrogel after subcutaneous injection.  
1.4.1.4 Enzymatic crosslinking  
Enzymatic crosslink occurs when enzymes, such as transglutaminase and peroxides catalyse crosslinking 
reactions between polymer chains. This approach has been used to form fast gelling, non-toxic stable 
hydrogels, [68].  
 
1.4.2 Physical Crosslinking 
Physically crosslinked hydrogels are usually created by intermolecular reversible interactions, such as 
ionic/electrostatic interaction, hydrogen bonds, polymerized entanglements, hydrophobic/hydrophilic 
interactions, crystallization/stereo-complex formation, metal coordination and π–π stacking. In ionic 
interactions, hydrogels can be crosslinked under mild conditions, at room temperature and physiological 




metallic ions yields stronger hydrogel [86]. For stereocomplex formation, a hydrogel is formed through 
crosslinking that is formed between lactic acid oligomers of opposite chirality [86]. Hydrophobic 
interactions result in the polymer to swell and uptake water that forms the hydrogel. Polysaccharides 
such as chitosan, dextran, pullulan and carboxymethyl curdlan [86] are reported in literature for the 
preparation of physically crosslinked hydrogels by hydrophobic modification. Protein interaction 
involves block copolymers that contains repetition of silk-like and elastine-like blocks called ProLastins 
[85]. These ProLastins are fluid solutions in water and can undergo a transformation from solution to gel 
under physiological conditions because of the crystallization of the silk-like domains [86]. Crystallization 
involves freezing-thawing process and creates a strong and highly elastic gel [64]. The prominent 
advantage of a physical crosslink is biomedical safety owing to the absence of chemical crosslinking 
agents, thus, avoiding potential cytotoxicity from unreacted chemical crosslinkers. More importantly, 
physically crosslinked hydrogels are stimuli-responsible with self-healing and injectable properties under 
room temperature. These hydrogels can be designed as bioactive hydrogels for the encapsulation of living 
cells and drug delivery of therapeutic molecules.  
1.4.2.1 Ionic Crosslinking 
The ionic/electrostatic interaction that has been extensively applied to the construction of hydrogels is the basis 
of a routine physical crosslink with 2 molecules of opposite electric charges cytostatic interactions occur 
between the opposite charged macromolecules and those macromolecules interact with each other to yield 
polyelectrolyte complexes [87]. The hydrogels generated from those polyelectrolyte complexes can be 
modulated with a number of factors, including the charge density of the polymers, the mixed ratio and the 
amount of each polymer, as well as the soluble microenvironment of polymer. The specific advantage of an 




can be broken at high stress and reform once the stress is removed. However, the mechanical strength of 
hydrogel is extremely limited owing to the crosslinking strategy of the ionic/electrostatic interaction. 
1.4.2.2 Hydrogen Bonding 
Hydrogen bond is one of the most important noncovalent interactions. For example, hydrogen bond could 
stabilize a secondary structure during a peptide or agarose based hydrogel formation. For hydrogel formation, 
amide, urea, carboxylic acid, pyrrole, carbazole and hydroxyl groups could form hydrogen bonds among 
themselves or interact with electron donor groups, such as pyridine and imidazole groups. However, a single 
hydrogen bond is generally not strong enough to support hydrogel formation.  Can be used to form non-
covalently crosslinked hydrogels, stabilized through physical chain interaction. Microparticles prepared 
by polymerization method result in a polymeric matrix with covalent linkages which make them 
chemically resistant as well as mechanically durable as compared to other methods. However, radicals 
generated during polymerization can cause serious problems considering their biotoxicity. Solidification 
droplets through temperature induced physical gelation and freezing can avoid some of these issues. The 
gelation method is applicable to droplets made of collagen, agarose and gelatin, which can be transformed 
into hydrogel by simply changing the temperature. The freezing method relies on the fact that some 
hydrocarbon molecules and lipid molecules including glycerides process melting point at or above room 
temperature. Microcapsule prepared by freezing exhibit large pores in the shell, inducing leakage of 
encapsulatns. 
 
1.4.3 Physico-chemical processes 
1.4.3.1 Solvent Evaporation 
This process is carried out in a liquid manufacturing vehicle phase. The microcapsule coating is dispersed 




be microencapsulated is dissolved or dispersed in the coating polymer solution. With agitation the core 
material mixture is dispersed in the liquid manufacturing vehicle phase to obtain the appropriate size 
microcapsule. The mixture is then heated if necessary to evaporate the solvent for the polymer of the 
core material is disperse in the polymer solution, polymer shrinks around the core. The core materials 
may be either water soluble or water in soluble materials. Solvent evaporation involves the formation of 
an emulsion between polymer solution and an immiscible continuous phase whether aqueous (o/w) or 
non-aqueous. 
1.4.3.2 Phase separation technique 
This process is based on the principle of decreasing the solubility of the polymer in organic phase to 
affect the formation of polymer rich phase called the coacervates. In this method, the particles are 
dispersed in a solution of the polymer and an incompatible polymer is added to the system which makes 
first polymer to phase separate and engulf the drug particles. Addition of non-solvent results in the 
solidification of polymer. The process variables are very important since the rate of achieving the 
coacervates determines the distribution of the polymer film, the particle size and agglomeration of the 
formed particles. The agglomeration must be avoided by stirring the suspension using a suitable speed 
stirrer since as the process of microspheres formation begins the formed polymerize globules start to 
stick and form the agglomerates. Therefore, the process variables are critical as they control the kinetic 













Biomimicking the Extracellular 









2.1 Extracellular matrix of soft tissues 
The extracellular matrix (ECM) is a complex scaffold consisting of structural and functional proteins, 
proteoglycans, glycoproteins and glycosaminoglycans arranged in a tissue-specific orientation. Working 
and interacting together, the individual ECM components direct the processes of acute inflammation, 
healing and tissue remodeling to achieve tissue function and restore homeostasis when tissue integrity is 
disrupted. It is the presence of these matrix factors and their inhibitors in tightly controlled concentrations 
and states of activity that lead to successful tissue restoration following injury. For example, fibrillar 
collagens provide the support and tensile strength that give the ECM its structural integrity. Following 
tissue trauma, type I collagen stimulates the respiratory burst, granule exocytosis and cytokine secretion 
by human leucocytes, leading to chemotaxis of cell types needed for wound healing [88]. Glycoproteins, 
such as fibronectin and laminin, provide attachment sites for cells of various types. Fibronectin attracts 
and binds cells through integrins, allowing them to repopulate the site of injury [89]. Laminin helps direct 
the formation and stabilization of blood vessels and also provides attachment sites for fibroblasts and 
endothelial cells [90]. Glycosaminoglycans, such as hyaluronic acid, aid in retaining matrix hydration 
and act as signalling molecules that direct tissue repair and regeneration [91]. Hyaluronic acid also 
inhibits the excessive formation of scar tissue by inhibiting platelet aggregation and the release of 
platelet-derived growth factor and other cytokines [91]. Growth factors and matrix metalloproteinases 
contribute to matrix turnover, actively directing the local cells to increase matrix production, initiate 
angiogenesis and vasculogenesis, and migrate and proliferate to where they are needed. For example, 
transforming growth factor-b and connective tissue growth factor (CTGF) stimulate collagen deposition 
following injury and inhibit matrix degradation [93,94]. Vascular endothelial growth factor (VEGF), 




vascular supply needed to provide nutrients for healing and rid the damaged area of dead cells, tissue 
debris and metabolic waste [94,95].  
The ECM is a dynamic environment in which components act and react with each other—and with the 
cells that are contained within it—to maintain homeostasis in the uninjured state and to restore 
homeostasis in the case of injury or tissue loss. The ECM is not a static structure but is highly involved 
in regulating the tissue microenvironment. The components within the ECM protect growth factors from 
degradation and modulate their synthesis, assist in orchestrating the complex processes of tissue 
inflammation and repair and modulate the localized innate immune response [91,94,96]. Because of its 
integral roles in maintaining tissue homeostasis and providing structural support, a biological ECM graft 
material that recapitulates the function and structure of the lost tissue can provide the key extracellular 
signals and cues needed to restore damaged tissues to their natural state. In vivo, cells reside in a complex 
yet highly organized environment containing a diverse collection of soluble and insoluble proteins, 
sugars, and other cells, and the exact composition and spatial orientation of a cell’s microenvironment 
dictates the local mechanical environment that a cell is exposed to. The mechanical environment is 
composed of endogenous forces generated by the cells themselves, as well as exogenous forces that are 
applied to cells by the surrounding microenvironment. Endogenous forces are largely produced by 
cytoskeletal contractility within cells [97, 98], whereas exogenous forces exist in a variety of forms, 
including gravity, shear stress, and tensile and compressive forces. Cells receive these exogenous forces 
through interaction with the ECM, and the local stiffness of the ECM is an important mechanical effector 
of cell behavior. Interestingly, external physical forces can shape the mechanical environment and make 
it a continually evolving and dynamic microenvironment for cells. Physical forces have long been known 
to contribute to tissue development and homeostasis through clinical observations of brain morphology 
and bone remodeling [99]. cells are constantly synthesizing, breaking down, or otherwise rearranging 




fundamentally important role in dictating cell behavior, and as such, any changes in ECM dynamics will 
influence adjacent cells and influence their cellular activities. By maintaining this feedback loop between 
cells and their ECM, tissues can become very Reprintedive to the physical forces imposed on it. However, 
when tissue homeostasis becomes imbalanced, tissue function generally becomes impaired as a result of 
aberrant cellular behavior. Thus, it is critical to understand how cells respond to their mechanical 
environment for the treatment and prevention of a variety of diseases. Stiffness, or rigidity, of a material 
is defined as the extent to which a material resists deformation in response to an applied force. Stiffness 
is used to indicate whether a material is compliant (soft) or rigid (hard). In biology, stiffness has been 
used to collectively represent mechanical properties of a biological substrate. Our tissues, which are 
composed of a variety of different ECM molecules, feature a wide range of elastic moduli (figure 1.1), 
and each tissue/organ has specific stiffness for fulfilling physiological needs. An ideal material for soft 
tissue reconstruction must be strong, easy to handle and biocompatible while supporting the growth of 
new tissue [99].  
 
 
Figure 2.1 Distinct modulus of human tissues suggesting tissue-specific stiffness. Different tissues with their specific 




2.2 CNS -  extracellular matrix 
The extracellular matrix (ECM) in the brain plays a defining role in regulating stem cell differentiation, 
migration and proliferation during development. The brain ECM takes on many different forms and 
compositions throughout neurogenesis [101]. The role of extracellular matrix (ECM) in neurological 
development, function and degeneration has evolved from a simplistic physical adhesion to a system of 
intricate cellular signaling. While most cells require ECM adhesion to survive, it is now clear that 
differentiated function is intimately dependent upon cellular interaction with the ECM [102]. Biological 
components form a major structural component of the CNS extracellular environment are 
glycosaminoglycans (GAGs) and also contain collagen (I, III, IV, V, and VI), fibronectin and laminin. 




Figure 2.2 Extracellular matrix in brain. The extracellular matrix (ECM) in the brain is divided into three major 
components. The basement membrane (basal lamina) which lies around the cerebral vasculature, the perineuronal net 




between cells in the parenchyma. The blue, purple, and yellow cells depict astrocytes, microglia, and neurons, respectively 
(Reprinted from Kim Y. et al, [103]). 
 
The first is the basement membrane, a layer that surrounds the endothelial cells of blood vessels, which 
is mainly composed of laminin, perlecan, fibronectin and heparin sulphate proteoglycan. The second 
section consists of perineuronal nets (PNNs) that surround neuronal cell bodies and smaller neurons. 
The final section is the neural interstitial matrix, a dense network of ECM components furthest away 
from the basement membrane and perineuronal nets. The ECM polymer network itself is primarily 
composed of a hyaluronic acid-based backbone [101] functionalized with ECM proteins. Brain ECM 
proteins such as collagens, laminins and fibronectins provide mechanical support as well as important 
molecular cues for cell behaviour.  Fibronectin is a large multidomain glycoprotein expressed as an ECM 
protein or as a soluble plasma protein. In the adult CNS, fibronectin is restricted to the vasculature and 
is not expressed by neurons and glia [104]. Laminins are heterotrimeric glycoproteins composed of α-, 
β- and γ-subunits. To date, 14 different laminins have been identified [105], of which only Laminin 111 
has been identified in the CNS, while multiple forms have been found in the peripheral nervous system 
(PNS).  
 
Figure 2.3 Perineuronal nets (PNNs). Brain stained with microtubule-associated protein 2 (MAP2) (green) and Wisteria 
floribunda agglutinin (WFA) (red) (A). Model of PNNs (B). Hypothetical PNN ternary complex of tenascin, chondroitin 




While laminin expression has been detected during pathway development [106], the major function of 
astrocyte-derived laminin in the adult is to maintain the blood brain barrier through actions on pericyte 
differentiation [107]. In culture, laminins universally promote neurite outgrowth, and an integrin-binding 
peptide (IKVAV) derived from laminin has similar actions and has been used to promote regeneration in 
vivo [108].   PNNs are reticular networks observed on the surface of neuronal cell bodies and proximal 
dendrites (Figure 2.3). This structure includes lecticans, hyaluronic acid (HA), Tenascin-C and 
Tenascin-R. It is thought that the HA–lecticans–tenascin complex deposited on neuronal surfaces may 
form a repulsive barrier against approaching axons and dendrites [101]. Lecticans are large secreted 
proteoglycans that carry mainly CS side chains and include aggrecan, neurocan, brevican and versican. 
These proteoglycans are characterized by the presence of an HA-binding domain. Two families of 
membrane-bound heparan sulfate proteoglycans (HSPGs) abundantly expressed in the CNS are 
glypicans and syndecans. Hyaluronan (also called hyaluronic acid: HA) is a unique GAG which is not 
attached to a core protein and whose sugars are not modified by sulfation or epimerization. Many of 
hyaluronan’s physiological properties, including providing biomechanical integrity, altering tissue 
hydration and facilitating tissue assembly, are dependent on its size, concentration, and localization 
[104]. Tenascin-C and Tenascin-R are oligomeric multi-domain anti-adhesive proteins expressed in the 
CNS and are known to have roles in cell adhesion, neuronal migration, migration and differentiation of 
oligodendrocytes and cellular responses to growth factors [109]. Tenascin-C is expressed by astrocytes, 
oligodendrocytes and some neuronal populations [110], while Tenascin-R is expressed by 
oligodendrocytes and neurons [111]. They are predominantly expressed during embryonic development 
and then again in response to nervous system injuries in both animals and humans [104].  PNNs are a 
structural defined part of the ECM composed of a variety of proteoglycans. The diversity of 




alternative splicing and transcription–termination, as well as variations in the length and types of 
glycosaminoglycan (GAG) side chains.   
 
Figure 2.4 Major brain proteoglycans. Proteoglycans consists of a protein core decorated with unbranched sulfated 
glycosaminoglycan sugar chains. CSPG core proteins are decorated with one or more chondroitin sulfate sugar chains. 
Based on the core protein they are classified into lecticans (which includes neurocan, brevican, versican, and aggrecan), 
phosphacan, and NG2. HSPGs are decorated with HS chains. Syndecans are transmembrane proteins, while glypicans are 
anchored to the cell membrane with a GPI linkage. Decorin is a secreted proteoglycan with dermatan sulfate side chains 
(Reprinted from George N et al, [104]). 
 
 
As major components of brain ECM, proteoglycans mediate cell-cell interactions and modulate growth 
factor and cytokine signaling during development as well as in response to various pathophysiological 
conditions in the adult [112]. The signaling functions of proteoglycans in the brain are primarily due to 
their GAG chains [117], while the core proteins contain specific domains that determine localization and 
mediate interactions with cells and other matrix molecules. Proteoglycans can either promote or inhibit 
neuritic growth and possibly synaptic remodeling. Both the protein core and GAG side chains contribute 




200 disaccharide repeats are attached through serine residues. Classified on the basis of disaccharide 
composition, GAGs are grouped as chondroitin/dermatan sulfate, heparan sulfate (HS) and keratan 
sulfate (KS). HA is a non-sulfonated polymer of glucosamine and glucoronic acid, which exists as a 
protein-free polysaccharide on cell surfaces and in the ECM [102]. Chondroitin sulfate (CS) or HS side 
chains compose most central nervous system (CNS) proteoglycans; some of them are constituents of the 
ECM and others are bound to cell surfaces by a transmembrane domain or anchored with glycosyl 
phosphatidylinositol (GPI). CSPGs are the most studied proteoglycan in the nervous system. CSPG core 
proteins are classified as lecticans, phosphacan, and NG2. The exact mechanism by which CSPGs affect 
axonal guidance is not known. CSPGs may affect neuronal growth and regeneration by inactivating 
neuronal integrins [114]. 
Dermatan sulfate (DS) GAG chains are derived from the epimerization of D-glucuronic acid in 
chondroitin sulfate to L-iduronic acid [115]. Although most of the functions of DS are related to the 
development and homeostasis of peripheral tissue, DS GAGs, especially over sulfated GAGs, stimulate 
neuritogenesis [116,117] 
HSPGs have important roles as modulators of cell signaling in brain, mainly by acting as co-receptors 
for many different cytokines and growth factors, such as FGFs [118], GDNF [119] and semaphorin 5A 
[120]. In contrast to the CSPGs, HSPGs binding to these receptors promotes axonal growth. HSPG core 






Polymer of disaccharide of N-acetylglucosamine and glucoronic acid. HS moieties of 






Polymer of disaccharide of N-acetylgalactosamine and glucoronic acid. 
Dermatan sulfate 
(DS) 
Polymer of disaccharide of N-acetylgalactosamine and iduronic acid. 
Keratan sulfate 
(KS) 
Polymer of disaccharide of N-acetylgalactosamine and galactose. 
Hyaluronic acid 
(HA) 
Non-sulfated polymer of N-acetylglucosamine and glucoronic acid. As opposed to 
other GAGs, it is not attached to a core protein. Component of PNNs. The biological 
effects of HA are mediated through cell surface receptors including CD44 and receptor 
for HA-mediated motility. 
 
Proteoglycans 
Glypican A family of six GPI-anchored cell surface HSPGs that are widely expressed in the 
CNS. Bind laminin, thrombospondin, FGFs, VEGF and IGF. Associated with 
neurogenesis and neurite outgrowth. 
Syndecan A family of four membrane-associated HSPGs. Bind tenascin-C, fibronectin, laminin, 
HB-GAM, bFGF and TGFβ. Associated with LTP and synaptic function and neurite 
outgrowth. 
Phosphacan A secreted CSPG. Bind Tenascin-R/C and HB-GAM. Associated with neurogenesis, 
neuronal migration and neurite outgrowth. 
Versican Secreted CSPG. Binds to HA, Tenascin-R and fibronectin. Different alternative spliced 
variants have been identified. Associated with neuronal migration and neurite 
outgrowth. 
Brevican Secreted and GPI-anchored CSPG. Binds to HA and tenascin-R. Associated with 
neurite outgrowth and synaptic function. 
Neurocan A secreted CSPG. Binds to HA, Tenascin-R/C and bFGF. Associated with neurite 
outgrowth and synaptic function. 
 
Other proteins 
Tenascin ECM protein associated with PNNs. Binds to brevican, phosphacan, neurocan, HA, 





Laminin A secreted family of key members of the ECM. Binds predominantly to integrins. 
Associated with migration, survival and synaptic function. 
 
ECM-modulating enzymes 
MMP Family of zinc-dependent extracellular proteases. Associated with neurogenesis, 
survival and plasticity. 
TIMP Inhibitor of MMPs. Associated with neuronal survival and plasticity. 
tPA Serine protease that converts inactive plasminogen to active plasmin. Key initiator of 
MMPs. Associated with neurite outgrowth, neuronal migration, survival and synaptic 
function. 
ADAMTS Protease family with aggrecanase activity associated with the ECM through a 
thrombospondin motif. 
Plasminogen 
activator inhibitor 1 
A serine proteinase inhibitor (serpin) plasminogen activator inhibitor. 
Hyaluronidase Family of enzymes that degrade HA. 
Heparanase An endo-β-D-glucuronidase that catalyzes the hydrolytic cleavage of the β-1,4-
glycosidic bond in HS. 
Chondroitinase Lyase that degrades CS. 
 
ECM-binding factors 
FGF FGFs constitute a large family of polypeptides (eg, aFGF, bFGF, KGF) that are 
important in the control of cell growth and differentiation and play a key role in 
oncogenesis, developmental processes and neuronal development. 
HB-GAM HB-GAM (also designated as pleiotrophin) and midkine form a two-member family of 
ECM proteins that bind tightly to sulfated carbohydrate structures such as HS. Binds to 
phosphacan and syndecan. Associated with neurite outgrowth, axon guidance and 
synaptogenesis. 
PDGF PDGF is one of the numerous growth factors that regulate cell growth and division. 
VEGF VEGF is an important signaling molecule involved in angiogenesis. 
 
 
Table 1: Extracellular matrix (ECM) components. Abbreviations: PNN = perineuronal net; CSPG = chondroitin sulfate 




glycosaminoglycan; CNS = central nervous system; GPI = glycosyl phosphatidylinositol; HSPG = heparan sulfate 
proteoglycan; FGF = fibroblast growth factor; VEGF = vascular endothelial growth factor; HB-GAM = heparin-binding 
growth-associated molecule; bFGF = basic fibroblast growth factor; TGFβ = transforming growth factor β; LTP = long-
term potentiation; MMP = matrix metalloproteinase; TIMP = tissue inhibitors of metalloproteinase; tPA = tissue 
plasminogen activator; ADAMTS = A disintegrin and metalloproteinase with thrombospondin motifs; PDGF = platelet-
derived growth factor; (Reprinted from Bonneh-Barkay D et al, [101]). 
 
ECM capacity to bind growth factors via HS and CS modulates their interaction with the cell surface. In 
fact, the localization and biological activity of factors such as fibroblast growth factors (FGFs) depend 
strongly on the presence and composition of the ECM. Cells that express high-affinity receptors but lack 
surface HS do not respond to these ligands [121]. HSPG can stabilize FGF, protect it from proteolysis 
and serve as a co-receptor influencing its interaction with cell surface high-affinity receptors [122]. 
Specific structural aspects, including sulfonation of HSPG, are required for the proper interaction of 
HSPG with FGF. Thus, the regulation of GAG biosynthesis and modification greatly influences the 
functions of HSPG. The differential binding characteristics of specific HS structures can potentiate or 
inhibit the biological activity of FGFs [102]. Other growth factor families, such as vascular endothelial 
growth factor (VEGF) and platelet-derived growth factor (PDGF), are known to bind to heparin/HS, 
which can modulate their biological activities [123]. The interaction between chondroitin sulfate 
proteoglycans (CSPGs) and growth factors has attracted less attention; however, recent evidence supports 
the ability of CS chains to bind growth factors and to modulate their role in growth factor cell signaling. 
During neurogenesis the ECM is constantly changing its morphology to modulate and guide axonal 
growth. The elastic modulus of the human brain varies across different regions. Different moduli are 
typically displayed by white and grey matter regions. The mammalian white matter, which is composed 




The mammalian grey matter, primarily composed of neuronal cell bodies, is elastically weaker with an 
elastic modulus of 1.4 kPa, [68].  
 
2.3 In vitro models of CNS  
Historically the culture of mammalian cells in the laboratory has been performed on planar substrates 
with media cocktails that are optimized to maintain phenotype. The study of neurons in 2D culture first 
became possible in 1907 when Rose Harrison introduced tissue culture by maintaining tissue explants 
outside of the animal and observing the outgrowth of nerve cells [124]. In vitro models are cell-based 
models which involve culturing cells in 2D on functionalized surfaces (tissue culture plastic, natural or 
synthetic polymer coatings), frequently co-cultured with other cell types [125]. In vitro cultures of 
neuronal cells on flat 2D surfaces offer simplified, high throughput systems to study disease, drug 
toxicity, and biological processes by controlling environmental factors and directly measuring cell 
responses [126,127]. These traditional in vitro models have provided a wealth of information about 
neural cell types; examples include spontaneous network formation, cell attachment sites for adhesion 
and migration, axonal guidance mechanisms, molecules (soluble and insoluble) in synaptic targeting, and 
the resting membrane potential of different cell types [128]. Since these early studies, in vitro tissue 
models of the CNS have advanced, however none are able to fully capture the functionalities and subtle 
mechanisms of the actual tissues. In fact, 2D cultures lack endogenous 3D cell-cell interactions and 
physiological cues provided by the ECM. This is due to challenges of complexity (structure, number and 
flux of bioactive factors), physiological relevance (substrate stiffness, cell-cell interactions, and 
ultrastructure) and methods for functional evaluation (electrophysiology). For these reasons, researchers 
are invested in the development of tissue-like models through tissue engineering. Tissue engineering 




for the in vitro study of cellular mechanisms and therapeutic development. 2D model systems still play 
a major role and are still considered the gold standard for (neuro)biological investigations [129,130]. 
Such 2D models are aimed not only at dissecting the fundamental mechanisms of neural communications 
and dynamics, but also at exploring the related effects of (novel) pharmacological compounds [131]. 
These networks are usually derived from animal tissue and grown onto rigid substrates, thus lacking most 
of the key in vivo-like constituents: cell morphology, cell-to-cell interactions, and spatially unrestricted 
neuritic outgrowth. While there is no substitute for the low cost and simplicity of 2D cell culture studies 
or the complexity provided by in vivo systems, the goal of 3D in vitro tissue modeling is to fill in the 
knowledge gap that exists between the 2D in vitro and in vivo approaches.  
 
2.4  2D neuronal network  
Most in vitro functional studies in the developing nervous system have been performed using traditional 
monolayer culture developed onto supports modified by extracellular matrix components such as 
glycoproteins: laminin, fibronectin, tenascin, the cell adhesion molecule Ll and the lectin concanavalin 
A (ConA) [131-137] and synthetic biopolymers such as poly-ornithine and poly-lysine [124,138-142], 
which are expressed at stages critical for neuronal differentiation in situ and are functional in neurite 
outgrowth in vitro [143-144], acting as adhesion proteins. In many studies, the role of cell-to-substratum 
adhesion in the initiation, elongation, and branching of axons from rat embryonic cells was investigated 
[141-142]. Neurons in culture showed that nerve outgrowth requires a solid substrate [145]. The first 
work studied the use of collagen purified from rat tails as adhesion factors because was the only option 
available. In 1974, poly-lysine proved an excellent substrate. Both adhesion and neurite outgrowth were 
markedly better than on collagen, and results were much more consistent. One year later, also poly-
ornithine pre-treated surfaces showed strong adhesive properties and enhanced neuronal morphogenesis 




electrostatic interaction of poly-cation whit the negative charges of the cell membrane, which promote 
cell adhesion and growth, figure 2.5.  
 
Figure 2.5 Chemical structures of poly-ornithine and poly-lysine. 
 
The 2D culture cannot fully represent the in vivo environment, but it still serves as a powerful tool for 
understanding fundamental relationships between cell function and microenvironment parameters. The 
development of hippocampal neurons in culture can be divided into 4 stages as shown schematically in 
figure 2.6 [124].   
 
 
Figure 2.6 Stages of development of hippocampal neurons in culture. (Reprinted from Dotti et al.[124]).  
 
Stage I: formation of lamellipodia. Shortly after the cells attach to the substrate, motile lamellipodia 




periphery of the cell. Because comparable structures have not been observed during neuronal 
development in situ, their appearance in culture may reflect the cell’s Reprintedation to growth on an 
artificial, two dimensional substrates. The lamellipodia, which initially surround most ofthe 
circumference of the cell, break up into discrete, motile patches at intervals along the cell periphery. 
Neurites appear to arise preferentially at these sites, the lamellipodial patches becoming the neuritic 
growth cones. 
 Stage 2: outgrowth of the minor processes. This stage of development is characterized by the 
transformation of lamellipodia into distinct processes, which, in the course of a few hours, extend to a 
length of 10-15 μm, after the appearance of minor processes, one of the minor processes begins to grow 
at a much more rapid rate 
Stage 3: formation and growth of the axon. Several hours after the appearance of minor processes, 
rather abrupt change occurs: one of the minor processes begins to grow at a much more rapid rate. From 
this stage onward, its rate of growth will average 5-10 times greater than the other processes of the cell. 
This process is the axon, and it can be identified unequivocally as soon as its growth spurt begins. At this 
point, the cell has become polarized. 
Stage 4: growth of dendrites. Like the axon, dendrites develop from the minor processes that appear 
during the first day in culture, but significant dendritic growth begins only after about 4 d in culture, 2-3 
d after axonal outgrowth. The temporal difference in the initiation of significant axonal. Dendritic growth 
differs from axonal growth in 2 other obvious but important respects. First, dendrites grow more slowly 
than axons. The rates, averaged over an interval of 24 hr, differ by at least a factor of 5 Second, unlike 
axons, several dendrites grow at the same time. If some internal mechanism prevents simultaneous 





From stage 3 onward, proteins that are homogeneously distributed over all cellular compartments at 
earlier stages become selectively enriched in major or minor neurites. Synapsin I, synaptophysin, and 
growth-associated protein 43 (GAP-43) become concentrated in major neurites [145], whereas 
microtubule-associated protein 2 (MAP2) becomes restricted to minor neurites [140]. Furthermore, the 
glycosylphosphatidylinositol-anchored glycoprotein Thy-l is enriched in axons of stage 5 neurons [138]. 
Ultrastructurally, hippocampal axons in vitro, as in vivo, lack polyribosomes that are prominent in 
dendrites [146]. Axons contain filamentous cytoskeletal elements that are packed more densely than in 
dendrites, with axoplasmic organelles being largely restricted to axonal branch points [147]. The 
orientation of microtubules also differs between axons and dendrites. In axons, all microtubules are 
oriented with their plus ends toward the axonal tip, whereas in dendrites both microtubules with minus 
and plus ends oriented toward the neurite tip are present [148]. The extracellular matrix components the 
mostly studied in the developing nervous system are t laminin and fibronectin, the neural cell adhesion 
molecule L1 and concanavalin A (ConA) which are expressed at stages critical for neuronal 
differentiation in situ and are functional in neurite outgrowth. Furthermore, several studies have stressed 
the importance of extracellular matrix molecules for the establishment of neuronal polarity. 
 
2.5 3D neuronal network – microbeads  
The intricate structure of the brain comprises highly organized interconnected neurons that interact with 
the extracellularmatrix (ECM) to form a complex network [149] During development, neural cells 
proliferate and migrate into discrete locations within the brain in response to various trophic cues [150]. 
Neurons also transduce topographical stimuli through interaction of the growth cone (a specialized axon 
tip containing filopodia) with the immediate environment [151,152] and mechanical cues that can direct 




connectivity within the overall neural circuitry, giving rise to specialized nuclei with specific functions 
within the brain. To promote neural regeneration within an unconducive environment, a scaffold needs 
to regulate cell adhesion, proliferation, migration and neurite elongation, recapitulating some of the 
events that occur during embryogenesis. Furthermore, this must occur within a three-dimensional (3D) 
architecture to allow for relevant and appropriate tissue reformation.  
Biomimicry requires modelling the 3D scaffold on the biological target tissue processes, properties and 
features. The current challenge of biomimicry is amplified by the incomplete understanding of the 
following properties of brain tissue as a biological system:  
• Heterogeneity: Neural tissue is comprised of varied anatomical regions due to the varied density and 
alignment of the tissues components (e.g. different cell types, biomolecules, blood vessels, fibrous 
proteins) in various regions. 
 • Complex 3D tissue: 3D culturing is a process crucial to reconstructing the in vivo structure-function 
relationship of the neural tissue. This would ensure that the newly formed tissue is 3D to enhance 
integration with the surrounding 3D tissue at the lesion zone. However, replicating the structural and 
functional framework has thus far been a challenge due to the high complexity of the 3D neural tissue 
network.  
• Unique neuronal micro-environment: In vivo, the immediate microenvironment of neural cells is 
composed of the interstitial system, which accounts for approximately 20% of the total brain volume. 
The interstitial system (ISS) or neural microenvironment comprises of the extracellular matrix and the 
interstitial fluid (ISF). Briefly, the interstitial fluid serves as a medium that bathes the cells in a rich 
environment (of for example, contains hormones, neurotransmitters) and facilitates waste removal, 




and anchors the cells as depicted in figure specifically highlights that the ECM enables intercellular 
adhesion and functions as a scaffold [154].  
 
Figure 2.7 Schematic depiction of the neural environment. (a) Spatial arrangement of the brain tissue compartments (cyan 
cells = neurons, purple cells = astrocytes, zoom-in subplot: ECM = a net-like cover attached to the surface of neural cells. 
(b) Enlarged view of the zoom-in subplot of the brain ECM in (a). The net-like cover = hyaluronic acid (HA) secreted by 
cells acting as a trestle for the ECM net-like structure. The penniform objects crossing the gaps between the HA chains = 
glycoproteins. Orange triple-circle = tenascin linking glycoproteins up. Multicoloured single circles = components of 
interstitial fluid (ISF), e.g., water molecules (H2O), extracellular vesicles (EVs), matrix metallopeptidase (MMP), glucose 
(Glu), dopamine (DA), and tissue plasminogen activators (tPAs). This figure is reused and reprinted from Progress in 
Neurobiology, Lei and co-workers. (Reprinted from Mahumane G.D. et al, [154]). 
 
 
The native ECM presents a macro to nanoscale topography, therefore, 3D scaffolds need to be processed 
to exhibit similar topographical cues (e.g. fibres and pores). Neural tissue has a dense vasculature in order 
to facilitate mass transport (e.g. of cells, nutrients, waste) [154]. Interconnected pores and channels 
designed in the architecture can accommodate for the absence of vasculature at the lesion site by 
facilitating mass transport within the 3D scaffolds. In addition, physical support must be offered to cells 
and axons, as well as physical properties similar to the native environment (e.g. elastic modulus). This 
poses a major scaffold design challenge because native brain tissue typically has an elastic modulus of 




through cell colonization, migration and biased differentiation [157] and altered neurite formation and 
trajectory [158]. For instance, after 8 days of stem cell culture on photopolymerizable methacrylamide 
chitosan hydrogels with stiffness between < 1 and 7 kPa, biased cell differentiation was observed such 
that the < 1kP a substrate produced 59% oligodendrocytes, 33% neurons, and 2% astrocytes, while the 
7kPa substrate produced 72% oligodendrocytes, 12% neurons, and no astrocytes, and the 3.5kPa 
substrate yielded intermediate values [159]. Furthermore, the rate of neurite extension of dorsal root 
ganglion cells is inversely proportional to substrate stiffness [158] and neurons produce more primary 
dendrites and shorter axons on stiffer substrates. A range of scaffolds including hydrogels, self-
assembling peptides, and electrospun nanofiber scaffolds have been investigated as candidates for neural 
tissue engineering within the brain.   Within CNS tissue, a greater proportion of the microscale tissue 
organization can be thought of as granular, with cells binding to cells. This is a colloidal structure, with 
dense cell packing as the main phase surrounded by proteoglycan rich extracellular space [159]. It is 
possible to replicate this architecture directly using densely packed cells, however, without the benefit 
of a vascular system, perfusion into and diffusion from tissue sections thicker than 200um is decreased, 
leading to the generation of toxic microenvironments [160]. To overcome this, hydrogels with higher 
internal porosity and lower cell densities can be used. The internal structure of this bulk hydrogel system 
needs to be optimized to support adequate cell adhesion and diffusion, whilst also entrapping expressed 
factors to support the generation of a niche cellular environment.  Alternatively, the hydrogel structure 
can be modified to take the form of a granular structure, better replicating the structure of brain tissue. 
This multiphase structure encompasses hydrogel granules surrounded by an ECM rich secondary phase 
into which cells are seeded. Modification of bulk hydrogels into granular systems conveys further 
advantages. Granular hydrogels readily fluidise when compressed, a property known as shear thinning 
[161]. This increases the injectability of these systems. Furthermore, cells can be mixed homogeneously 




mixing. The granules also act as a protective medium that supports cell viability during delivery. Granular 
systems work well as cell carriers. In a proposed stemcell delivery therapy for traumatic brain injury, a 
microsphere chitosan hydrogel scaffold functionalized with heparin to bind FGF-2 was shown to support 
radial glial cell (RGC) delivery when injected into a rat brain contusion model [162]. Analysis after 3 
days revealed that the RGCs remained positive for nestin, indicating that the microspheres supported 
RGC viability and maintained the cells in a progenitor state. Granular scaffolds have also been found to 
facilitate cell infiltration and promote vascularization in-vivo. In a recent example, a granulated chitosan 
hydrogel scaffold was implanted into a rat spinal cord injury model and the granular hydrogel was found 
to elicit a dynamic restorative process, promoting axon outgrowth, vasculature ingrowth and diminishing 
fibrous glial scarring and the inflammatory response [163]. In a similar way, a microsphere hydrogel 
scaffold was injected into a rat cortical stroke cavity model with the goal of accelerating neural repair 
[164]. The scaffold consisted of HA microgel particles functionalized with multiple groups known to 
support cell binding and promote tissue repair. The scaffold was found to alter poststroke astrogliosis 
and inflammation, enhancing vascularization and neural progenitor cell migration into the site of damage. 
Hydrogel granules and spherical carrier-embedded hydrogels have also been used in other controlled 
delivery applications [165]. In one example, poly(N-isopropylacrylamide) (PNIPAm) hydrogel granules 
were used to facilitate cell transplantation of neurons into rat hippocampus [166]. PNIPAm hydrogel 
granules have a thermo-switching capability, such that mature neurons can be dissociated from the 
granules without neurite damage. In use, the granules enhanced cell survival and minimized the number 
of carriers needed for cell transplant. Unlike cells encapsulated inside bulk hydrogel, many of the 
mechanical and biochemical properties of granular gels are effectively decoupled. Whilst it is the bulk 
material of the hydrogel granules that supports the scaffold and maintains space for diffusion, it is the 
extended interconnected interface structure that occurs between granules that facilitates and localizes the 










Chitosan as adhesion factor for 






3.1 Bioactivity of chitosan 
Chitosan (CHITO), a copolymer of glucosamine and N-acetyl-glucosamine, is obtained by alkaline deacetylation 
of chitin, which is the main structural component of exoskeletons of crustaceans, crabs, insects and fungal mycelia, 
figure 3.1, [169]. The deacetylation degree (DD) of chitosan represents the number of amino groups along the 
chains. It is calculated as the ratio of D-glucosamin and the sum of D-glucosamine and N-acetyl D-glucosamine. 
To be named “chitosan”, the deacetyleted chitin should contain at least 60% of D-glucosamine residues.  
 
Figure 3.1 Chemical structure of chitin and chitosan, (Reprinted from N. Acosta et al [169]). 
 
This polysaccharide is well known in biomedical application due to its attractive properties in terms of 
biocompatibility, biodegradability, muco-adhesiveness, antibacterial and antifungal activity and low 
cost [170]. The biocompatibility of chitosan depends on the preparation method (residual proteins could 
indeed cause allergic reactions) and on the DD, biocompatibility increases whit DD increase. Indeed, 
while the number of positive charges increases, the interaction between cells and chitosan increases as 
well, which tend to improve biocompatibility [170]. To explain chitosan biodegradability, it is important 
to remember that chitosan is not only a polymer bearing amino groups, but also a polysaccharide, which 
consequently contains breakable glycoside bonds [171]. Chitosan is actually degraded in vivo by several 




toxic oligosaccharides of variable length The degradation rate of chitosan is mainly related to its degree 
of deacetylation, but also to the distribution of N-acetyl D-glucosamine residues and the molecular 
weight. The mucoadhesion of chitosan for example, can be explained by the presence of negatively 
charged residues (sialic acid) in the mucin – the glycoprotein that composes the mucus. In acidic medium, 
chitosan amino groups are positively charged and can thus interact with mucin. The mucoadhesion is 
directly related to the DD of chitosan: actually, if chitosan DD increases, the number of positive charges 
also increases, which leads to improved mucoadhesive properties. Due to its positive charges, chitosan 
can also interact with the negative cell membranes, which can lead to reorganization and an opening of 
the tight junction proteins, explaining the permeation enhancing property of this polysaccharide. As for 
mucoadhesion, if chitosan DD increases, the permeation ability also increases. There are two main 
mechanisms to explain chitosan antibacterial and antifungal activities. In the first case, positively 
charged chitosan can interact whit negatively charged groups at surface of cells, and as a consequence, 
alter its permeability. This would prevent essential materials to enter the cell or/and lead to the leaking 
of fundamental solutes out of the cells. The second case involves the binding of chitosan with the cell 
DNA, which would lead to the inhibition of microbial RNA synthesis. Chitosan antimicrobial property 
might result from a combination of both mechanisms.  The abundance of sidechains in chitosan allows 
for easy modification and addition of other peptides or molecules. Moreover, chitosan can be easily 
molded into matrices of various forms such as films, porous scaffold, hydrogels, nanofibers and drug 
carriers.  It can behave as a polycation under acidic conditions (pH<6), due to the protonation of free 
amino groups [172,173]; its pH-dependent cationic nature shows the intrinsic ability to interact whit 
anionic component (glycosaminoglycans and proteins), increasing the biomimeticity of the chitosan in 
vivo environment.  Chitosan is commonly used in neural culture due to its linear structure similar to that 





      3.2 Aims  
As a first step, 2D physically cross-linked chitosan films were prepared by phase inversion (liquid to 
solid) in an ethanol/sodium hydroxide solution [174] and covalent crosslinking [175] to investigate their 
interaction with neurons, with and without treatment with adhesion proteins (a.p.).  
Then, the use of chitosan (CHITO) has been investigated as an alternative cell adhesion factor for in vitro 
preparation of two dimensional neuronal culture on different support (glass, polystyrene, silicon nitride). 
To validate the ability of chitosan to support neuronal adhesion, networks development and the 
differentiation capacity, morphological and functional characterizations were carried out and compered 
to the model proposed by Banker (figure 3.2) for the polarization process on hippocampal neurons 
growth on a substrate treat with a traditional adhesion factors, poly-ornithine. In the experiments, CHITO 
solutions at different concentrations were used as substrate by adsorbation and by nebulization whit an 
airbrush. Furthermore, using airbrush, there was the advantage to nebulize the material through the use 










 3.3 Materials and methods  
Materials 
Chitosan solution: CHITO (low molecular weight, 75-85% deacetylated, code 448877, lot 
MKBD4275V, from Pandalus Borealis) was dissolved in 0.1 M acetic acid at concentrations 0.01%, 
0.05%, 0.1%, 0.5%, 1%, 2% w/v and filtered through a syringe filter (5µm) to remove any undissolved 
material 
Neutralizing solution: H2Odd 40%, Ethanol 60% and sodium hydroxide 2% w/v 
Genipin solution: genipin 2% in H2Odd  
Methods 
Four different methods to produce CHITO films:  
1. Thick Films were prepared from CHITO solutions at concentrations 1% and 2% w/v. CHITO 
solutions (1 ml) were poured on a petri dish (∅35mm) and allowed to dry before exposing them 
to 1 ml of gelling solution overnight. The gelling solution was prepared by mixing H2Odd 40%, 
Ethanol 60% and NaOH 2% w/v. The gelling solution composition was optimized on the basis 
of the data present in the literature and on results obtained by the FT-IR characterization of 
CHITO samples crosslinked at different concentrations of NaOH and genipin [174-175]. The 
obtained films were washed several times with distilled water. 
2. Spray coating: CHITO solution was sprayed through airbrush onto different substrates petri 
dishes (plastic), micro-electrodes arrays (glass) and high density microelectrode matrices (MEA), 
high density-MEA (HD-MEA) (silicon nitride), giving also the possibility of producing a desired 
micro pattern through the use of stencil masks.  
The set-up is composed by a target-support where to place the substrate to be treated and an 
airbrush-support which allows to move the airbrush to the right and left. Films with different three 




evaluate which was the minimum concentration of chitosan and the minimum number of layers 
to create a films able to support cell adhesion.  
Definition of 1 layer: 1° spray for 2 second moving the airbrush to right and left, pause 
for 2 second 2° spray for 2 second  
3. Patterning: To obtain pattern, CHITO solution at 1% was nebulized onto petri dishes with a mask.  
After nebulization, the films were allowed to dry before exposing them to a gelling solution for 
20 min. The obtained films were washed several times with distilled water. All the procedure was 
performed at room temperature.  
4. Dip coating:  in order to obtain a complete comparison with the traditional adhesion factors, 
CHITO solutions at low concentration (0.1 %, 0.5%, 0.05%) were sterilized using a 0.22 μm 
sterile filters, poured by dip coating onto petri-dishes following the standard protocol and finally 
incubated for 4h, 8h and overnight at 37°C.  As a control, the day before plating, other petri-
dishes, MEA and HD-MEA were coated with poly-ornithine overnight. 
 
3.3.1 Airbrush 
The airbrush is an instrument that is used to spray various types of materials by nebulizing them with 
compressed air. It is used in precision work to produce thin lines, uniform color backgrounds and soft 
tones.  Two different types of airbrushes have been used:  a single-action, the simplest one, so called 
because the command button opens or closes the airflow, without adjusting the amount of mixture and a 
controlled double-action. It has a unique control that allows you to independently adjust the airflow and 
the amount of mixture released, moving back the command button, initially opens the air channel, then 
pressing deeper than the mixture. 
The airbrush is connected by a flexible tube to an air source. The body sprays the material by atomizing 






Figure 3.3. Set-up airbrush. 
 
In the experiments, two types of airbrushes have been used; a single-action airbrush, the simplest 
one, so called because the command button opens or closes the airflow, without adjusting the amount of 
mixture and controlled double-action airbrush. It has a unique control that allows you to independently 
adjust the airflow and the amount of mixture released, moving back the command button, initially opens 
the air channel, then pressing deeper than the mixture. The set-up was composed by a target-support 
where to place the substrate to be treated and an airbrush-support which allows to move the airbrush to 
the right and left (figure 3.3).  The main parameters for the process optimization are: nitrogen pressure, 
type of nozzle, distance between nozzle and target, time of spraying. The parameters were respectively 
set at 2.5 mbar (nitrogen pressure), 0.2 μm (the nozzle size), 6-7 cm (distance between nozzle and target) 








3.3.2 Patterned film 
Samples have been prepared in plastic petri dishes, on which 1% CHITO solution was sprayed. Before 
spraying the solution, the PLA mask made by a 3D printer, was inserted inside the petri dishes, figure 
3.4.   
 




This mask has a circular shape, with a diameter of 34 mm. It consists of 120 squares, arranged in an 
orderly manner, which have a side of 1.25 mm, so each square covers an area of about 1.56 mm2. CHITO 
solution was nebulized by the airbrush, maintaining a distance of 6-7 cm and an inlet pressure of 2.5 
mbar. 
The mask was removed and the samples were dried under a laminar flow hood for 5 min. The substrates 
were not treated by neutralizing solution, due to the fact that the CHITO solution sprayed was a very 
small amount. The samples were washing three times whit deionized water, sterilized in 70% ethanol, 





3.3.3 Cell preparation  
Hippocampi and cortical neurons were dissected and removed from embryonic Sprague-Dawley rats at 
gestational day 18 under sterile conditions. Hippocampal and cortex fetal tissue was enzymatically 
digested in Trypsin 0.125% in Ca++ and Mg++ free Hank’s (Gibco Invitrogen) for 20’ at 37°C. The 
enzymatic process was quenched by adding culture medium supplemented with 10% of FBS (Sigma-
Aldrich) then the tissue was mechanically dissociated with a smoothly fire-polished Pasteur pipette. 
Neurons were re-suspended in plating medium consisting of Neurobasal medium (Gibco Invitrogen) with 
2% w/v B-27 Supplement (Gibco Invitrogen), 1% Glutamax (Gibco Invitrogen), 1% Pen-Strepto (Gibco 
Invitrogen). Cultures were maintained in incubator at 37°C in a 5% CO2, 95% humidity atmosphere for 
3-4 weeks by replacing half of the medium once a week. The experimental protocol was approved by the 
European Animal Care Legislation (2010/63/EU), by the Italian Ministry of Health in accordance with 
the D.L. 116/1992 and by the guidelines of the University of Genova. All efforts were made to reduce 
the number of animals used for the project and to minimize their suffering   
 
 
3.3.4 Preparation of 2D networks on CHITO films 
To evaluate the bioaffinity between CHITO and neurons, cultures were prepared using thick films treated 
and untreated with adhesion proteins (a.p.). 
The day before plating, the thick films were sterilized in 70% ethanol for 1 hour and used for the cell 
culture experiments. In the first case, films were exposed to a mix of a.p., namely Laminin: P-D-Lysine 
(1:1), at the concentration of 0.05 mg/ml in sterile water (L-2020; P-6407 Sigma-Aldrich) and left in the 
incubator overnight at 37°C. The a.p. were then washed away from the films with sterile water. In the 




were washed in a Neurobasal medium. Hippocampal neurons were plated onto the film surface at a 
seeding concentration of 1000 cell/µl with a final cell density of 800 cell/mm2. 
Moreover, to investigate on the use of chitosan as a cell adhesion factor, petri-dishes are pre-treated with 
chitosan solutions and PORN poured by dip coating. CHITO solutions were filtered using a 0.22 sterile 
filters. The samples were washes with sterilized water, neutralized with medium culture and then used 
for the cell culture. For patterning, films are obtained by spray coating whit and without mask stencil 
onto petri dishes; instead onto MEA and HD-MEA film are made only without mask stencil.  Primary 
hippocampal and cortex neurons, isolated from embryonic day (E) 18 rat embryos, were plated at low 
concentration onto chitosan pre-treated petri dishes for the morphological studies (28-30 cell/mm2) and 
at medium concentration onto chitosan pre-treated MEA and HD-MEA.  
 
3.3.5 Characterization of CHITO films  
3.3.5.1 Morphological characterization of neuronal networks by 
immunocytochemistry 
To assess the expression of specific neuronal markers, hippocampal cultures were fixed in 4% 
paraformaldehyde in phosphate buffer solution (PBS), pH 7.4 for 30 min at room temperature. 
Permeabilization was achieved with PBS containing 0.5% Triton-X100 for 15 min at room temperature 
and non-specific binding of antibodies was blocked with an incubation of 45 min in a blocking buffer 
solution consisted of PBS, 0.3% BSA (bovine serum albumin Sigma) and 0.5% FBS. Cultures were 
incubated with primary antibody diluted in PBS Blocking buffer for 2 hours at room temperature or 
incubated at 4°C overnight in a humidified atmosphere. Cultures were rinsed three times with PBS and 
finally exposed to the secondary antibodies. Differentiation is the establishment of the two distinct classes 
of neuronal processes, axons and dendrites. To identify the major neurites as axons and the minor neurites 




(1.200, axon microtubule-associated protein) and Akirin G (1:200, axon initial segment) to study their 
localization during early stages of axonal and dendritic development, TUBULIN βIII, clone TU-20 ( 
1:500 ), NeuN 1:200 (neuronal soma), VGAT and VGLUT1 1:500 (GABA AND Glutamatergic 
vesicles), Synapsin 1:200 (synaptic vesicles), Dapi 1:10000 (nuclei). To verify the presence of glial cells 
in the culture, we fixed and exposed to the marker GFAP 1:1000 (glial marker). ImageJ and NeuronJ 
have been used to analyze, trace and measure neuritic processes. 
 
3.3.5.2 MEA and HD-MEA recording and analysis 
The spontaneous electrophysiological activity of 2D hippocampal and cortical neuronal networks was 
recorded at 15-25 days in vitro (DIV) by means of micro-electrode arrays (MEAs) made up of 60 planar 
microelectrodes (TiN/SiN, 30 µm electrode diameter, 200 µm spaced) arranged over an 8 X 8 square 
grid (except the four electrodes at the corners), supplied by Multi Channel Systems (MCS, Reutlingen, 
Germany). The electrophysiological activity was acquired with the 2100 System (MEA 2100-System, 
MCS), and signals were sampled at 10 kHz.  
Furthermore, the spontaneous electrophysiological activity of 2D hippocampal and cortical neuronal 
networks was also recorded at 19-30 days in vitro (DIV) by means of high density micro-electrode arrays 
(HD-MEAs) made up of 4096 microeectrodes (electrode size 21µm x 21µm, electrode pitch 81 µm) 
arranged over a 64 X 64 square grid, supplied by 3Brain.  
The electrophysiological activity was acquired with the Biocam X. Recordings were performed for 30 
min outside the incubator at a temperature of 37 °C. To prevent evaporation and changes of the pH 
medium, a slow flow of humidified gas (5% CO2, 20% O2, 75% N2) was constantly delivered during 






3.3.5.3 Data and Statistical analysis 
Data analysis for electrophysiological activity acquire by MEA set-up was performed by using a custom 
software package named SPYCODE [176], developed in MATLAB (The Mathworks, Natick, MA, 
USA). Instead, data analysis for the recordings acquired by HD-MEAs was performed by usng a custom 
software ackage nemde BrainWave. Spike detection was performed by using the Precise Timing Spike 
Detection (PTSD) algorithm [177]. The algorithm requires three parameters: a different threshold set to 
8 times the standard deviation of the baseline noise, a peak lifetime period (set at 2 ms) and a refractory 
period (set at 1 ms). To characterize the electrophysiological activity, we extracted some first order 
statistics. In particular, we evaluated the mean firing rate (MFR), i.e., the number of spikes per second 
of each channel and the percentage of random spikes, i.e., the fraction of spikes outside bursts. We also 
performed burst detection according to the method described in [178]. A burst is a sequence of spikes 
having an ISI (inter-spike interval, i.e., time intervals between consecutive spikes) smaller than a 
reference value (set at 100 ms in our experiments), and containing at least a minimum number of 
consecutive spikes (set at 5 spikes). The parameters extracted from this analysis are the mean bursting 
rate (MBR) and the mean burst duration (MBD), which are the frequency and the duration of the bursts 
at the single channel level respectively. The same approach used for the detection of bursts was applied 
for the detection of quasi synchronous events at network level called network bursts [177]. The extracted 
parameters are the network bursting rate (NBR) and the network burst duration (NBD), which are the 
frequency and the duration of the bursts at global net level respectively. 
Statistical analysis was carried out using OriginPro 8 (OriginLab Corporation, Northampton, MA, USA). 
All data are presented as mean ± standard error of the mean. Statistical analysis was performed using a 
non-parametric Kruskal-Wallis test, since data do not follow a normal distribution (evaluated by the 




Differences were considered statistically significant when p<10-3. In order to determine which of the 
sample pairs are significantly different, post-hoc test, using Dunn’s test, has been applied. 
 
3.4 Results 
3.4.1 Characterization of CHITO crosslinking 
The structure of the neutralized and genipin cross-linked chitosan, were analyzed by FT-IR spectra. In 
the case of neutralized CHITO, infrared measurements on fixed (2%) CHITO samples were made at 
different molarities of the neutralizing solution in order to determine the concentration of the neutralizing 
solution components (figure 3.5). From the results obtained, the increase in the NaOH concentration 
corresponds to a relative decrease in intensity of all the characteristic bands of chitosan, which 
corresponds to a decrease in functional groups on the surface of the CHITO sample.  
 
Figure 3.5 FT-IR spectra of CHITO samples neutralized in NaOH solution at different molarity, a) pure chitosan (blu), 2% 
CHITO in NaOH 0.8 M (red), 2% CHITO in NaOH 0.25 M (pink), 2% CHITO in NaOH 0.1 M (yellow). The spectrum of 





For the protocol developed in this experiment, it has been chosen the 0.25 molarityto allow the formation 
of the hydrogel and to maintain, however, a certain amount of exposed surface charges (particularly that 
of the protonated amine groups).  
The same evaluation was carried out on chitosan samples crosslinked in genipin: the covalent cross-
linking with genipin follows the neutralization procedure, therefore the measurement was done on 
neutralized chitosan samples and neutralized chitosan further crosslinked with genipin, and the results 
showed that following the reaction with the crosslinking agent there is a decrease in intensity of the bands 
of the dNH of chitosan (1596 cm-1), however the presence of amine groups persists (figure 3.6). The 
reason for maintaining a certain amount of surface charge of the polymeric substrate (especially of the 
amino groups) must be attributed to the interaction of the polymeric substrate with the cell population. 
 
 
Figure 3.6 FT-IR spectra of CHITO samples cross-linked with genipin; 1 % CHITO in NaOH 0.25 M (blue), 1% CHITO in 





3.4.1 Characterization of sprayed CHITO films  
The minimum number of layers able to support cell adhesion and growth was evaluated and characterized 
by optical and atomic force microscopies, by using 1% chitosan solution accordingly to the previous 
results [18]. Figures 3.7 A-D shows the optical images of 4 different number of layers; increasing the 
number of layers the film become more compact and homogeneous. Measurements of thickness were 
carried out by AFM microscope; apparently 1L films presented discontinuity with a thickness around 10 
nm, instead 6 and 10 layers created a compact film, having millimeter thickness. From these preliminary 
results, 3 layers (3L) CHITO film, apparently more homogeneous than 1L but thinner than 6 and 10L, 
were sprayed also onto MEA and HD-MEA devices to carry out a preliminary electrophysiological 
characterization, figures 3.7 E-F. Moreover, cells were plated also onto petri- dishes coated with 1L. 
Surprisingly, the results showed that also 1% chitosan 1L film was enough to promote e support adhesion 
cells and growth.  
 
 
Figure 3.7 Optical images of 1% CHITO films obtained with different sprayed layers A) 1L, B) 3L, C) 6L and D) 10L; E-F) 






For this reason, all the new experiments based on spray coating, including patterning, were carried out 
onto 1% CHITO 1L film. Spray coating with low concentration of chitosan (< 1%) was evaluated highly 
insufficient to create a film; instead, it was observed that these chitosan concentrations (0.05%, 0.01%, 
0.1%, 0.5%) were able to support adhesion and growth on substrates obtained by dip coting.  
. 
3.4.3 Characterization of 2D neuronal networks on CHITO films  
As a first step, the bioaffinity of CHITO towards neurons was characterized. To conduct this study, a 
simplified standard 2D culture model was adopted and cells were thus plated onto the surface of CHI 
films. In order to evaluate the ability of physically cross-linked CHITO to promote neuronal adhesion 
and development, untreated and treated films with a.p. have been tested.  
 
 
Figure 3.8 Optical contrast phase images of 2D neuronal network: (A) 2% CHITO film untreated with a. p. at DIV 15; (B) 
2% CHITO film treated with a. p at DIV 15; (C) petri dish untreated with a. p. at DIV 15; (D) 2% CHITO untreated film 




Figure 3.8 shows the images of neuronal networks developed onto (A) 2% CHITO untreated film, (B) 
2% CHITO film treated with a.p. and (C) petri dish untreated with a.p. at DIV 15 and (D) 2% CHITO 
untreated film, labeled for Tubulin-βIII and NeuN at DIV 25. With respect to the morphological 
development of the neuronal network, it can be observed that cell morphology is similar when cells are 
plated onto untreated and treated 2% CHITO films (figures 3.8 A and 3.8 B). 
Same results were obtained for cells cultured onto 1% CHITO films. In figure 3.8C, considered as the 
negative control, neurons, as expected, tended to form clusters and no network was obtained. Cells 
showed a homogeneous distribution and the formation of a dense network onto 2% CHITO untreated 
film even at DIV 25 (figure 3.8 D). Moreover, the presence of functional structures at DIV 25 was 
evaluated by 2D networks on 2% CHITO film labeled for Synapsin and VGAT-VGLUT, figure 3.9.  
 
 
Figure 3.9 (A) Neurons grown for 25 DIV on CHITO film marked for the pre-synaptic antibody vs Synapsin (green) and 
NeuN (red); Scale bar: 20 µm. (B) Neurons grown for 25 DIV on CHITO film marked for vesicular GABA transporter, 
VGAT (red) and vesicular glutamate transporter, VGLUT (green); Scale bar: 50 µm. 
 
These results confirm that CHITO naturally promotes adhesion, neurite growth and structural 
development of the network, even without any treatment with a.p.. Overall, both treated and untreated 




of a stable network. Furthermore, in order to confirm chitosan bioaffinity, it was observed the 
morphological development of the neuronal network onto treated and untreated chitosan films 
neutralized and cross-linked with genipin.  Both non-pretreated CHITO films were able to support 
neuronal growth during a period of more than 15 days (figure 3.10 A-B). In all cases, cell behavior is 
similar showing a homogeneous distribution and a dense network. 
 
 
Figure 3.10 Optical contrast phase images of 2D films neuronal network at DIV 15, CHITO film untreated with adhesion 
proteins (a.p.), (left); CHITO-Genipin film untreated with a.p.(middle); CHITO membrane coated with a.p. (right);  
Scale bar: 50 µm. 
 
 
In order to quantify the composition of the cells population during the in vitro network development on 
untreated film, a percentage variation of both the neuronal and glial population has been evaluated, 
according to the method described by Brewer et al. In this method, the serum-free medium is used, which 
allows the development and survival of hippocampal neurons at low levels of glial cells presence. 
Moreover, it should be considered that hippocampal cultures are typically derived from late stage 





Figure 3.11 Immunostaining for GFAP and NeuN to distinguish the two different populations. (A) The population of neuron 
and glia at DIV 3, 7, 15 and 21. (B) Percentage variation of glia vs neurons at DIV 3,7,15,21. 
 
In conclusion, while the glial population is present in our culture, its quantity never exceeds that of the 
neuronal population. Our starting population (DIVs 3) was determined by immunostaining (GFAP and 
NeuN) to be around 95,06 % neurons and 4,94% glia. The population of neuron and glia was determined 
also at DIVs 7, 15 and 21 (figure 3.11).  
 
3.4.3.1 Characterization of 2D neuronal networks on chitosan as a cell adhesion factor  
For the adhesion assay, cells at low density (28-30 cell/mm2) were plated onto poly-ornithine and 




were determined in two experiments by counting at two different step (4 and 24 h) the total number of 
cells attached to the culture substrate in at least 10 visual fields per experiment, figure 3.12. 
 
 
Figure 3.12: Optical images of hippocampal neurons at 4h and 24 on CHITO at 0.01% (A-B), 0.05 % (C-D), 0.1 % (E-F), 
0.5% (G-H) and on PORN substrates (I-L) Scale bar: 30μm. 
 
The number of cells attached after 4 and 24h on CHITO 0.01%, 0.05%, 0.1%, 0.5% and PORN are 
reported in figure 3.13.  
  
Figure 3.13 Plating efficiency, n° neurons adhered after 4h and 24h on different CHITO concentrations substrates and 




Individual cells in low-density cultures were selected, observed after 4h, 24h, 48h, and 72h in culture 
onto chitosan and poly-ornithine. ImageJ and NeuronJ have been used to analyze, trace and measure 
neuritic processes, figure 3.14.  
 
 
Figure 3.14 Stages of neuronal development, A-D) Optical images of hippocampal neurons at 4, 24, 48, 72 hours on spray 
coating 1% CHITO 1L and onto PORN (E-F). Scale bar: 50μm. 
 
The cells reported in figure 3.14 show the same basic series of developmental changes. To compare the 
two substrates, the number of neurites per cell, the average neurites length per cell and the length of the 
major neurite and the total length of minor neurites per cells at different stages 4h, 8h, 24h, 72h were 
evaluated. The number of neurites per cell, increased during the whole culture period (figure 3.15A). 
Neurons were maintained onto both CHITO and PORN substrates, the proportion of cells with neurites 
increased only during the first 24 hr of culture, after 4 hr in culture, less than 5% of cells maintained on 
PORN substrate (control) had developed neurites instead 90% on CHITO substrates. On the CHITO 
substrate, after 4 h, the average total neurite length is almost twice than the control, 15.41±6.59 (CHITO) 





Figure 3.15 Time dependence of the effects of substrate-bound chitosan on neurite lengths. Cells were maintained for 4, 24, 
48, 72hr in culture, and the length of all neurites of process-bearing cells was measured for neurons on the control 
substrate (PORN) and on chitosan (CHITO). Results show the number of neurites per cells (A), the average lengths of all 
neurites (B), the average lengths of major neurites per cell (C), the total lengths of minor neurites (C). 
 
Observing the cultures during the first 72h, the neurites length increased steadily with time on both 
CHITO and PORN substrate (figure 3.15B). To investigate polar growth, that is, asymmetric growth of 
axonal versus dendritic compartments, the longest neurite of a given cell (major neurite) was measured 
separately from the minor neurites of this cell (figure 3.15 C, D). Onto PORN substrates, the growth of 
minor neurites was faster than growth of major neurites. Instead, the growth of major neurites onto 




Differentiation is the establishment of the two distinct classes of neuronal processes, axons and dendrites. 
Because they are differentially distributed, microtubule-associated proteins (MAPS) might be considered 
prime candidates to regulate the spatial control of microtubule function during neuronal development. In 
the processes of mature neurons, MAP-2, is preferentially localized in dendrites, whereas TAU, is 
preferentially localized in axons. At the time that hippocampal neurons become polarized, however, 
MAP-2 and TAU are not differentially distributed; both are present in the axon and in the minor 
processes. To identify the major neurites as axons and the minor neurites as dendrites, the hippocampal 
cultures were stained for MAP-2, TAU and Akirin G (axon initial segment) to study their localization 
during early stages of axonal and dendritic development. Images, in figure 3.16 A-L, show hippocampal 
neuron development onto chitosan and poly-ornithine coatings, in according with Banker’s model figure 
2.  
 
Figure 3.16 A-E) Hippocampal culture development on spray-coating chitosan staining for MAP-2 (green) and TAU (red) 




(green) and TAU (red) at 4, 24,72 hours 5 and 7 days in vitro. Scale bar: 20 μm. M-N) Hippocampal culture development 
on spray-coating chitosan staining for AnkG (green) and TAU (red) at 72 h in vitro. Scale bar: 10 μm. 
 
Despite the double staining, during the first stages in culture (4-24 h), processes were still immature and 
it was difficult to differentiate neuritic processes in axons or dendrites, due to the overlap of the markers. 
After 3 days in vitro, axons and dendrites were well-differentiated and the distribution of these two 
proteins was found to be quite different. Finally, after 72 hours in culture, it can be observed that 90 % 
of neurons grown onto both chitosan and poly-ornithine present the major process, much higher than 80 
µm, consistent with the data provided by Banker. As a result, the average growth rate of the longest 
neuritic process was calculated.  
The average growth rate for poly-ornithine is higher than for chitosan between 24 and 48 hours, while 
between 48 hours and 72 hours the speed is higher for chitosan than for poly-ornithine. The growth values 
are expressed in µm/h. The data described is visible in Table 3.1, Banker affirm that from the second 
day in culture, it is possible to distinguish axon, this one growth at an average speed of 60 µm/d. It can 
be observed that from the second day in culture, the average daily growth rate onto PORN substrate is 
































 Finally, the average growth rate, expressed in µm/d, of the longest neuritic process has been 





































3.4.6 Patterned film 
In each sample it is possible to observe the square pattern according to the geometry of the mask. As can 
be seen in figure 13, the pattern outlined by the cells, is in accord withthe geometry of the mask and the 
low cell density allowed a fairly homogeneous distribution throughout the available area, with the 
exception of the edges where cell clusters can be seen. By enlarging area, it is possible to observe that 







Figure 3.17 2D neuronal network on CHITO patterned film, Hippocampal culture development on spray-coating chitosan 
patterned film staining for MAP-2 (green) and GFAP (red). Scale bar:500 µm. 
 
 
A preliminary spray coating macro-pattern test showed that neurons were homogeneously distributed 
only on the area coated by 1% chitosan 1L film, following perfectly the spray patterned, figure 3.17.   
 
 
3.4.6 Functional characterization of 2D networks. 
The electrophysiological activity of 2D cortical neuronal networks onto HD-MEA was recorded from 
DIV 19 to DIV 30 from hippocampal cultures and from DIV 15 to DIV 30 form cortical neurons, in order 










Figure 3.18: (A) number of active electrodes (hippocampal culture), (B) number of active electrodes (cortical culture), (C) 
Neuronal culture development on CHITO substrate on MEA staining for MAP-2 (green) and NeuN (red) at DIV 24, scale 
bar: 20 µm; (D) Comparison of mean firing rate between 2D neuronal networks developed on CHITO and PORN 
substrates at DIV 22, (E) Comparison of mean bursting rate between 2D neuronal networks developed on CHITO and 
PORN substrate at DIV 22. (F) Neuronal culture development on CHITO substrate on HD-MEA staining for MAP-2 
(green) and NeuN (red) at DIV 24, scale bar: 50 µm. 
 
The number of active electrodes increases up to triplicate at DIV 25, figures 3.18 A and B, for both types 
of cultures. The Mean firing rate and mean bursting rate were evaluated for 2D neuronal networks growth 
on both chitosan and poly-ornithine substrates. In figures 3.18 D-E a comparison between the main 
parameters extracted from 2D networks on both substrates at DIV 22 is reported. This comparison 




coating on both devices, supports the development of a dense and highly connect networks, as it can see 
in figures 3.18 C and D 
 
 
Figure 3. 19 Spontaneous activity characterization of hippocampal cultures: (A) Raster plot showing 10 min of spontaneous 
activity of 2D network on CHITO substrates from DIV 19 to DIV 30. 
 
A quasi-synchronous network bursts (NB) were mixed with random spiking activity from DIV 19 to DIV 
21. The 2D culture exhibited a global activity characterized by long bursts at DIV 23, that became 
completely synchronous from DIV 29, figure 3.19. 
 
         3.5 Discussion 
In the effort of investigating the intrinsic bioaffinity of CHITO, we firstly characterized its ability to 
induce cell attachment and neurite outgrowth without any pre-treatment with adhesion proteins. As a first 
step, this characterization was carried out using standard 2D cell culture models onto the surface of 




were able to support neuronal growth during a period of more than 15 days. A similar observation was 
previously done for soft alginate hydrogels, which were able to support neural cell cultures in monolayer 
or spheroids [19,20]. However, the use of alginate as supporting material for neuronal cultures is 
controversial, since it requires Ca2+ ions for its ionic cross-linking and it is well known that neurons and 
glial cells are extremely sensitive to Ca2+ ions, even at nM concentrations [21]. To our knowledge, this 
is the first work reporting the ability of pure CHITO to support neuronal cell attachment and functional 
neuronal network development. This represents a valuable contribution in the search for low-cost 
biomimetic culture systems, which can have important applications in neuropharmacology, toxicology, 
and regenerative medicine [22,23].  Individual cells, in low-density cultures were selected and observed 
after 4h, 24h, 48h, and 72h in culture onto chitosan and poly-ornithine substrates. The cells in figure 14 
follow the basic developmental changes of the Barker’s model. The number of neurites per cell increased 
during the first 24 hr of culture on both control and chitosan coatings, figure 3.15A. On chitosan 
substrates, 4h after plating, the cells developed the first neuritic processes more than on the control one, 
where cells without neuritic processes were more than 70%. On both substrates, the proportion of cells 
with neurites increased steadily until 24 hr, when it all neurons bearing processes. Between 24 - 48h, the 
number of neurites per cell on chitosan and on poly-ornithine did not increase further, leading to 
significantly lower values on chitosan than under control conditions. Then, a strong increase was 
observed after 48h when the numbers of neurites per cell on control and chitosan substrates reached 
similar values, figure 3.15A. Furthermore, the total length of all neurites per cell increased steadily with 
time on both substrates, but chitosan showed higher values than poly-ornithine, figure 3.15B. Both 
chitosan and poly-ornithine affect neurite outgrowth in a manner dependent on the culture time. The total 
length of minor neurites per cell was higher on the control substrate during the first 48 hr of culture and 
this result has been supported also by the fact that PORN substrates showed the highest number of 




onto CHITO substrate, figure 15D. The total length of minor neurites on chitosan substrates increased 
in accord to the rapid growth in the number of neurites after 48h, figures 3.15 A-C. Chitosan thus favored 
growth of major neurites over growth of minor neurites and therefore increased neuronal polarity at later 
stages of neuritogenesis, figure 15D. After 72 h in vitro, axons and dendrites were well-differentiated 
and the distribution of MAP-2 and TAU confirmed this thesis. In all cases, petri dishes, MEA and HD-
MEA coated with 1% chitosan 1L were able to support neuronal growth and cell behavior was similar 
showing a homogeneous distribution and a dense network, figure 3.18 C and F.  In addition, the same 
data were compared with the data provided in the literature, taking into account that the neurons studied 
by Banker were grown on poly-lysine substrates. By comparing the average growth of the longest neuritic 
process of neurons grown on CHITO and PORN substrates with the data provided by Banker, it is 
possible to affirm that the neuritic process growth mode depends on substrate types.  The growth of the 
major process on PORN (black) is gradual and very similar to the model describied by Banker for poly-
lysine-grown neurons (magenta) and this is not surprising given the similarity between PORN and poly-
lysine as growth factors. For the neurons grown on CHITO (green), at 24h and 48h, the behavior is 
similar to PORN and poly-lysine, while at 72h it is completely different, figure 3.20.  
 




The standard methods for the functionalization of supports used for 2D cell cultures are based on the use 
of poly-lysine and PORN, which generally have a high cost. These macromolecules containing amino 
groups, have been frequently used as coating materials for in vitro neuronal substrates, as electrostatic 
attraction between the positive charges of the NR3
+ groups on a culture substrate and the negatively 
charged neuronal membranes has been suggested as an indispensable factor for stable neuronal adhesion 
and proper development. In this work, CHITO has been introduced as an alternative adhesion factor used 
to support neuronal culture. CHITO can behave as a poly-cation under acidic conditions (pH<6), due to 
the protonation of free amino groups, showing along the chains NR3 + groups in a similar way of that 
one present along the standard macromolecules, figure 3.21. 
 
 
Figure 3.21. Chemical structures of Chitosan, poly-ornithine and poly-lysine. 
 
            3.6 Conclusions 
The 2D cultures growth onto chitosan films were investigated in the view of gain information on the 
bioactivity of chitosan in terms of cell adhesion ad network development. We demonstrated that the 
natural and low-cost polysaccharide chitosan possesses excellent processability, film forming properties 
and more importantly bioactivity towards all tested neuronal populations. The spray-coating technique, 
through a conventional airbrush, was selected as coating method since it is widely recognized as a 




giving also the possibility of producing a desired micropattern through the use of stencil masks. The use 
of the chitosan as adhesion factor leads to the development of a homogeneous, dense and highly 
connected electrically active network.  The main advantages of this disclosure are related to the speed-
up of the supports preparation before cell seeding, with the possibility of preparing micropatterned 




















Chitosan– based microbeads 




This chapter was adapted from the following publication: 






4.1 Chitosan microbeads scaffolds 
In literature is reported that hydrogel structure can be modified to take the form of a granular structure, 
better replicating the structure of brain tissue. This multiphase structure encompasses hydrogel granules 
surrounded by an ECM rich secondary phase into which cells are seeded. Granular hydrogels readily 
fluidize when compressed, a property known as shear thinning [179]. This increases the injectability of 
this systems. Cells can be mixed homogeneously whit hydrogel granules, which act as a protective 
medium that supports cell viability during delivery. In a stem cells delivery therapy for traumatic brain 
injury, a microsphere chitosan hydrogel scaffold functionalized whit heparin to bind FGF-2 was shown 
to support radial glial cell (RGC) delivery when injected into a rat brain contusion model [180]. 
Moreover, granular scaffolds have also been found to facilitate cell infiltration and promote 
vascularization in-vivo. In a recent work, chitosan microspheres based scaffold was implanted into a rat 
spinal cord injury model and the granular hydrogel was found to elicit a dynamic restorative process, 
promoting axon outgrowth, vasculature ingrowth and diminishing fibrous glial scarring and the 
inflammatory response [181]. Chitosan microspheres have been produced via different techniques as 
spray drying [182,183], emulsification [184], internal gelation [185,186], electrospinning and freeze 
drying processes.  
 
4.2 Aims 
Physically and covalently cross-linked chitosan microbeads were then fabricated by an aerodynamically 
assisted jetting technique, characterized by optical and atomic force microscopies (AFM) and then used 
as scaffold for 3D hippocampal neuron cultures. The 3D neuronal networks were characterized 
morphologically by transmission electron microscopy (TEM), by immunofluorescence techniques and 




3D networks were recorded after 21 days of in vitro culture (21 DIV); results were compared with those 
obtained using glass microbeads [187] as 3D scaffold for neuronal growth. 
 
     4.3 Materials and methods  
 
Materials  
Chitosan (CHI) solution: CHITO (medium molecular weight, 75-85% deacetylated, code 448877, lot 
MKBD4275V, from Pandalus Borealis), was dissolved in 0.1 M acetic acid at concentrations 1% and 2% 
w/v under continuous stirring for two hours and filtered through a syringe filter (5µm) to remove any 
undissolved material.   
Neutralizing solution: H2Odd 40%, Ethanol 60% and sodium hydroxide 2% w/v  
Genipin solution: genipin 2% in H2Odd  
Laminin: P-D-Lysine (1:1) solution:  concentration of 0.05 mg/ml in sterile water  
Filtered CHITO solutions were extruded using a microencapsulation unit (Nisco Encapsulation Unit 
VAR J30) equipped with a conical nozzle having a diameter of 0.25 mm [32], figure 22. The extrusion 
flow rate was 0.4 ml/min under 100 mbar pressure for 1% CHITO, whereas for 2% CHITO the extrusion 
flow rate was 0.5 ml/min under 200 mbar pressure. The generated micro-droplets were collected into 150 
ml of gelling solution bath while continuously stirring at 200 rpm. The distance from the nozzle to the 
gelling solution was set at 6 cm. The resulting microbeads were left in contact with the gelling solution 
for 30 min at room temperature to ensure complete solidification. Afterwards, the gelling solution was 
removed through. The production yield was evaluated using optical microscopy. An inverted optical 
microscope (IX-51 Olympus microscope equipped with a DP70 digital camera and with a 10X N.A. 0.25 




the “analyze articles tool” of ImageJ software (NIH, USA) was used to evaluate the projected areas of 
the microbead. Areas of particles touching each other were separated by watershed segmentation. 
 
4.3.1 Nisco Encapsulation Unit VAR J30 
The J30 is the aerodynamically assisted jetting equipment shown on the figure 4.22. The product enters 
through a central needle. The exit orifice, which is centrally in line with the axis of the needle, has been 
counter-sunk externally. The counter sunk leads to the aero dynamical effect so that the jet has a smaller 
diameter when passing the orifice than before at the needle. The needle is enclosed in a pressure chamber 
with an exit through the orifice. The size of the drops is determined by the product flow rate and the 
pressure inside the chamber. The product flow rate is typically controlled by a syringe to be connected 
to the product nozzle. The pressure in the pressure chamber is controlled by the specifically for the J30 
developed Nisco pressure control unit consisting of a pressure sensor and a digital indication. The 
pressure set point can be fixed with a potentiometer.  
Parameters to be monitored for the process optimization are Flow rate, nitrogen pressure, type of nozzle 
(100, 250, 350, 500, 1000 μm), distance between nozzle and neutralizing solution, speed of stirrer.  
 
 




The generated micro-droplets were collected into the gelling bath while continuously stirring. The 
resulting microbeads are left in contact with the gelling solution for 30 min at room temperature to ensure 
complete solidification. Afterwards, the gelling solution was removed through centrifugation (1000 rpm 
for 5 min), followed by four washing steps in distilled water.  
In our case, chitosan films and microbeads were synthetized by physically and chemical cross-linking:  
Phase-inversion, using neutralization solution (H2Odd 40%, Ethanol 60% and NaOH 2% w/v)  
 
CHITO-NH3 + OH → CHITO-NH2 + H2O 
 
Covalent cross-linking, using a naturally crosslinking agent genipin. Genipin is extracted from the fruit 
of the gardenia plant. Chemical crosslinking is achieved by the covalent bond between two chitosan 
primary amines through one genipin molecule (figure 4.23). Chemical crosslinking of chitosan by 









Before the covalent cross-linking with genipin, 1% CHITO films and microbeads are neutralized by 
NaOH solution. The prepared CHITO films and microbeads are, respectively, immersed in the genipin 
solutions for crosslinking (12h). followed by four washing steps in distilled water.  
 
4.3.2 Cell preparation  
Hippocampi were dissected and removed from embryonic Sprague-Dawley rats at gestational day 18 
under sterile conditions. Hippocampal fetal tissue was enzymatically digested in Trypsin 0.125% in Ca++ 
and Mg++ free Hank’s (Gibco Invitrogen) for 20’ at 37°C. The enzymatic process was quenched by 
adding culture medium supplemented with 10% of FBS (Sigma-Aldrich) then the tissue was 
mechanically dissociated with a smoothly fire-polished Pasteur pipette. Neurons were re-suspended in 
plating medium consisting of Neurobasal medium (Gibco Invitrogen) with 2% w/v B-27 Supplement 
(Gibco Invitrogen), 1% Glutamax (Gibco Invitrogen), 1% Pen-Strepto (Gibco Invitrogen). Cultures were 
maintained in incubator at 37°C in a 5% CO2, 95% humidity atmosphere for 3-4 weeks by replacing half 
of the medium once a week. The experimental protocol was approved by the European Animal Care 
Legislation (2010/63/EU), by the Italian Ministry of Health in accordance with the D.L. 116/1992 and 
by the guidelines of the University of Genova. All efforts were made to reduce the number of animals 
used for the project and to minimize their suffering.  
 
4.3.3 Characterization of chitosan microbeads  
The mean particle size and size distributions were evaluated using optical microscopy. The mean particle 
size was evaluated using ImageJ software as described above.  To perform SEM imaging, microbeads 






4.3.3.1 Water content 
2.5x106 microbeads in 0.5 ml of water were weighed inside an Eppendorf tube and were then lyophilized. 
The weight of the dried microparticles was measured and the water content was calculated using the 
following equation, where Ws is the weight of hydrated microbeads and Wd is the weight of the 
lyophilized ones:  
Water content = ((Ws - Wd))/(Ws)) x 100% 
 
4.3.3.2 Atomic Force Microscopy (AFM) 
A commercial atomic force microscope, equipped with a closed loop scanner capable of 9 μm vertical 
range (Keysight Technologies, model 5500ILM), was used to measure both the topography and the 
stiffness of the microbeads. Rectangular micro-cantilevers (Mikromash HQ: CSC38, type B, nominal 
spring constant k=0.03 N/m) either with a conical tip or without any tip were employed. Images of the 
topography of single beads were obtained in contact mode, by careful adjusting the lowest possible force 
to keep the contact during the whole scan. In order to evaluate the stiffness of the beads, standard force 
curves were recorded and the region after contact was considered for further analysis. The applied load 
for cantilever deflections was calculated by first converting the output voltage, from the AFM four-
segment photodetector, into nanometers of deflection, and then by multiplying the deflection by the 
cantilever spring constant. The conversion factor was calculated by taking several force curves onto a 
hard glass substrate each time the laser spots on the cantilever had to be adjusted, and by considering the 
reciprocal of the average slope of the constant compliance region of the curves. When using sharp conical 
tips, the load versus indentation curve was evaluated to extract the elastic modulus of the sample using 
the model proposed by Oliver and Pharr [188] as already described in [189]. When using tipless 
cantilevers the load versus microbead deformation curve was evaluated in order to extract the stiffness 




constant approaching/retracting speed of 1 mm/s. This allowed us to compare results, despite the viscous 
(i.e. speed-dependent) response of the CHITO microbeads. In order to take into account intra-sample 
heterogeneity, 16×16= 256 force curves were recorded over a regular grid over a 5×5 μm.  
Microbeads were adsorbed onto the surface of a petri dish pre-modified by the deposition of a layer of 
polyethylenimine (PEI 1mg/ml in pure water, from Sigma Aldrich), followed by a layer of polystyrene 
sulfonate (PSS 2mg/ml, Sigma-Aldrich). For both samples, three maps of 16×16 curves were collected 
onto three different microbeads randomly selected over the petri surface. 
 
4.3.3.3 Preparation of 3D networks on CHITO microbeads 
The day before plating, microbeads were sterilized by exposure to ethanol 70% for 2h. The sterilized 
samples were then washed with sterile water 5 times, normalized in cell culture medium and used for the 
cell culture experiments. To evaluate the bioaffinity between CHITO and neurons, cultures were prepared 
using both microbeads treated and untreated with adhesion proteins (a.p.). 
In the first case, microbeads were exposed to a mix of a.p., namely Laminin: P-D-Lysine (1:1) solution, 
and left in the incubator overnight at 37°C. The microbeads were centrifuged three times, for 5 min at 
1000 rpm. Each centrifugation step was followed by a washing step in sterile water. In the second case, 
microbeads were sterilized and used without any further treatment. Before cell plating, microbeads were 
washed in a Neurobasal medium and then exposed to the cell suspension in complete Neurobasal 
medium; the ratio of the number of microbeads to the number of neurons was nominally 1:4. Eppendorf 
vials were used for this step; 106 microbeads/ml and 4x106 cells/ml were mixed and after an interval of 
around 3-4 hours they aggregated and formed small clusters. The vials were kept in horizontal position 
and turned for 12-16 times at 20-25 min intervals in order to expose the whole microbead surface to the 
suspended cells. At the end of the incubation-adhesion phase, the neuron-microbead aggregates were left 




small volumes (30-35µl), and directly transferred onto standard petri dishes (∅35mm) for subsequent 
immunocytochemistry characterization, or plated onto the MEA surface for electrophysiological 
characterization.  The day before plating, MEAs were assembled with donuts-shaped Poly-dimethyl-
siloxane (PDMS) structures (internal and external diameters: 5 and 22 mm respectively, height: 650 µm) 
to confine the self-assembled microbeads and neurons onto a circular surface of 20 mm2 around the active 
electrodes area (figure 4.24A). MEAs (assembled as explained above) were sterilized in the oven at 120° 
for 2 hours. At the end of the sterilization process, the chips were treated only on the area delimited by 
the PDMS structure, with a mix of a.p. namely Laminin: P-D-Lysine (1:1), at the concentration of 0.05 
mg/ml in sterile water (L-2020; P-6407 Sigma) and left in the incubator overnight at 37°C. The coating 
solution was removed from the MEA which was then washed twice with water and left to dry under the 
laminar hood until the plating took place. Similarly, to what performed in [187], hippocampal neurons 
without microbeads were first plated onto the MEA surface to create a first monolayer of cells at a final 
concentration of 800-1000 cell/mm2. 3-4 hours after plating, 30-35 µl of neuron-microbead aggregates 
were transferred inside the PDMS confinement structure onto the area on which hippocampal neurons 
were previously seeded (figure 4.24B). Around 4.5x104 microbeads and 1.5x105 cells were transferred 
into MEAs. 
 
Figure 4.24 Set-up configuration, (A) Micro-electrode arrays (MEAs) made up of 60 planar microelectrodes (TiN/SiN, 30 
mm electrode diameter, 200 mm spaced) arranged over an 8 X 8 square grid with inserted PDMS (internal diameter 5 mm) 




4.3.3.4 Morphological characterization of 3D neuronal networks by transmission 
electron microscopy 
In order to analyze the samples with Transmission Electron Microscopy (TEM), the 3D networks on CHI 
2% were fixed for 2 hours in a fixative solution (2% Glutaraldehyde, in buffer Na-Cacodylate 0.1M) and 
then post-fixed (2h) in a solution 1% OsO4, 1,5% Potassium Hexacyanoferrate, in Na-cacodylate buffer 
0.1M. Subsequently, they were stained overnight in a 1% Uranyl acetate aqueous solution and dehydrated 
with series of alcohols. TEM samples were infiltrated with Propylene Oxide and low viscosity Spurr 
resin (SPI-Chem). Once the resin hardened, 70 nm thick sections were cut with a Leica EMU C6 ultra-
microtome. TEM images were collected by means of Jeol JEM 1011 (Jeol, Japan) TEM, operating at an 
acceleration voltage of 100 kV, and recorded with a 11 Mp fiber optical charge-coupled device (CCD) 
camera (Gatan Orius SC-1000). All used reagents were from Sigma-Aldrich. 
 
 
4.3.3.5 Morphological characterization of neuronal networks by 
immunocytochemistry 
To assess the expression of specific neuronal markers, hippocampal cultures were fixed in 4% 
paraformaldehyde in phosphate buffer solution (PBS), pH 7.4 for 30 min at room temperature. 
Permeabilization was achieved with PBS containing 0.5% Triton-X100 for 15 min at room temperature 
and non-specific binding of antibodies was blocked with an incubation of 45 min in a blocking buffer 
solution consisted of PBS, 0.3% BSA (bovine serum albumin Sigma) and 0.5% FBS. Cultures were 
incubated with primary antibody diluted in PBS Blocking buffer for 2 hours at room temperature or 
incubated at 4°C overnight in a humidified atmosphere. Cultures were rinsed three times with PBS and 
finally exposed to the secondary antibodies. The following primary antibodies were used for CHITO 




(similar TUJ1) 1:500 (Chemicon Millipore), NeuN 1:200 (Chemicon Millipore), Dapi 1:10000 (Sigma).  
Cultures were rinsed twice with PBS and finally exposed to the secondary antibodies: Alexa Fluor 488, 
Alexa Fluor 549, Alexa Fluor 633 Goat anti mouse or Goat anti rabbit, diluted 1:700 and 1:1000 
(Invitrogen Life Technologies S. Donato Milanese). 
To observe the perineuronal net-like structure, we exposed samples to Wisteria floribunda 1:200 (Sigma-
Aldrich) as primary antibody for 24h and Streptavidin Alexa Fluor 488, 1:700 (Invitrogen Life 
Technologies S. Donato Milanese) for 6h as secondary antibody. 
 
4.3.3.6 Optical microscopy and confocal imaging 
An inverted IX-51 Olympus microscope equipped with a DP70 digital camera coupled with CPlan 10X 
N.A. 0.25 PhC objective was used to acquire contrast phase images of CHI microbeads coupled with 
neurons. An Olympus BX-51 upright microscope was used for immunofluorescence evaluation of the 
biological samples and the image acquisition was done with a Hamamatsu Orca ER II digital cooled 
CCD camera driven by Image ProPlus software (Media Cybernetic). 
Confocal imaging was acquired on two different microscopes: Leica TCS SP5 AOBS Tandem DMI6000 
inverted microscope coupled with objective Leica IRAPO 25X, 0.95 NA (Leica Microsystems, 
Mannheim, Germany) and Leica TCS SP5 AOBS Tandem DM6000 upright microscope coupled with 
objective Leica IRAPO 25X, 0.95 NA (Leica Microsystems Srl, Italy). Data were analyzed by means of 
the LASX V2.0 software (Leica Microsystems Srl, Italy). 
 
4.3.3.7 MEA recording and analysis 
The spontaneous electrophysiological activity of 3D hippocampal neuronal networks was recorded at 21-
24 days in vitro (DIV) by means of micro-electrode arrays (MEAs) made up of 60 planar microelectrodes 




electrodes at the corners), supplied by Multi Channel Systems (MCS, Reutlingen, Germany). The 
electrophysiological activity was acquired with the 2100 System (MEA 2100-System, MCS), and signals 
were sampled at 10 kHz. Recordings were performed for 30 min outside the incubator at a temperature 
of 37 °C. To prevent evaporation and changes of the pH medium, a slow flow of humidified gas (5% 
CO2, 20% O2, 75% N2) was constantly delivered during the measurement sessions into a small plastic 
box covering the experimental MEA setup. 
 
  4.3.3.8 Data and Statistical analysis 
Data analysis was performed by using a custom software package named SPYCODE [176], developed 
in MATLAB (The Mathworks, Natick, MA, USA). Spike detection was performed by using the Precise 
Timing Spike Detection (PTSD) algorithm [177]. The algorithm requires three parameters: a different 
threshold set to 8 times the standard deviation of the baseline noise, a peak lifetime period (set at 2 ms) 
and a refractory period (set at 1 ms). To characterize the electrophysiological activity, we extracted some 
first order statistics. In particular, we evaluated the mean firing rate (MFR), i.e., the number of spikes per 
second of each channel and the percentage of random spikes, i.e., the fraction of spikes outside bursts. 
We also performed burst detection according to the method described in [178]. A burst is a sequence of 
spikes having an ISI (inter-spike interval, i.e., time intervals between consecutive spikes) smaller than a 
reference value (set at 100 ms in our experiments), and containing at least a minimum number of 
consecutive spikes (set at 5 spikes). The parameters extracted from this analysis are the mean bursting 
rate (MBR) and the mean burst duration (MBD), which are the frequency and the duration of the bursts 
at the single channel level respectively. The same approach used for the detection of bursts was applied 
for the detection of quasi synchronous events at network level called network bursts [176]. The extracted 
parameters are the network bursting rate (NBR) and the network burst duration (NBD), which are the 




Statistical analysis was carried out using OriginPro 8 (OriginLab Corporation, Northampton, MA, USA). 
All data are presented as mean ± standard error of the mean. Statistical analysis was performed using a 
non-parametric Kruskal-Wallis test, since data do not follow a normal distribution (evaluated by the 
Kolmogorov-Smirnov normality test). Differences were considered statistically significant when p < 10-
3. In order to determine which of the sample pairs are significantly different, post-hoc test, using Dunn’s 
test, has been applied. 
 
 4.4 Results 
      4.4.1 Preparation and characterization of CHITO microbeads 
1% and 2% CHITO microbeads were prepared and characterized in view of their use as scaffolds for 
neuronal growth. The instrumental parameters, for microbeads production, were optimized in order to 
promote the formation of the micro-droplet spray and to avoid aggregation of microbeads on the 
air/gelling solution interface. The production yields were evaluated to be around 0.9x106 and 0.7x106 per 
batch for 1% and 2% CHITO respectively. Optical microscopy images of the obtained samples were 
acquired and analyzed. The results indicated a spherical shape and a size ranging from 40 to 90 µm, with 
an average diameter of 66 ± 20 µm, for 1% CHITO, while for 2% CHITO the size ranged from 40 to 160 
µm, with an average diameter of 100 ± 40 µm, figures 4.25 A-B. Water content values were found to be 
98.4% and 99.3% for 2% and 1% CHITO microbeads, respectively.  
AFM topography showed nanometer sized features onto a rounded profile. The elastic modulus of the 
microbeads was first evaluated by AFM indentation measurements using microcantilevers with conical 
tips. The elastic modulus measured on 2% CHITO microbeads was in the range 15-25 kPa, whereas 1% 






Figure 4.25 Characterization of CHITO microbeads, (A) Histogram of the distribution of 1% CHITO microbeads size; (B) 
Histogram of the distribution of 2% CHITO microbeads size; (C) Topography AFM image (second order flattened) of 15 X 
15 mm2 of a single 2% CHITO microbeads in culture medium, the insert shows the profile of the raw data from a single line 
(blue line); (D) Stiffness values measured by AFM on 1% and 2% CHITO microbeads. 
 
 
Figure 4.26 Three representative AFM force-distance curves taken on 1%, 2% CHITO microbeads, and a reference hard 
surface, respectively, using a the same tipless cantilever. Both approach-loading and retract-unloading portions of the 
curves are plotted (black and red lines, respectively). A rather constant slope in the region after contact can be clearly 
observed for all curves. The lower slope when pressing against a CHITO microbead indicates that the bead deforms under 




Therefore, we used a tipless cantilever of the same type to press against a single microbead. The slope 
of the force curve after contact resulted constant for a wide range of applied forces (1-10 nN) and with 
negligible hysteresis between loading and unloading (figure 4.26). This slope represents the stiffness of 
the microbeads. Stiffness values obtained from the constant compliance region of curves performed on 
different microbeads using the same cantilever and the same approach-retract speed can be directly 
compared. In figure 4.25D average stiffness values measured on 1% and 2% CHITO microbeads are 
plotted. The values are normalized versus the average stiffness of 2% CHITO beads. 1% microbeads 
were found to be, on average, 18 fold softer than the average stiffness of the probed 2% microbeads. 
Interestingly enough, the range of the elasticity value for 1% CHITO microbeads that can be inferred by 
our measurements (1/18 of 15-25 kPa) falls in the same range of reported elasticity values for brain tissue 
(0.7-1 kPa) [190,191].   In addition, also, genipin-crosslinked microbeads were characterized. These 
microbeads shown a spherical shape and a size ranging from 120 to 140 µm. Water content values were 
found to be 96,8% The elastic modulus of the microbeads was in the range of 0,8-1 kPa.  
 
 
Figure 3.27 FE-SEM images, (A) 1% CHITO microbead, scale bar: 20 μm; (B) 2% CHITO microbead, scale bar: 5 μm; 




microbead surface, Scale bar: 2 μm; (F) 2% CHI microbeads, Scale bar: 100 μm; (G) zoom of 2% microbead surface, Scale 
bar: 2 μm. 
 
The surface morphology was then characterized by FE-SEM (figure 4.27).  1-2 % CHITO microbeads 
show a surface rough and porous; instead, genipin-crosslinked microbeads have a compact and smooth 
surface.  
 
 4.4.2 Preparation and characterization of 3D neuronal networks on CHITO 
microbeads 
As a first step, in order to verify the bioaffinity of CHITO also in the form of microbeads, cells were 
cultured onto CHITO microbeads both untreated and treated with a.p. The obtained 3D cultures were 
observed by contrast phase optical microscopy during the first two weeks of culture in vital conditions. 
In both cases, a branched and entangled expression of neurites and the presence of healthy neurons, which 
was demonstrated by the refractivity of the neuronal soma, were observed. All subsequent experiments 
were carried out onto 3D neuronal networks grown onto 1% and 2% CHITO microbeads pre-treated with 
a.p.. This was done in order to compare the properties of the 3D networks grown onto CHITO microbeads 
with the ones grown onto glass microbeads as described in [25]. TEM characterization was carried out 
in order to appreciate the interaction between CHITO microbeads and cultured cells. From low 
magnification imaging (figure 4.28A) it is clear that cells and microbeads (marked with black 
asterisks) create a dense network. Because of the electron microscopy staining, cell bodies and dendrites 
appear darker compared to the microbeads, allowing to observe that cells both envelop and penetrate the 
chitosan scaffold. Higher magnification images show more in detail the interaction among neurons and 
CHITO microbeads. Figure 4.27B shows a neuronal cell and its axon pushing out between two beads, 





Figure 4.28 Low-mag TEM micrograph of a portion of chitosan scaffold with the neuronal network, (A) CHITO 
microbeads are marked with the asterisks, while cells appear darker, the dark arrow highlight a glial cell. (B) A neuron 
grown between two microbeads (1000x). The dark arrows indicate dendrites inside the chitosan. (C) A detail (2500x) of the 
interface cell-CHITO microbeads. Synapses are marked with the letter s. (D) High-mag (15000x) detail of dendrites taken 
far (15 mm) from the bead surface. 
 
Besides this, it is clear how smaller dendrites enter inside the chitosan, as underlined by the black arrows. 
In figure 4.27C is reported a detail of the interface between cells and CHITO microbeads, where many 
neurons components are evident: cell bodies, axons with distinct tubulin cytoskeleton, small dendrites, 
spines and synapses. From these two images, it is clear that on the microbeads surface there is a dense 
network made up of axons and dendrites of different size, while only the smaller dendrites penetrate into 




surface (about 15 µm). The size of these terminations is smaller (<400 nm), but they are clearly neural 
dendrites, as suggested by some details as the cytoskeleton and the vesicles.  
Indirect immunofluorescence techniques were then used to assess the in vitro morphological and 
functional cell behavior and to characterize the 3D structure of the network. To this purpose, after 25 
DIVs, at the end of the recording sessions, 3D cell-scaffolds were fixed with PFA 4% and labeled by 
using a panel of ad-hoc selected antibody molecules. The 3D neural networks were then characterized 
by confocal microscopy on MAP-2 labeled neurons and on MAP-2 and Tubulin βIII. Overall, the 
thickness of the 3D neuronal network on the 2% CHITO microbeads was evaluated to be around 300-
500 µm. Figure 4.29 shows the neuronal network development around the CHITO microbeads (A, C) 
and around glass microbeads (B). We can see (figure 4.29A, left and middle) neuronal soma from which 
rich neuritic arborizations depart. This is particularly evident around the CHITO microbead surfaces 
while it becomes partially fragmented due to the penetration of neurites into the microporous volume of 
the microbeads (white arrows). In the case of the glass microbeads, the neuronal network development 
was confined onto the surface of microbeads, without any fragmentation (figure 4.29B, left). Moreover, 
the shape of the soma was found to be spherical in both cases (figures 4.29 A-B, middle), as the one 
observed in vivo [25, 34]. Figure 4.29A (right) shows a section of the 3D culture where it is possible to 
observe the close assembly between CHITO microbeads mediated by neuronal cells. Instead, in the case 
of glass microbeads a hexagonal structure was observed characterized by well-defined and separated 
microbeads (figure 4.29B, right). Figure 4.29C left shows the structural proteins of the cytoskeleton of 
the 3D network on 2% CHITO microbeads. Figure 4.29C right shows the high density of synaptic puncta 
present on the 3D network. In the formation of brain-like constructs a pivotal role in the survival and 





Figure 4.29 Confocal microscope images of 3D neural network at DIV 25: (A) 3D neural network on 2% CHITO 
microbeads (left), single 2% CHITO microbead surrounded by almost six neurons (middle) and a section of 3D neural 
network on 2% CHITO microbeads (right), MAP-2 (green) and Synapsin (red). (B) 3D neuronal network on glass 
microbeads (left), single glass microbead surrounded by five neurons (middle) and a section of 3D neural network on glass 




fragmentation. (C) 3D neural network on 2% CHITO microbeads (left) labeled for MAP-2 (green), Tubulin βIII (red) and 
DAPI (blue), 3D neural network on 2% CHITO microbeads (right) labeled for Synapsin (green) and DAPI (blue). 
 
 
In order to highlight the morphology of glia cells, fixed 3D and 2D cultures were exposed to GFAP 
primary antibody followed by secondary antibody Alexa Fluor 549. It can be observed that the GFAP 
positive cells cultured both on 2D film and 3D microbeads 2% CHITO (figures 4.30 A-B) present a 
different morphology compared to GFAP positive cells cultured at the same conditions but on the 2D 




Figure 4.30 Optical images of glial cells labeled for GFAP (DIV 25): (A) 2D network on CHITO film; (B) 3D network on 
2% CHITO microbeads; (C) 2D network on petri dish. The white arrows point CHITO microbeads. 
 
 
These results suggest that the chemical and mechanical environments play a relevant role on the 
morphological behavior. Similar observations were already reported in previous works [35-40].  The 3D 
structure of neuronal networks after 24 days of culture fixed and immunolabeled for the dendritic marker 





Figure 4.31 Max intensity projection, Orthogonal View and Rendering 3D of population neurons network on the scaffold 
labeled (DIV 24) for MAP-2: Cross-sectioning along different axes XZ (A), XY(C), YZ (D); (B) Volumetric representation 
(XYZ) of neuronal networks from the same sample. 
 
. 
 Both the 3D reconstruction of 148 µm z-stack of the hippocampal network and the projections along 
different axes are shown, thus giving a comprehensive view of the neuronal network onto the CHITO 
microbeads scaffold (figure 4.31B). The max intensity projection of the orthogonal view is represented 
in this figure: XZ projection (figure 4.31A) shows CHITO microbeads profiles wrapped by neuronal 
network; figure 4.31C and 4.1D show XY – YZ projections.  
 
           4.4.3 Functional characterization of 3D networks 
In order to perform the electrophysiological characterization of the 3D networks grown onto CHITO 
microbeads and to compare the obtained results with the ones reported in [187], CHITO microbeads were 




this final step, a 2D neuronal network was directly coupled to the active area of MEA in order to establish 
a good communication between the 3D culture and the underlying microelectrodes. Figure 4.32 shows 
the spontaneous activity (raw signal) of 10 s of a 3D CHITO network as recorded from one 
microelectrode and characterized by two bursts and random spikes. The global electrophysiological 
behavior of representative 3D networks, is qualitatively showed in the raster plots of figures 4.32B and 
C, where 300 s of spontaneous activity are displayed. In both experimental conditions (CHITO, figure 
32B and glass microbeads, figure 4.32C, quasi-synchronous network bursts (NB) are mixed with random 
spiking activity. However, 3D networks with CHITO microbeads scaffold exhibit a global activity 
characterized by longer bursts than glass microbeads ones. After 21 DIV, we recorded 30 minutes of 
spontaneous activity of n = 3 CHITO 1% networks, and n = 3 CHITO 2% networks, and we compared 
the obtained results to n = 3 cultures where the 3D scaffold was realized by means of glass microbeads. 
Figures 4.32 D-I show the parameters extracted from the analyzed spike data. CHITO 1% networks 
presented values of MFR (2.3±0.14 spikes/s), statistically different from the CHITO 2% ones (0.86 ± 
0.05 spikes/s; p < 0. 001) but similar to the MFR of the 3D glass microbeads networks (2.97±0.55 
spikes/s). All the 3D experimental configurations display high values of random spiking activity (figure 
4.32E): specifically, CHITO 1% and 2% networks show higher (statistically significant) values with 
respect to glass microbeads ones. Regarding the bursting behavior, the MBR of CHITO 2% networks 
showed the lowest value (3.74 ± 0.31 (bursts/min)) which is significantly different (p < 0.001) from the 
CHITO 1% and glass microbeads networks. (ms)) significantly higher (p < 0.001) than the other two 
configurations that share similar MBD values (175.10 ± 16.41 ms and 190.70 ± 10.53 ms for CHITO 2% 





Figure 4.32 Spontaneous activity characterization, A) 10 s of raw data recorded from a single microelectrode. Raster plot 
showing 300 s of spontaneous activity of 3D network on (B) 1% CHITO microbeads and(C) on glass bead; (D) mean firing 
rate, (E) percentage of random spiking activity, (F) mean bursting rate, (G) mean burst duration, (H) network bursting rate, 




On the other way, round (figure 4.32G), 1% CHITO networks exhibited a MBD (310.5 ± 18.19). Finally, 
the NB activity was investigated by computing the network mean bursting rate (NBR; figure 4.32H) and 
duration (NBD; figure 4.32I). NBR was similar for 1% CHITO and glass microbeads networks and 
statistically different with respect to 2% CHITO networks. Again, for the NBD, 1% CHITO was different 
from 2% CHITO and glass microbeads that are in turn characterized by shorter bursts (0.32± 0.036 s and 
0.43± 0.067 s, respectively). 
   
 4.5 Discussion 
          4.5.1 Characterization of CHITO microbeads 
In this work, we explored the use of CHITO microbeads to actively support 3D functional neuronal 
cultures.  CHITO was chosen for its biocompatibility, biodegradability, and low cost [171]. Moreover, 
in the literature it is reported that the positive charges of primary amines onto the polymer backbone 
favor the electrostatic interaction with the negatively charged cell membranes [192-195], promoting cell 
adhesion and growth.  In general, the stiffness, porosity, and electrostatic charge of the scaffold concur 
in neuritic development and extension. In our case, the stiffness of 1% CHITO microbeads was found to 
be comparable to that of brain tissue (figure 4.25D). A difference in the stiffness, among 1% and 2% 
CHITO microbeads, was observed and could be attributed to the increase in the concentration of CHITO, 
corresponding to an increase in the density of the polymeric chains. Therefore, higher ionic interactions 
between the CHITO chains seem to be quite predictable, as the concentration of chitosan increased from 
1% to 2% [196]. Besides, as shown by water content result, microbeads with lower concentration of 
chitosan have a higher content of water which consequently caused a decrease in stiffness [197] However, 




remarkable and it is logic to state that the increase in the ionic interactions is the main mechanism for the 
stiffness growth.  
Finally, AFM revealed darker areas on the surface, which might represent holes whose apparent 
dimensions are in agreement with data obtained by TEM (figure 4.28C). These characteristics combined 
with bioaffinity of CHITO, due to the presence of primary amines, contributed to the formation of a 
dense neuronal network onto CHITO microbeads. 
 
 4.5.2 Characterization of 3D neuronal networks on CHITO microbeads 
The experimental design of this study was partially inspired by the results of a previous work in which a 
scaffold made by glass microbeads was used [187]. Indeed, to allow a direct comparison of results 
deriving from the use of CHITO and glass microbeads, CHITO microbeads were pre-treated with a.p. 
and employed as 3D support for cell attachment and growth. 
The immunocytochemistry and confocal microscopy characterization allowed us to gain information on 
(i) the morphology of the 3D structure of mature neuronal networks after 24 days of culture and (ii) the 
distinct features of the two cell populations dissected from hippocampal rat brain tissues, namely neurons 
and glial cells. 
Regarding cell morphology, the neuronal somata were found to be round, like the ones observed in the 
brain tissue. The ability of CHITO microbeads to maintain the in vivo cell morphology was already 
reported by Garcia-Giralt et al., who studied their interaction with human chondrocytes [198]. 
This result underlines that the combination of different factors, including substrate stiffness, 3D 





The scaffold topography, characterized by confocal microscopy, showed that while the micro-scale 
dendritic extensions were distributed on the external surface of the CHITO microbeads, the nano-scale 
ones tended to penetrate the hydrogel, contributing to the formation of a compact structure. 
This speculation was confirmed by TEM analysis, which allowed to understand in depth the micro- and 
nano- structure of the neuron-microbeads assembly. TEM micrographs (figure 4.28) clearly support the 
data obtained by confocal microscopy, putting in evidence that CHITO microbeads are enveloped in a 
dense network of neural dendrites and axons. At the same time, we had the evidence that smaller 
dendrites are allowed to enter and spread inside the CHITO microbeads, proving its porosity to neural 
dendrites. 
The astrocyte glial fraction also proliferates on CHITO microbeads and its morphology was again similar 
to the one found in brain tissue (i.e., having a thin morphology and expression in GFAP). This 
observation was already reported by others [199-201] for 3D in vitro cultures, thus suggesting a substrate-
induced morphological dependence. Interestingly, also the morphology of glial cells cultured onto 
CHITO film was found to be stretched (figure 4.30). 
In the meanwhile, glial cells and the natural ECM, spontaneously produced by the neurons network in 
culture, were responsible for the assembly of the microbeads after four-weeks in culture. In order to 
verify the presence of natural ECM, we assessed the formation of perineuronal net-like structures in our 
culture systems using WFA. 
Finally, it is worth mentioning that no evident differences between the microbeads made by CHITO at 
1% compared to those at 2% were observed in terms of neuronal morphology and distribution of the 






 4.5.3 Functional characterization of 3D neuronal networks on CHITO microbeads 
Regarding the electrophysiological characterization, after 21 DIVs, the 3D neuronal networks developed 
onto CHITO microbeads presented electrophysiological patterns similar to the ones observed for the 
glass microbeads in terms of the percentage of random spiking and bursting behavior. As already 
observed by Frega et al [187] in the case of glass microbeads, the percentage of random spiking of the 
3D CHITO networks presents higher values than those observed in 2D cultures. Here we found a further 
increase of random spiking with respect to the 3D glass microbeads networks. Moreover, we observed 
that 3D CHITO 1% networks show more synchronous bursts (MBR, NBR), with respect to 3D CHITO 
2% with associated longer duration for both bursts and network bursts. This activity indicates the 
formation of a very dense network with a high degree of connectivity as also suggested by the 
immunostaining for Synapsin (figure 28C right) and for MAP-2 (figure 4.30). Therefore, the 3D CHITO 
model presents possible advantages that would merit further investigations: (i) stiffness similar to the 
living brain tissue; (ii) no need for pre-treatment with a.p.; (iii) high-level of connectivity; (iv) in vivo 
like electrophysiological behavior. 
From the other side, it should be considered that the number of active electrodes was significantly lower 
in the case of CHITO microbeads based 3D cultures. This was due to a lack of contacts between the 
substrate and the 3D assembly. Neurons were partially transferred onto the surface of the overhanging 
3D assembly because of the higher bioaffinity of CHITO than the MEA surface. Moreover, it should be 
considered that we observed a stable assembly between CHITO microbeads and cells only after the first 
week in culture. Therefore, the mechanical stresses caused by replacements of the medium in the first 
week of culture might have contributed to the displacement of the 3D assembly. 
Arrays of 3D microelectrodes ad hoc designed would provide easier physical integration with the culture 




     4.6 Conclusions 
Chitosan microbeads based scaffolds were specifically optimized and adapted in order to be integrated 
onto planar MEAs to study and better understand the functional properties of biomimetic 3D 
hippocampal networks. Two types of chitosan microbeads were tested and both of them proved to be 
reliable supports, able to sustain the neuronal population during the growth in a 3D space. At the same 
time, the chitosan microbeads guaranteed both a morphological and structural development of a 
functional network. In conclusion, CHITO seems to be a promising scaffolding-support for developing 
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5.1 Biodegradation of chitosan 
Porous scaffolds play a critical role in providing successful regeneration by acting as a three-dimensional 
(3D) template to carry nutrients/metabolites and promote matrix deposition along with the concomitant 
removal of waste and products [202].  The controlled degradation of hydrogel scaffolds is an important 
physical parameter in tissue engineering. Hydrogels used for implantation must degrade at a rate that is 
compatible with the desired function, into non-toxic products that can be easily cleared from the body, 
leaving healthy tissue post degradation [203]. Biodegradation of a scaffolds aimed at tissue engineering 
is also a complex phenomenon, the rate of which is dependent on several intrinsic and morphological 
factors such as pore size, pore morphology, surface area, hydrophilicity and porosity percentage and it 
affects cell vitality, cell growth, and even host response [205]. The rate of degradation should be ideally 
tailored to be inversely proportional to the rate of new regenerated tissue [204]. Once implanted in the 
body, a scaffold should maintain mechanical properties and structural integrity until the loaded cells 
adapted to the environment and excrete sufficient amount of extracellular matrix, etc.; on the other hand, 
after the scaffold accomplishes its mission, it could be completely degraded and absorbed by the body, 
leaving no trace [206]. Chitosan has been shown to be degraded in vivo, mainly by enzymatic hydrolysis.  
Lysozyme (EC 3.2.1.17) is the main enzyme responsible for the in vivo chitosan degradation. The enzyme 
exists in various forms within the fluids of the human body and in tissues, with a concentration from 4 
to 13 mg / L in serum and from 450 to 1230 mg / L in tears [207]. Chitosan degradation is closely related 
to the degree of deacetylation (DD). When the degree of deacetylation is high (DD> 85%) degradation 
slows down and can last for months in vivo; vice versa if the degree of deacetylation is lower, the 
degradation increases [207]. Recent studies have shown that the degradation of chitosan films placed in 
solution with lysozyme can be controlled by N-acetylation based on measurements of weight loss [202]. 
Chitosan can be degraded by enzymes that hydrolyze the glucosamine-glucosamine (GlcN-GlcN), 




(GlcNAc-GlcNAc) bonds [209-211].  Enzymatic degradation of chitosan scaffolds coupled with 
neuronal cultures (neurons and glia), by lysozyme, has led to negative outcomes inducing the lost of their 
functionality and the degenertion of the neuronal networks. This result suggests that other enzymatic 
degradation methods must be adopted, by using other types of enzymes.  As it is reported n literature, 
chitosan can be degradate by chitinases and chitosanase. Chitosanase (EC 3.2.1.123) is the enzyme that 
hydrolyzes the glycosidic bonds β (1-4) of chitosan. The degradation products are called oligosaccharides 
which could be converted into mono-saccharides by β-Glucosidase (EC 3.2.1.21), [212,213].  
 
5.1.1 Chitosanases 
Chitosanases are specific enzymes, related to the class of hydrolases, able to hydrolyze chitosan. 
Chitosanases belong to the GH5, GH7, GH8, GH46, GH75 and GH80 families. In 2004 the "Enzyme 
Nomenclature Committee" defined the chitosanases (EC 3.2.1.132, Chitosan N-
acetylglucosaminohydrolase) as the enzyme capable of carrying out endo (1 - 4) endohydrolysis between 
the residues GlcN (glucosamine) of chitosan partially acetylated starting from the ends [214,215]. 
Chitosanases are produced by plants and microbes, in which they play an important role in nutrition and 
defense.  Chitosanases can be divided into: 
• Bacterial chitosanases: obtained through different bacteria such as Bacillus, Serratia, 
Janthinobacterium, Paenibacillus and Streptomyces.  
• Fungal Chitosanase: there is not much information about this type of chitosanase, however it has 
been observed that some chitosanases are produced by fungi such as Aspergillus, Gorgronella, and 
Trichoderma; 
• Cyanobacterial Chitosanase: this is an extremely different group of photosynthetic prokaryotes that 
exhibit different physiological, morphological and developmental characteristics; 




Chitosanases are classified into three distinct subclasses: 
1. Subclass I: act on both the GlcN-GlcN and the GlcNAc-GlcN bonds, figure 5.1; 
2. Subclass II: act only on the GlcN-GlcN bonds (most common and most constant properties), figure 
5.2; 
3. Subclass III: act on the GlcN-GlcN and GlcN-GlcNAc bonds; 








Figure 5.2 Catalytic action of the chitosanase of subclass II 
 
In this study, chitosanase derived from "Streptomyces coelicolor" (belonging to the GH46 family of 




degradation and a second phase of slower degradation [216]. In the rapid phase the GlcN-GlcN bonds 




Figura 5.3 Structure of GH46 (reprinted from Shoko Shinya et al. [215]) 
 
The difference between chitinases (EC 3.2.1.14) and chitosanases is that chitinases are able to act on 
chitosan with different degrees of deacetylation (preferring the more acetylated chitosan) while 
chitosanases act on chitosan whit high degree of deacetylation [217-219]. The catalytic activity of 
chitosanases is influenced by the following factors: 
• degree of deacetylation 
• viscosity 
• concentration of the chitosan solution 
• type of acid used to dissolve chitosan 
• concentration of the enzymatic solution 





The activity of chitosanase can be determined by measuring the viscosity reduction of the substrate, or 
by quantitatively estimating the reduced sugars produced by the chitosan substrates, [220]. The 
biochemical properties depend mainly on the source of the enzyme, [220-222]: 
• Molecular mass: many chitosanases have an apparently low molecular mass which is in the range 
of 20 and 75 kDa; 
• pH and optimal temperature: the optimal pH of chitosanases is between 4 and 8. The temperature 
range is from 30 ° C to 60 ° C. Many chitosanases in nature are thermolabile, however there are 
also those thermostables that have greater advantages in industrial applications thanks to the fact 
that high temperatures can accelerate reactions, decrease viscosity and increase the solubility of the 
raw material. The chitosanases thermostable at higher temperatures also allow to dissolve the 
chitosan when it is found in higher concentrations; 
• Structure of the enzyme. The structure of the chitosanase derived from Streptomyces shows a length 
of about 55 Å and a secondary structure composed of 10 α-helices and 3 β-sheets. The surface of 
chitosanase is dominated by the appropriate electronegative slit to bind a positively charged 
substrate, while the analogous chitinase cleft is considerably neutral.  
 
The degradation products of chitosanases are the COSs (chito oligosaccharides) which differ from the 
native form of chitosan due to molecular weight and solubility in water, thanks to short chains free from 
amino groups. In addition to having low molecular weight and being soluble in water, the COS possess 
bio functional properties much larger than those of chitosan, such as antimicrobials, antioxidants, lower 
blood cholesterol, lower blood pressure, have a protective role from infectious agents and increase the 







Cellulose is one of the most important polysaccharides on earth, and is the main structural component of 
plants. It consists of a large number of glucose molecules (from about 300 to 3000 units) joined together 
by a β (1 - 4) glyosidic bond [223]. Cellulases are enzymes that belong to the family of hydrolases that 
catalyze the hydrolysis of the 1,4-β-D-glyosidic bonds of cellulose and cereal β-D-glucans. There are 5 
classes of cellulases and the sequential action of these enzymes leads to the degradation of the 
polysaccharide (cellulose) in simple glucose subunits. 
First, the Endocellulases break the bonds of the crystalline structure by exposing the individual chains. 
Then, the Esocellulases intervene which take (always through hydrolysis) from 2 to 4 units giving rise 
to: 
• Tetrasaccharide 
• Trisaccharides (Cellotriose) 
• Disaccharides (Cellobiose) 
Finally, Cellobiasis or β-Glucosidases, further hydrolyse the products forming single glucose 
monosaccharides. 
 β-glucosidase (β-D-glucoside glycosolase; EC 3.2.1.21) may have different origins: bacteria, animals 
and plants.  
 
 




It shows high specificity to break up the β-glycosidic bonds that combine glucosides and disaccharides. 
Different forms of β-Glucosidase also the purification method. The most used β-Glucosidase in the 
degradation studies, is the one derives from the emulsin of almonds thanks to the simple extraction 
method. It has also been observed that the β-Glucosidase that originates from the almond emulsin has a 
small activity of hydrolysis on the chitin substrates, thanks to the presence of a dose of chitinase. Chitosan 
can be degraded by enzymes belonging to the chitinase and chitosanase families. However, chitinases 
and chitosanases are very expensive enzymes, and for this reason not commonly used in commercial 
application.  So, many studies and experiments were carried out to validate the partial catalytic activity 
β-Glucosidase in the degradation of chitosan with different molecular weights and different degrees of 
deacetylation [210]. Almost all β-Glucosidases have more or less the molecular weight in a range from 
55 to65 kDa and the pH optimum is between 5-6. 
β-Glucosidase is also used in the synthesis of glucosides, shows potential applications in the 
pharmaceutical, cosmetic and detergent industries, it is also used as an aromatization of fruit and wine 
juices and intervenes in the biosynthesis of oligosaccharides. 
 
5.2 Aims  
The aim of this study was to define a protocol for the enzymatic degradation of chitosan –based 
microbeads scaffold for 3D hippocampal cultures. The degradation protocol was defined starting from 
studies reported in the literature: Chitosanase is the enzyme with the greatest catalytic activity on 
chitosan, while β-Glucosidase is an enzyme able to hydrolyzing only the disaccharides. For this reason, 
firstly, the chains of chitosan should be partially degraded by chitosanase, secondly they can be 





    5.3 Materials and methods  
The protocol for the production of 2% CHITO microbeads and the preparation of a 3D neuronal cultures 
is reported in Chapter 4. 
 
5.3.1 Optical microscopy  
An inverted IX-51 Olympus microscope equipped with a DP70 digital camera coupled with CPlan 10X 
N.A. 0.25 PhC objective was used to acquire contrast phase images of CHI microbeads coupled with 
neurons. An Olympus BX-51 upright microscope was used for immunofluorescence evaluation of the 
biological samples and the image acquisition was done with a Hamamatsu Orca ER II digital cooled 
CCD camera driven by Image ProPlus software (Media Cybernetic). 
 
5.3.2 Degradation protocols 
The first protocol involved the application of two enzymes to 25 µl of 2% CHITO microbeads 
suspended in 250 µl of culture medium. The degradation test involves three phases: 
• Phase 1 (day 1): addition of the first dose of Chitosanase enzymatic solution (50 µl, 1 U / ml) to 
the microbeads suspension. 
• Phase 2 (day 2): change of culture medium and addition of the second dose of Chitosanase (50 
µl, 1 U / ml) to the microbeads suspension. 
• Phase 3 (day 3): change of culture medium and addition of β-Glucosidase dose (50 µl, 1 U / ml) 




This protocol was applied also to neuronal cells cultured for 5 days to check if the enzymes trigger cell 
toxicity. 
The second protocol foreseesed to put for 19 days CHITO micorbeads in incubator at 37 ° C and then 
exposed them to the ap two enzymes solutions. The addition of the enzymes at DIV 19 is dictated by the 
fact that the formation of the neuronal network occurs over a period of 19 - 21 days, only after that the 
degradation of the scaffold could start. The degradation test involves three phases: 
• Phase 1 (day 1): 25 µl of microbeads suspended in 250 of culture medium and placed in an 
incubator at 37 ° C for 19 days 
• Phase 2 (day 19): addition of the dose of enzymatic solution of Chitosanase (50 µl, 1 U / ml) to 
the microbeads suspension. 
• Phase 3 (day 20): addition of the 50 µl of β-Glucosidase enzyme solution (1 U / ml) to the 
microbeads suspension. 
Finally, in order to evaluate scaffold degradation in cell culture, a preliminary study was conducted to 
verify the toxicity of the two enzymes for neuronal cells. The first protocol defined in the previous 
paragraph was applied directly onto a 2D neuronal culture and onto a 3D neuronal culture on chitosan 
microbeads scaffold. To demonstrate if the exposure to the enzyme triggers has a toxic effect on the 
neuronal cells, the first dose of Chitosanase was added at DIV 5 and maintained in culture for 24 days. 
 
5.4 Results 
Two different concentrations of chitosanase enzymatic solutions (0.5 U/ml and 1 U/ml) were evaluated 
to define the best concentration for the degradation of CHITO microbeads. In the first case, 25 µl of 






Figure 5.5 Optical images of 2% CHITO microbeads exposed to 25 µl of Chitosanase solution at (0.5 U/ml). A) 0h, B) 6h, 
C) 24h, D) 48h, E) 6 days. Scale bar: 100 µm. 
 
Then, 25 µl of CHITO microbeads were suspended in 31 µl of enzymatic solution at 1 U/ml, figure 5.6. 
As can be seen in the figures 5.5 and 5.6, both concentrations of chitosanases determined the degradation 
of CHITO micorbeads. In particular, a completly degradation was observed after 24h h by the activity of 
chitosanase at 1 u/ml, figures 5.6A-E. From this results, all the experiments were carried out by using 




Figure 5.6 Optical images of 2% CHITO microbeads exposed to 25 µl of Chitosanase solution at (1 U/ml). A) 0h, B) 6h, C) 
24h, D) 48h, E) 6 days. Scale bar: 100 µm. 
 
25 µl of CHITO microbeads were suspended in 300 µl of culture medium were exposed at three different 
combinations of Chitosanase and β-Glucosidase solutions. The first experiment involved the addition of 




added. After 48 h, 50 µl of β-glucosidase were added to the microbeads suspension, figure 5.7A (1-5). 
In the second experiment, the first steps are the same of the first experiment but after 48h, the microbeads 
suspension were exposed at 50 µl of β-glucosidase are added + 25 µl of Chitosanase solution., figure 
5.7B (1-5). Finally, the third experiment involves the addition of 25 µl of Chitosanase + 25 µl of β-
Glucosidase at 1 U / ml. As in experiment 1, the culture medium is changed every 24 h and degradation 
is monitored up to 72 h, figure 5.7C (1-5). 
 
 
Figure 5.7 Optical images of 2% CHITO microbeads treated following the first protocol in three different conditions at the 
last step of the protocol (A) β-glucosidase (50 µl), (B) β-glucosidase (50 µl) + Chitosanases (25 µl), (C) β-glucosidase (25 





Images of CHITO microbeads trated following the first protocol, are showed in figure 5.7 It is possible 
to observe a degradation of micorbeads at different time points for all three experiments. The best result 
is observed whit the combination of 50 µl β-Glucosidase and 25 µl of Chitosanase as the last step. 
The first experiment of the second protocol involved the addition of 50 µl of β-Glucosidase enzyme 
solution at 1 U/ml to the microbeads in the medium, figure 5.8A (1-5). For the second experiment, 50 µl 
of Chitosanase enzymatic solution was added immediately to the microbeads suspension. After 24h in 
incubator, 50 µl of β-glucosidase solution was added, figure 5.8B (1-5). Instead, the third experiment 
involved the combination of both enzymes, 25 µl of β-glucosidase + 25 µl of Chitosanase added to the 
microbeads suspension, figure 5.8C (1-5). 
 
 




(A) only β-glucosidase (50 µl), (B) Chitosanases (50 µl) and then β-glucosidase (50 µl), (C) β-glucosidase (25 µl) + 
Chitosanases (25 µl ), at different time points 1) 0h, 2) 6h, 3) 12 h, 4)24 h an 5) 48h. Scale bar: 100 µm. 
 
In order to evaluate the cytotoxicity of the Chitosanase solution on primary neuronal culture, 50 µl of 
Chitosanase solution (1 U/ml) was added directly onto 2D culture. The addition of Chitosanase’s enzyme 
solution to 1 U/ml did not trigger a toxic effect on neurons and onto the neuronal network, figure 5.9. 
 
 
Figure 5.9 Optical images of 2D neuronal network. A) 2D neuronal culture not exposed to enzymicatic solution; B) 2D 
neuronal culture immediately after the exposition to the enzymicatic solution; C) 2D neuronal culture exposed to 
enzymicatic solution after 20 DIV. Scale bar: 50 µm. 
 
The last experiment involved the addition of 50 µl of Chitosanase (1 U/ml) to 3D neuronal network 
developed on CHITO microbeads scaffold after DIV 19, figure 5.10. The enzymatic solution was added 
every time that the culture medium was changed. Only after the third change of medium, it was possible 






Figure 5.10 Optical images of 3D neuronal networks on CHITO microbeads based-scaffold exposed to enzymes solutions: 
A) not exposed to enzymicatic solution, B) 24h after the exposition to the enzymicatic solution, C) 48h the exposition to the 
enzymicatic solution and D) 72 h the exposition to the enzymicatic solution. Scale bar: 100 µm. 
 
5.5 Discussion 
For the first protocol, the percentage of not degraded microbeads was decreased very rapidly in the first 
12 hours, with a further decrease from 57% of intact microbeads to 23%, especially after the addition of 
the second dose of Chitosanase, figure 5.11, red line. Adding the β-Glucosidase after 48 h, a further 
17% decrease is observed. The addition of only 25 µl of Chitosanase determined a slow degradation. The 
addition of only the mix solution didn’t show any improvements in the degradation. Observig the black 
line, it can be deduced that the addition of a mix of β-Glucosidase and Chitosanase had an inhibitory 
effect on degradation. This effect is probably due to insufficient activity of β-Glucosidase. As described 
in the section on β-Glucosidase, it is an enzyme that intervenes in the hydrolysis of cellulose, which 





Figure 5.11 Time dependence of the effects of Chitosanase and β-Glucosidase solutions on CHITO microbeads. 
Microbeads were exposed for 12, 24, 48, 72hr and the number of the microbeads not degraded was measured. Results show 
the effect of 50 µl of chitosanase solution after 24h and 50 µl of β-Glucosidase solution after 48h (blue line), 25 µl of 
chitosanase solutions after 24h and 50 µl of β-Glucosidase solution after 48h (red line), and chitosanase + β-Glucosidase 
solution after 48h (black line). 
 
As it is reported in literature, in general cellulose is degraded by the hydrolysis of cellulase, an enzyme 
composed of three sub-enzymes: 
• Exo glucanase or cellobiohydrolase (CBH I - CBH II) 
• Endo glucanase 
• β-Glucosidase  
The exo glucanases produce the cellobiose, which is the same inhibitor of CBH I and II, when it is 




into monosaccharides, [225]. It is therefore assumed that β-Glucosidase added to Chitosanase inhibits 
the degradation of microbeads by Chitosanase. Therefore, to have an almost total degradation, it is 
necessary to add the Chitosanase first, which has a greater catalytic effect on the chitosan and only after 
48 h, add the β-Glucosidase, which, as known from the literature, hydrolyses only the beta glycosidic 
bonds in disaccharides.  
 The second protocol, firstly, foreseesed to put in incubator CHITO micorbeads suspended in 
medium culture for 19 days. After that, CHITO microbeads were exposed to different enzymatic solution: 
forthe first experiment the starting solution was β-Glucosidase solution, for the second and the third 
experiment 50 µl Chitosanase solution. With the second protocol only β-Glucosidase solution (pink line) 
had not catalytic effect on the CHITO microbeads, due to its inabilityto hydrolyse the (1-4) glycoside 
bonds in the disaccharides. 
 
Figure 5.12 Time dependence of the effects of Chitosanase and β-Glucosidase solutions on CHITO microbeads after 19 in 




measured. Results show the effect of the only 50 µl of β-Glucosidase solution (pink line), 25 µl of chitosanase + 25 µl of β-
Glucosidase solutions after 24h (red line), and 50 µl of β-Glucosidase solution after 24h (blue line). 
 
The degradation of chitosan with the addition of only β-Glucosidase could occur in the case of a very 
high concentrations of enzymatic solution. In accord of the results obtained, the microbeads suspension 
was fisrtly exposed to chitosanase and then to the chitosanase- β-Glucosidase mixed solution after 24 h 
for the first enimatic exposure. In the first 12 hours there was a greater catalytic effect due to the 
chitosanase activity, and a further degradation due to the activity of the mix of the two enzymes, figure 
5.12, red line.  The best degradation was observed with the protocol which provided the addition of only 
β-Glucosidase solution after 24h, figure 5.12, blue line. For both these two protocols the completely 
degradation was observed afetr 72h. 
 
5.6 Conclusion 
A new protocol for the degradation of 2% CHITO microbeads was developed and characterized. 
Chitosanase and β-Glucosidase solutions were able to degrade CHITO microbeads in 72 h a 37 ° C in 
incubator.  The best degradtation was observed exposing firstly, the CHITO microbeads at 1 U/ml nd 
then to β-Glucosidase solution.  However, only a partial degradation was observed onto the 3D 
microbeads scaffold seeded with cells, due to the fact that neuronal cells developped a dense network 
around the hydrogel which created obstacle shield for the homogenous diffusion of the enzyme molecules 
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This chapter was adapted from the following publication: 
Sheiki A.et al., “Microengineered Emulsion-to-Powder Technology for the High-Fidelity Preservation 






6.1 Granular hydrogel scaffold 
Granular hydrogel scaffolds has opened new opportunities for overcoming some of the shortcomings of 
bulk hydrogels biomedical applications. These hydrogels, when decorated with physically/chemically 
cross-linkable moieties, provide injectable, soft platforms [225-228] that may mimic the extracellular 
matrix (ECM) while maintaining interconnected micrometersized pores. The injectable microporous 
scaffolds facilitate cell infiltration in vivo without requiring degradation, which significantly reduces 
inflammation and healing time. Accordingly, injectable granular hydrogels have secured an important 
role in accelerated wound healing and tissue regeneration. [227,229,231]. The building blocks of granular 
hydrogels are typically tens of micrometer-sized hydrogel particles physically and/or chemically cross-
linked and suspended in an aqueous phase, such as phosphate-buffered saline (PBS) or cell culture media. 
Challenges associated with the sterilization of aqueous suspensions, the short lifetime of active 
substances in aqueous media, bacterial and viral contamination, reduced long-term stability, and the need 
for having an in-house microfluidic facility to produce fresh beads have limited the broad reach of such 
microfluidic-enabled biomaterials [231,231]. Converting a stabilized hydrogel suspension to a dried solid 
phase may overcome these challenges; however, current efforts for drying colloidal dispersions and 
suspensions mainly rely on solvent evaporation and spray-drying [233], freeze-drying [234,235], 
electrospinning [236], and electrospraying [237], none of which have been able to decently preserve the 
physical and/or chemical properties of the fragile dispersed phase upon rehydration. Importantly, 
cryoprotectants, e.g., polyethylene glycol (PEG), are highly prone to vitrification and have only been 
able to partially protect dispersed phases in a colloidal system during freeze-drying when the freezing 
rate is low and/or the concentration of the additive is very high, e.g., 40 wt % (14). Accordingly, fragile 




can recover all physicochemical properties when rehydrated. Furthermore, separating the dispersed phase 
of emulsions, particularly when the particle size is small, has been extremely cumbersome [1238,239]. 
 
6.2 Aims   
We introduce a novel, facile technology for the ondemand conversion of water-in-oil emulsions to fine 
powders with completely preserved molecular, colloidal, and bulk properties. We introduce the 
microengineered emulsion-topowder (MEtoP) technology to inhibit the aggregation and permanent 
deformation of dispersed phase drops or hydrogel particles undergoing harsh deep-freezing and low-
pressure lyophilization via use of a heat-conductive, volatile oil as a continuous phase. We first convert 
two model microgel particle systems, gelatin methacryloyl (GelMA), to uniformly sized droplets-in-oil 
emulsions, followed by physical/chemical cross-linking to form hydrogel microbeads. Subsequently, we 
show that in contrast to the conventional lyophilization of hydrogel microbeads once phase transferred 
to an aqueous continuous phase, which produced permanently clumped polymer aggregates with lost 
functionality, the MEtoP technology is able to convert the microgels into dried and disaggregated fine 
particles that can be successfully resuspended in an aqueous medium. Once resuspended, the particles 
can regenerate their shape, size, and chemical functionality with no difference from freshly manufactured 
particles.   
 
6.3 Materials and methods  
Materials 
Silicon wafers were purchased from University Wafer (MA, USA), negative photoresist was from KMPR 
1050, MicroChem Corp. (MA, USA), and the microfluidic chips were fabricated using 




MI, USA). The microfluidic tubing was 1569-PEEK Tubing Orange 1/32" OD x .020" ID (IDEX Corp., 
IL, USA) and Tygon Flexible Plastic Tubing 0.02" ID x 0.06" OD (Saint-Gobain PPL Corp., CA, USA). 
The microfluidic device was treated with Aquapel® Glass Treatment (Pittsburgh Glass Works LLC, PA, 
USA). 3M™ Novec™ 7500 Engineered Fluid (Novec 7500 oil) was purchased from 3M (MN, USA). 
Photoinitiator 2-hydroxy-1-(4-(hydroxyethoxy)phenyl)-2-methyl-1-propanone (Irgacure 2959), gelatin 
from porcine skin (type A, 300 bloom), methacrylic anhydride (MA, 94%), 1H,1H,2H,2H-perfluoro-1-
octanol (97%), and fluorescein isothiocyanate (FITC)-dextran (500 kDa) were provided by Sigma-
Aldrich (MO, USA). Milli-Q water (electrical resistivity ~ 18.2 MΩ cm at 25 °C) was from Millipore 
Corporation. Dialysis membranes (molecular weight cutoff ~ 12-14 kDa) were purchased from Spectrum 
Lab Inc (CA, USA). Cover slips (No. 1) and VistaVision™ Microscope Slides (Plain 3” x 1”) were 
provide by VWR (PA, USA), and microscope glass slides (18 mm x 18 mm x 300 µm) were purchased 
from Fisher Scientific (PA, USA). Pico-Surf™ 1 (5% (w/w) in Novec™ 7500) was provided by Sphere 
Fluidics Inc (Cambridge, UK). Dulbecco's phosphate-buffered saline (DPBS) solution (1X) was from 
Gibco (NY, USA).  
Methods 
6.3.1 Microfluidic device fabrication 
 To generate uniform-sized spherical microbeads, a high-throughput microfluidic water-in-oil emulsion 
method [240-242] was modified and used. Highly parallelized step emulsification devices were 
fabricated as previously reported [1243] using standard soft lithography techniques. Master molds were 
fabricated using a two-layer photolithography process. Mechanical grade silicon wafers (4 in) were 
sequentially layered with photoresist (32 um KMPR 1025, 160 um KMPR 1050) and patterned using 
standard photolithography techniques. At a ratio of 10 to 1, the PDMS base and the curing agent were 




(65 °C for >4 h). The PDMS device was detached from the mold and perforated (0.8 mm holes) at the 
inlets and outlets. To seal the microchannels, both the device and a glass slide were activated via air 
plasma for 40 s (PLasma Cleaner, Harrick Plasma, NY, USA) and bonded together. To render the channel 
surfaces fluorophilic, the device was treated with Aquapel, followed by washing with the Novec 7500™ 
oil.  
 
6.3.2 GelMA synthesis 
Gelatin type A was modified with a high degree of methacryloyl substitution to synthesize GelMA 
following our previous protocols [244,245]. Briefly, 10 g of gelatin was dissolved in 100 mL of warm 
DPBS (50 °C), followed by the dropwise addition of 8 mL of MA while stirring the solution at 240 rpm. 
This resulted in a turbid biphasic mixture, which was allowed to react by stirring for 2 h at 50 °C. This 
condition prevents protein hydrolysis [246]. Upon completion of reaction duration, excessive DPBS was 
added to the mixture to stop the reaction. The mixture was then loaded in the dialysis membranes and 
stirred in DI water (40 °C) for at least seven days to remove methacrylic acid and other impurities. The 
result of dialysis was a clear GelMA solution, which was lyophilized and stored in room temperature 
before using for microgel fabrication.  
 
6.3.3 GelMA bead fabrication 
Freeze-dried GelMA was dissolved in a mixture of DPBS and the photoinitiator (0.5% w/v, Irgacure 
2959) at 80 °C for ~20 min to yield GelMA solutions (7-20 % w/v). These solutions provided the 
dispersed (aqueous) phase in the high-throughput microfluidic device, which were injected in the 




the microfluidic device using syringe pumps (Harvard Apparatus PHD 2000, MA, USA) to form 
surfactant-stabilized 100 µm beads of GelMA in the engineered oil (continuous) phase. The microfluidic 
setup including the syringes and tubing were maintained at 37-40 °C to avoid GelMA sol-gel transition 
and device blockage. A microcentrifuge tube was used to collect the bead suspension in oil and store at 
4 °C.  
 
6.3.4 Microengineered emulsion-to-powder (MEtoP) technology 
MEtoP technology is based on protecting the dispersed phase of an emulsion to preserve its physical and 
chemical cues during harsh freezing and lyophilization procedures. In our experiments the interface of 
dispersed (aqueous) phase is stabilized using an engineered oil (Novec™ 7500) including a surfactant 
(Pico-Surf™). The oil is highly heat conductive, volatile, and has a low freezing point. The oil/surfactant-
stabilized aqueous phase is deep frozen (e.g., at -80 °C and/or -196 °C) and transferred to a lyophilizer 
(Labconco FreeZone Benchtop Freeze Dry System) to sublimate the ice and remove the volatile oil under 
vacuum (e.g., 0.06 mbar) for at least 6 h. This process results in a one-step conversation of emulsions to 
powders made up of microengineered particles with preserved properties 
.  
6.3.5 Conventional lyophilization of hydrogel microbeads 
The hydrogel microbead-in-oil emulsions were pulse centrifuged (6300 rpm, 10 s, GmCLab mini 
centrifuge, Gilson, France), and the excess oil was removed using a pipette. To break the emulsion, a 
perfluorooctanol solution (20%) in Novec™ 7500 oil was added to the bead suspension (1:1 volume 
ratio), which removed the surfactant. The GelMA beads were always maintained at 4 °C and the PEG-




(GelMA) or chemically-crosslinked (PEG-VS) microbeads were pulse centrifuged and the supernatant 
was removed. The beads were transferred to another microcentrifuge tube using a positive-displacement 
pipette (MICROMAN® E, Gilson, WI, USA) and always maintained in DPBS. The tubes were frozen 
at -80 °C overnight, followed by lyophilization at ~0.06 mbar bar for at least 24 h. The process was 
conducted in a way that the frozen samples never melted and always remained frozen until competing 
the ice sublimation process.  
 
6.3.6 Beaded hydrogel powder imaging and rehydration  
Powders were transferred onto a cover gas and imaged using a camera (Axio cam 503 mono, 60N-C 1” 
1,0X). The microstructures of powders were visualized using dark or bright filed microscopy (Axio 
Observer 5, Zeiss, Germany). The rehydration (swelling) of powder GelMA beads was investigated by 
suspending them in cold DPBS (1X, 4°C). Similar experiment was conducted with PEG-VS at room 
temperature. Brightfield microscopy at predefined time intervals was conducted to image the beads and 
measure their size via image analysis using ImageJ (Version 1.52e, National Institute of Health, USA). 
 
6.3.7 Fabrication of beaded GelMA (B-GelMA) scaffolds 
 To evaluate the properties of beads produced using the MEtoP technology and compare them with the 
freshly-prepared beads as well as the conventionally-lyophilized ones, the oil-free microbeads were 
suspended in DPBS (4 °C) containing the photoinitiator (0.5% w/v, Irgacure 2959), followed by pulse 
centrifugation for 10 s to pack the bead at the bottom of container. Using a positive displacement pipette, 
the concentrated microbeads suspension was transferred into a PDMS mold (diameter ~ 8 mm, height ~ 




(360-480 nm, Omnicure, Excelitas, CA, USA) exposure (intensity ~ 10 mW cm-2) for 2 min, yielding 
chemically-crosslinked and possibly annealed microbeads.  
 
 6.3.8 Characterization of GelMA microbeads 
6.3.8.1 Pore size analysis 
Chemically-crosslinked hydrogel scaffolds were incubated in a FITC-dextran solution (15 mM) to fill 
the void space in the scaffolds with the dye. The large molecular size of dextran prevents its diffusion 
into the beads, enabling us to visualize the void spaces. The dye-infused scaffolds were imaged using a 
Leica inverted SP5 confocal microscope (Germany) at the California NanoSystems Institute (CNSI). For 
each sample, 77 z-slices were captured to cover total height of ~150 µm, and at least 3 samples per 
condition were analyzed. Median pore diameter and void space fraction were measured using a custom-
developed Matlab code (Matlab, version 2017b). The stacked images were converted into discrete 
regions using an Reprintedive thresholding, and the void space fraction was calculated based on the voxel 
volume of void space regions. Average pore diameter was calculated based on a previously-published 
method [8].  
6.3.8.2 Mechanical analyses (compression tests)  
Crosslinked beaded GelMA samples (UV intensity ~ 10 mW cm-2, exposure time ~ 2 min) in PDMS 
molds (diameter ~ 8 mm and height ~ 1 mm) were transferred to the Instron mechanical tester (Instron 
5542, Norwood, MA, USA) and compressed at a rate ~ 1 mm min-1. The linear stress-strain region was 






6.3.8.3 Statistical analysis 
Measurements were performed at least in triplicate. The data were reported as mean values ± standard 
deviation. The one-way analysis of variance (ANOVA) was carried out followed by Tukey’s multiple 
comparisons. Statistically significant differences were identified when p-values were lower than 0.05 
(*p<0.05), 0.01 (**p<0.01), 0.001 (***p<0.001), and 0.0001 (****p<0.0001). 
 
6.4 Results 
The principles of MEtoP technology is based on protecting the dispersed phase of an emulsion during 
harsh freezing and lyophilization steps using an engineered oil that (i) has a decent heat conductivity, (ii) 
is easily removed under vacuum during lyophilization, (iii) preferably has a very low freezing point, and 
(iv) is well mixed with a surfactant to stabilize the oil-water interfaces. The heat conductivity of the oil 
(continuous phase) facilitates the deep freezing of the dispersed phase, while the oil remains unfrozen, 
followed by the vacuum-mediated removal during lyophilization. We selected the mixture of Novec™ 
7500 oil with a surfactant (PicoSurf, 0.5 wt%), which satisfies all of our design criteria. Many other oils 
can potentially be used for this purpose. To evaluate the capability of MEtoP technology in converting 
an aqueous dispersed phase to a powder with preserved molecular, colloidal, and bulk properties, the 
uniformly-sized microspheres of hydrogels (e.g., GelMA) were produced using a high-throughput step 
emulsification microfluidic device, shown in Figure 1a, in which varying concentrations of GelMA 
dissolved in an aqueous solution were injected along with the engineered oil mixture (continuous phase) 







Figure 6.1 MEtoP technology to convert microfluidic-enabled hydrogel particle emulsions to powders. A)  parallelized step 
emulsification device was used for the high-throughput fabrication of GelMA polymer microbeads. B) Procedure to convert 
emulsion microbeads in powder. 
 
Droplet generation is driven by a sudden expansion at the end of each of the droplet generation channels. 
As the dispersed phase reaches the end of the channel, the expansion induces an instability that drives 
uniform drop formation [44]. The surfactant-stabilized hydrogel beads were deep-frozen at -80 °C as 
presented in Figure 6.1B, leaving the oil phase as a liquid with a pour (melting) point of ~ -100 °C liquid. 
The partially-frozen samples were transferred to a lyophilizer and maintained under vacuum for at least 
6 h. We have also frozen both the hydrogel particles and the oil using liquid N2, which resulted in the 
formation of all-frozen samples undergoing oil melting within a few minutes during lyophilization. 
Regardless of the freezing method, the MEtoP process results in the formation of fine powders that can 





Figure 6.2 Comparison between the powders produced via the MEtoP technology and conventional freeze-drying. A) 
Schematic of individual beads produced via the MEtoP technology compared to those yielded through the conventional 
freeze-drying. C) The average size of GelMA aerogel beads obtained from the MEtoP technology showing that regardless of 
polymer concentration (7−20%), the bead size is uniform and depends only on the initial microgel size. SEM images of 
GelMA beads post conventional lyophilization (D) and MEtoP processing (E). 
 
In Figure 6.2, the powder generated using the MEtoP technology is compared with the powder produced 
by freeze-drying the GelMA beads once exchanged into an aqueous phase (conventional lyophilization). 
At the macro-scale, the powder that was produced using the MEtoP technology had very fine particles 
as shown in Figure 6.2A, whereas the conventional lyophilization yielded large aggregated clumps. At 
the micro-scale, the dark field optical images of powders show that the microengineered powder was 
made up of extremely fine, segregated particles while the conventional method resulted in the aggregated 




schematically shown in Figure 6.2B. The particle size of bead powders including 7%, 10%, and 20% of 
GelMA, presented in Figure 6.2C, shows that independent of the biopolymer concentration, the dried 
beads have an average particle diameter of ~ 50 µm. This is almost half of the freshly-prepared beads as 
a result of water removal and biopolymer shrinkage. Images of GelMA (7-20%) powders and their 
constituent beads are presented in Figure 6.3.  
 
 
Figure 6.3 Effect of freeze-drying on GelMA microbeads converted to powders via the MEtoP method. Powder GelMA 
obtained from microgels including (A) 7% w/v, (B) 10% w/v, and (C) 20% w/v of polymer. The freezing process was 
conducted (1) at -80 °C followed by 5 min of liquid N2-assisted freezing or (2) without the liquid N2 freezing step.  
 
As can be seen in the figure, there is no significant difference between the powders prepared via an 
extended liquid N2 freezing compared to the ones that were only frozen at -80 °C. Accordingly, even the 
temporary freezing of oil does not have any effect on the outcome of MEtoP technology, attesting to its 
robustness in producing fine, segregated beads. To assess the capability of lyophilized powders in 
recuperating their original shape and size, the time evolution of their diameter upon resuspension in 
DPBS was measured using optical microscopy. Figure 6.4 shows that the dry microbeads produced via 




introducing them into the aqueous phase. The swelling of the microengineered beaded powder completes 
in less than 10 min, resulting in fully swollen beads with sizes similar to the freshly-prepared beads 
(Figure 6.4B). 
Figure 6.4 Swelling recovery of beaded GelMA powders produced via the MEtoP technology compared with the 
conventional method. (A) The swelling time-lapse of powder particles obtained from the MEtoP and conventional methods. 
(B) The diameter of GelMA beads produced via the MEtoP method undergoing swelling in cold DI water versus incubation 
time.  
 In the contrary, the powder produced via the conventional method does not yield individual beads and 
remain permanently aggregated in the aqueous medium. This attests to the promising potential of MEtoP 
in providing an infrastructure for preserving the macro- and microscale properties of lyophilized 
substances. Images of the rehydration of beads produced via the MEtoP technology (with or without the 
liquid N2 freezing step) are presented in Figure 6.5. As can be seen in this figure, the beads regain their 





   
Figure 6.5 Effect of freeze-drying on the swelling recovery of GelMA microbeads prepared via the MEtoP method. Panels 
show the rehydration dynamics of powder GelMA obtained from microgels including (A) 7% w/v, (B) 10% w/v, and (C) 
20% w/v of polymer. The freezing process was conducted with or without liquid N2-assisted post-freezing.  
 
The preservation of chemical cues in photoactive hydrogels, such as GelMA, during MEtoP processing 
was compared with the hydrogels underwent the conventional lyophilization method. To this end, 




active photoinitiator. The resuspended beads were exposed to UV light to initiate the chemical 
crosslinking of methacryloyl or vinylsulfone groups. Figure 6.6B shows the crosslinked scaffolds post-
UV light exposure. The scaffolds that were constructed from the beads produced via the conventional 
method were not able to hold their shape due to the lack of effective bead-bead chemical conjugation. 
Interestingly, the crosslinking of beads prepared via the MEtoP method formed self-standing hydrogel 
constructs, which implies that the photoactivated bead-bead annealing has taken place successfully.  
  
Figure 6.6 Annealing capability of hydrogel beads (GelMA) prepared using the MEtoP technology or conventional 
lyophilization. (A and C) Optical images of hydrogel beads prepared via the conventional method and MEtoP technology.  
(B- D) Exposure to UV light in the presence of a photoinitiator (PI). 
 
The properties of annealed scaffolds were evaluated to investigate the differences between the hydrogels 




macro-scale and micro-scale properties of the annealed scaffolds. Optical images of annealed GelMA 
scaffolds made up of MEtoP beads including 7% (Figure 6.7A), 10% (Figure 6.7B), and 20% (Figure 
6.7C) GelMA show that even at low concentrations of GelMA (i.e., soft beads), MEtoP beads are able 
to form a self-standing hydrogel construct. At the microscale, all these hydrogels are made up of annealed 
microspheres that form a packed structure with permanent micropores (Figure 6.7 (G-I)). Infusing a 
large fluorescent dye (FITC-dextran) in the pores of hydrogels enabled us to image layers of these 
constructs. Figures 7 G-I show examples of z-stacks obtained from confocal microscopy of hydrogels 
constructed from MEtoP GelMA beads with 7%, 10%, and 20% biopolymer, respectively. The images 
were processed using a custom-built Matlab code in which the fluorescent-labeled spaces were filled 
with varying diameters of spheres. The processed void spaces (examples shown in Figures 6.7 J-L from 
70 stacks (height ~150 µm) provided the median pore diameter and void space fraction of annealed 
hydrogels. Figure 6.7M presents the median pore dimeter of hydrogels prepared via crosslinking the 
MEtoP beads (7-20 %) immediately, after 5 min, or after 10 min post-transferring to a PDMS mold. 
Regardless of the GelMA concentration, all the hydrogel samples attain a similar median pore diameter, 
which is almost independent of the incubation time. The pore dimeter of hydrogels fabricated from 
freshly-prepared GelMA microbeads is ~ 20 µm [30], which is almost identical to the MEtoP beaded 
gels. The median pore diameters of beaded scaffolds constructed from the freshly-prepared beads were 
similar to the MEtoP-based scaffolds (~18±2 µm). Figure 6.7N shows the void space fraction of annealed 
hydrogels. Similar to the pore dimeter, the void space is neither affected by the GelMA concentration 






Figure 6.7 Microstructure and mechanical strength of annealed hydrogels obtained from the MEtoP powders. Self-standing 
hydrogels may readily be constructed by annealing resuspended (A) 7, (B) 10, or (C) 20% GelMA beads, obtained from the 
METoP technology. Bright-field images of hydrogels in panels A−C are presented in panels D−F, respectively, which show 
packed structures made up of spherical beads. Two-dimensional (2D) slices of annealed beaded hydrogels obtained from 
confocal fluorescence microscopy show that regardless of the polymer concentrations (G: 7%, H: 10%, and I: 20%), the 
beads are able to make microporous structures. Analysis of 2D slices among the annealed beads with GelMA 
concentrations (J) ∼7, (K) 10, and (L) 20%. (M) Median pore diameter of annealed beaded GelMA scaffolds versus pre-UV 
exposure incubation time. (N) Void space fraction for beaded GelMA scaffolds prepared using varying biopolymer 
concentration and precross-linking incubation time. (O) The compression moduli of beaded scaffolds. pValues lower than 





Such an excellent similarity between the MEtoP-based beaded hydrogels and the freshly-prepared ones 
attests to the unique capability of MEtoP in preserving the original properties of colloidal particles and 
macromolecules undergoing harsh lyophilization. To evaluate the strength of hydrogel constructs, 
compression tests were conducted. Figure 6.7O presents the compression modulus of annealed beaded 
hydrogels fabricated from MEtoP (powder) or freshly-prepared beads. Increasing the biopolymer 
concentrating increases the compression modulus; however, there is no significant difference between 
the compression modulus of beaded hydrogels fabricated from the fresh or MEtoP beads. The 
independency of porosity and void fraction has been shown for the microporous beaded GelMA 
hydorgels prepared from fresh beads [30]. Figures 6.7 M-O show that the MEtoP technology can provide 
powders that can generate swollen microbeads with identical physical and chemical properties to the 
freshly-prepared, never dried microgels.  
 
6.5 Conclusion 
Preserving the physical and chemical properties of macromolecules and colloids post-drying is of utmost 
importance in a broad range of application in order to avoid contamination, to allow stability and a to 
find proprer method for storage and shipment. We have invented a method called the MEtoP 
(microengineered emulsion-to-powder) technology involving the stabilization of a dispersed phase using 
an engineered oil, which acts as a protective layer and preserves the properties of dispersed phase during 
lyophilization. The engineered oil phase is heat conductive and can readily be evaporated, which provides 
a physical barrier among the dispersed phase components while permitting proper heat and mass transfer. 
For the first time, we show that, within a few hours, emulsions can be readily converted to powders that 




to convert functionalized gelatin (GelMA) hydrogel microbeads into finely-separated spherical particles 
































Cells in the body perform bioactivities in response to the stimulation from a highly complex 3D 
microenvironment. Introduction of 3D cell culture approaches, aiming to model the in vivo interactions 
of tissues, has opened new possibilities for morphological and functional characterizations. Hydrogels 
are commonly chosen and adapted for use as support matrices for 3D cell cultures. Many different 
techniques have been used to add microstructure to hydrogels for various biomedical applications. 
The aim of this thesis is to fabricate and characterize biopolimeric microbeads by dripping and 
microfluidic techniques to be applied in soft tissue engineering. To these purpose microbeads should be 
biocompatible, stable, injectable, and should demonstrate desired and predictable degradation kinetics. 
 In particular, in this thesis, microbeads are used as a micro-unit to construct a modular (granular) scaffold 
for soft tissue engineering, focusing on CNS tissue.  
Firstly, the ability of chitosan to favor spontaneous neuronal adhesion is shown; the bioadhesive and 
bioactivity properties lead these material to be considered as an alternative biopolymer to the standard 
and expensive adhesion factors used in neurobiology, supporting a natural development of neuronal cells 
and a homogeneous and highly connected network, reducing laboratory reagents costs. Chitosan 
possesses excellent processability properties to be used by different techniques (spray coating, dip 
coating) for coating thin layers onto any kind of substrates and producing a desired micropattern through 
the use of stencil masks.   
The stability and ability Chitosan microbeads, obtained by dripping technique, to sustain neuronal cells 
are demonstrated. Due to their mechanical properties, porosity, and availability of functional groups, 
these microbeads are a promising scaffold for the development of 3D neuronal networks towards the 
design and implementation of brain-on-a-chip microsystems for research into basic neuroscience and 
drug screening. 
Different protocols for the enzymatic degradation chitosan microbeads have been developed. 




The microbeads can be completely degraded by two enzymes when cells are not present. However, it is 
hard to observe a complete degradation of the 3D microbeads scaffold seeded with cells, due to the fact 
that neuronal cells develop a dense and huge network around the scaffold that tend to create a mask 
which prevent the homogenous diffusion of the enzyme molecules inside the hydrogel. Interestingly, the 
two enzymes do not induce any toxic response onto neuronal networks 
Finally, GelMA microbeads have been obtained by a microfluidic device and an innovative and fast 
method to convert emulsion to powder has been developed. MEtoP (microengineered emulsion-to-
powder) technology is based on the stabilization of the dispersed phase in an engineered oil/surfactant 
continuous phase, followed by the deep-freezing and lyophilization. This technology decreases the risk 
of contamination, degradation, facilitating shipment and decrease processing energy and cost, preserving 
physical and chemical properties of the systems. 
All microbeads based-models proposed in this thesis, offer a higher reproducibility and the ability to 
support cells culture. These granular systems convey further advantages. Microbeads hydrogel fluidize 
when compressed, this is a property known as shear thinning, that increases the injectability property of 
these systems. 
Furthermore, cells can be mixed homogeneously with microbeads enabling the adhesion of the cells 
directly on their surface, this method can avoid the effect of settling following mixing.  The engineered 
microbeads with controlled sizes, monodispersity, diverse morphologies, and specific functions are gain 
an important role in biomedical fields. Microbeads systems could be considered for their shear thinning 
properties as an alternative ink for 3D bioprinters and moreover, could facilitate cell infiltration 
promoting, in vitro vascularization. 
Finally, the microbeads -models developed in this thesis can found application as microsystems to model 
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